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Summary 
y-aminobutyric acid is the major inhibitory neurotransmitter in the adult mammalian 
central nervous system (CNS) and may also play a neurotrophic role during eNS 
development. Diversification of GABAA receptor mediated responses are in part a result of 
variation in subunit composition in the receptor complex. This variation arises both from the 
number of different SUbtypes of GABAA receptor subunits (a 1-6, ~ 1-4, yl-3, 01, P 1-3, e, 
p), as well as from post-transcriptional processes such as RNA splicing. In this thesis, I 
have investigated the developmental onset of GABAA receptor gene expression and the 
distribution and temporal expression of GABAA receptor subunit mRNAs and 12 splice 
variants within the developing and adult murine eNS. 
Preliminary studies using S 1 nuclease protection analysis demonstrated that a I, ~P and 
12 were the predominant subtypes of GABAA receptor subunits expressed at embryonic day 
14 and in the adult murine CNS. In situ hybridisation analysis demonstrated overlapping but 
distinct spatial and temporal patterns of GABAA subunit mRNA expression during postnatal 
development and in the adult murine eNS. Analysis of y2 mRNA splice variants 
demonstrated that the y2S transcript is the predominant y2 mRNA expressed during latter 
stages of embryogenesis, while the 12L transcript is the predominant y2 isoform present in 
the adult eNS. 
Since there is a 29 to 47 percent amino acid identity among the various GABAA receptor 
subunits, I have also demonstrated through site-directed mutagenesis studies, that changes 
in a conserved amino acid in the cysteine loop of the bovine a 1 GABAA receptor subunit 
resulted in a loss of agonist and antagonist binding (DI49N), while a change in a conserved 
amino acid in the Ml transmembrane domain of the bovine al GABAA receptor subunit 
resulted in loss of agonist binding and reduction in the Bmax and Kd for antagonist binding 
(P243A). 'These results are in contrast to the effect of identical mutations in the bovine ~ 1 
subunit and suggest that if the pentameric GABAA receptor assembly is composed of 
EalF2E~NFNEN2F2I then changes in highly conserved amino acids in the al receptor subunit 
would have a greater distortion on the structure of the receptor complex. 
xv 
Chapter 1 
General Introduction 
Chapter 1 General Introduction 
Immense numbers of individual units, the neurons, completely independent, 
simply in contact with each other, make up the nervous system. 
Santiago Ramon y Cajal, Histology of the Nervous System 
1.1 COMMUNICATION 
The ability of the central nervous system to respond to environmental stimuli is 
dependent on an elaborate communication network, within and among the individual 
neurons. Although sharing many characteristics with cells found in other tissues and 
organs, neurons have several specialized features which effect the flow of information 
between cells. These include the axon, specialized for intercellular information transfer, 
the dendrite, a site where signals are often received from other neurons, and the synapse, 
the point of information transfer between neurons (Levitan and Kaczmarek, 1991). 
Electrical signals or action potentials arriving at the pre-synaptic terminals are converted 
into chemical signals through the release of neurotransmitters into the synaptic cleft. The 
neurotransmitters interact with molecules on both pre- and post-synaptic elements of the 
synapse to elicit a series of electrical and/or biochemical signals, which act through 
effector systems to generate a biological response (Figure 1.1). The accurate 
communication of information requires a high degree of specificity, both at the pre- and 
postsynaptic sites. This precision is accomplished by a variety of specialized proteins 
termed receptors. 
When a cell is receiving synaptic input, the processing of information is achieved by 
neurotransmitters, interacting with receptors in the plasma membrane of the neuron, and by 
depolarization or hyperpolarization of the membrane, or via activation of G-protein 
coupled receptor mechanisms. Many of the receptors are associated with pores or channels 
which span the lipid bilayer and allow selective flow of ions at a controlled rate across the 
membrane. These are known as ligand-gated ion channels. Table 1.1 illustrates the ion 
conductance characteristics of various ligand-gated and voltage-gated ion channels and the 
number of transmembrane spanning regions associated with the channel topology. 
1 
Chapter 1 
Receptor 
Effector 
Transport of ions 
or molecules 
Enzyme activation 
or inacti vation 
Protein Synthesis 
Release of 
hormones or 
transmitters 
Biological Response 
General Introduction 
~ Binding (recognition) 
~ Transduction 
~ Ampl if i cat i on 
Figure 1.1 Schematic Model of Ligand-Receptor Interaction 
Extracellular signals, such as hormones, neurotransmitters and drugs, are molecules 
which exhibit selective binding interactions with receptors in the plasma membrane. The 
binding of the molecule, in this example, is coupled with an element which initiates a 
biological response, such as an ion channel. The activation of the ion channel results in 
the flow of selective ions across the membrane, resulting in either depolarization or 
hyperpolarization of the membrane. The biological response is seen in the excitation or 
inhibition of synaptic activity. 
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Receptor Ion Selectivity TMDomains References 
or Channel 
Potassium K+ 6 Miller, 1991 
Calcium Ca2+ 24 Catterall, 1991 
Sodium Na+ 24 Catterall, 1991 
GABAA Cl-, HC03- 4 Schofield, et al., 
1987 
Glycine Cl-, HC03- 4 Langosch, Becker, 
Betz, 1990 
ACh Na+, K+ 4 Galzi, et al., 1991 b 
muscle 
nicotinic 
ACh Na+, K+, Ca2+ 4 Galzi, et al., 1991 b 
neuronal 
nicotinic 
Glutamate Na+,K+, Ca2+ 4 Hollmann, et al., 
non-NMDA 1989 
Glutamate Na+, K+, Ca2+ 4 Wisden and 
NMDA See burg, 1993 
5-HT3 Na+, K+ 4 Maricq, et al., 
1991 
Table 1.1 Ion Selectivity of Transmitter-Gated and Voltage-Gated Ion Channels 
TM domains indicates the number of putative transmembrane spanning domains 
associated with the receptors listed. The receptors listed are associated with ion channels 
which are modulated through a gating mechanism, by an endogenous, extracellular 
molecule or by changes in the membrane resting potential. (Modifiedfrom Barnard, 1992) 
1.2 ION CHANNELS 
The diversity and plasticity of the central nervous system derives not only from the 
different types of receptors and channels found, but also in the developmental regulation, 
alternative and differential expression of the mRNAs, and in the post-translational 
modification of the encoded polypeptides. For every class of ion channel receptor so far 
identified, these factors playa role in the diversity and hence heterogeneity observed 
among the various functional receptor subtypes. This heterogeneity is discussed below for 
the two classes of receptors, with specific emphasis on the GABAA ion channel receptor, 
which is the subject of study in this thesis. 
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The gating mechanisms of ion channels and receptors define two broad classifications: 
1) P-domain ion channels, which are voltage-gated and include potassium, calcium and 
sodium voltage-sensitive receptors and 2) ligand-gated ion channel receptors which 
include neuronal and muscle nicotinic acetylcholine, 'Y-aminobutyric acid (GAB A), 
glycine, serotonin (5-HT3), and glutamate (N-methyl-D-aspartate (NMDA) and AMPA(a-
amino-3-hydroxy -5-methy lisoxazole-4-propionic acid)lkainate). 
1.2.1 P-Domain Channels 
The voltage-gated ion channels are responsible for the generation of action potentials 
in electrically excitable cells (Na+, Ca2+), participate in the regulatory processes in non-
excitable cells (Na+, Ca2+, K+) and control the resting potential and excitability of the 
membrane (K+) (Reviewed by Catterall, 1991). The ion conductance activity of voltage-
gated ion channels is both rapid and highly selective. The gating activity of voltage-gated 
channels is described by two rate processes: 1) activation which determines the rate of 
channel opening and; 2) inactivation which determines the rate of channel closure. 
Voltage-gated ion channels are not directly regulated by known physiological ligands, but 
are targets for numerous neurotoxins, therapeutically useful drugs, and can be modulated 
via second messenger systems. 
1.2.2 Calcium Channels 
Calcium channels (T-, L-, N- P- Q- and R-type) can be distinguished according to their 
voltage dependence, single-channel properties, ionic selectivity and pharmacological 
profiles (Snutch et ai., 1991: Zhang et ai., 1993: Randall & Tsien 1995). The subunit 
composition of the L-type Ca2+ channel from skeletal muscle consists of four different 
subunits, aI, a2-o, p and'Y (Campbell, Leung and Imagawa, 1988; Caterall, Seager and 
Takahashi, 1988). Molecular cloning has determined the complementary deoxyribonucleic 
acid (cDNA) sequences of a subfamily of 0.1 subunit related proteins and 0.2, p, and 'Y 
(Snutch et al., 1990, 1991; Ellis et al., 1988; Ruth et aI., 1989; Jay et al., 1990). 
Expression of functional DHP-sensitive L-type Ca2+ channels is seen in Xenopus oocytes, 
injected with complementary ribonucleic acid (cRNA) from the cloned 0.1 calcium channel 
receptor subunit (Mikami et al., 1989; Biel et al., 1990). The heterogeneity within the 
subfamily of a 1 related proteins (6 genes), and the functional expression in Xenopus 
oocytes, suggest that the a I-subunit is the central functional component of the receptor 
complex. Mutations introduced into single residues of the a 1 subunit lead to dramatic 
alterations in the affinity of calcium channels for calcium ions (Yang et ai., 1993), further 
suggesting that this subunit forms the channel pore. The mRNA of aI-subunits encode a 
protein of 212-273 kD, with four homologous domains, each with six putative a-helical 
transmembrane segments. Rat brain Ca2+ channel a 1 subunits, rbC-l and rbC-Il differ by 
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a three amino acid insert in the putative cytoplasmic loop between domains II and III and 
by a twenty-eight amino acid substitution corresponding to the third transmembrane 
segment (S3) of the fourth domain. These distinct forms of the a 1 subunit are generated 
by alternative splicing and are differentially expressed in the rat CNS (Snutch et ai., 1991). 
Further diversity is introduced by posttranslational proteolytic cleavage (De Jongh et ai., 
1991). The a.l-subunits are present in a complex with the non-membrane spanning ~­
subunit of 55 kD and a glycosylated transmembrane y-subunit of 30 kD. The a 1-, ~JI "(-
complex interacts with a disulfide-linked glycoprotein complex of a2 - and <i-subunits. 
The a2- and (i-subunits derive from a single gene, whose protein product is proteolytically 
cleaved to yield the disulphide-linked a2- and <i-polypetides (De Jongh, Warner, and 
Catterall, 1990). While the a 1 subunits are capable of generating functional calcium 
currents when expressed in isolation, coinjection of a 1 with ~JI y- and a2/<i leads to a 
much greater level of channel expression. The ~ subunit can alter the kinetics and voltage 
dependence of a1 subunits (McClesky 1994). 
1.2.3 Voltage-Gated Sodium Channels 
Voltage-gated sodium channels are large membrane glycoprotein complexes composed 
of a 230-270 kD a-subunit (Agnew et ai., 1980). There are a number of distinct a 
subunits (Suzuki et aI., 1988; Gautron et aI., 1992), and additional diversity is added by 
splice variants (Mandel 1992). Brain and muscle voltage-gated sodium channels also 
contain one to two smaller subunits (Hartshorne and Catterall, 1981; Barchi, 1983). The 
~ 1- (36kD) and ~2J (33kD) subunits are found in the brain and the ~PJ (38kD) subunit is 
found in muscle. The stoichiometry of channels expressed in the brain appears to be 
a~ 1 ~2I with the ~2Jsubunit covalently bound to the a-subunit through a disulphide bridge 
(Hartshorne et al., 1982). Complementary DNA sequences have been identified for the 
Na+ channel a.-subunit from eel electroplax, rat brain, skeletal muscle and heart (Noda et 
ai., 1984, 1986a; Kayano et al., 1988; Trimmer et aI., 1989; Auld et al., 1988; Kallen, et 
aI., 1990; Rogart et al., 1989). From the cDNA sequences the predicted topology of the (1-
subunit resembles the topology described for the Ca2+ channel a-subunit, which is 
composed of four homologous domains with six proposed transmembrane segments per 
domain. Expression of the sodium channel a-subunit in Xenopus oocytes results in 
functional channels, but inactivation rates and gating properties are different from those 
seen in vivo (Trimmer et al., 1989; Auld et al., 1988; Goldin et al., 1986; Noda et ai., 
1986b). Transient expression of a-subunits in mammalian cells gives rise to sodium 
channels with normal physiological properties and normal toxin sensitivity (Catterall, 
Seagar, Takahashi, 1988). These channels can also be phosphorylated by protein kinase A 
and C (Li et ai., 1992; Numann et aI., 1991) leading to functional modulation. 
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1.2.4 Voltage-Gated Potassium Channels 
Four complementary deoxyribonucleic acid (cDNA) sequences of outwardly-rectifying 
potassium channel subunits have been identified in Drosophila and encode channels with 
unique activation and inactivation kinetics (Shal, Shah, Shaker and Shaw) (Butler, et al., 
1989; Wei, et at., 1990; Papazian, et at., 1987; Pongs, et al., 1988; Kamb, Tseng-Crank 
and Tanouye. 1988). Mammalian homologues of these Drosophila genes have been 
identified, as well as subunit variants (Pak, et al., 1991a, 1991b; Frech, et at., 1989; 
Yokoyama, et al., 1989; Roberds and Tamkun, 1991). Diversification and related 
plasticity within a subfamily of potassium channels is best described in the Shaker 
potassium channel gene family in vertebrates and invertebrates. To date there have been 12 
different mammalian Shaker subfamily genes identified. suggesting diversification through 
gene duplication (Rudy et al., 1991; Jan and Jan, 1990). In contrast, only one Shaker 
Drosophilia gene has been cloned. However, the Drosophilia Shaker mRNA can undergo 
multiple alternative-splice events, thus generating a number of gene products (Salkoff, et 
aI., 1992). Like sodium and calcium channels these a. subunits can express functional 
channels in vitro. Recently an auxilliary potassium channel subunit has been cloned. the ~ 
subunit (Scott et al., 1994). Three ~ subunits have been isolated to date (Scott et al., 1994; 
Morales et al .• 1995). 
The topology of the potassium channel is outlined in Figure 1.2. The receptor subunit 
has 6 predicted transmembrane domains, which span the lipid bilayer. The potassium 
channel is more elementary than the sodium or calcium channels. and may be representive 
of an ancestral voltage-gated channel from which these three channels derive (Hille, 1992). 
a. subunits can form ion conducting pores but require the combination of four a. subunits in 
a tetrameric oligomer. The ~ subunit is a cytoplasmic protein that copurifies with pore-
forming subunits. Some Shaker-type potassium channels have a unique inactivation 
mechanism (ball and chain), which has been localized to the first twenty amino acids at the 
5'-terminus, through deletion mutagenesis analysis and peptide replacement experiments 
(Hoshi, Zagotta and Aldrich. 1990). An alternative method of inactivation involves the ~ 
subunit (Rettig et al., 1994). The presence of ~ subunits can convert non-inactivating a. 
subunits into inactivating subunits. The hyperkinetic locus in Drosophila codes for a 
potassium channel ~ subunit (Chouinard et ai., 1995). 
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Figure 1.2 Membrane topology of a subunit of the Voltage-gated Potassium Channel 
The potassium channel receptor subunit has six putative transmembrane spanning 
domains represented by cylinders (Sl-6). The receptor has sites for glycosylation and 
neurotoxin binding on its extracellular surface and can be phosphorylated by protein 
kinases on its intracellular face. The S4 transmembrane domain contains positively 
charged amino acids and acts as the voltage sensor to detect changes in transmembrane 
electrical potential, which when detected result in a conformational change of the channel 
to the active, ion conducting state. The H5 region lines the channel or pore when subunits 
are in a tetraoligomeric structure. 
1.3 SYNAPTIC EXCITATION AND INHIBITION IN THE CENTRAL NERVOUS 
SYSTEM 
1.3.1 Synaptic Excitation 
Rapid excitatory synaptic transmission within the central nervous system is primarily 
mediated by acetylcholine and glutamate-activated receptors. Excitation results in the 
depolarization of the membrane and may lead to neuronal firing. 
1.3.2 Acetylcholine Receptor 
The nicotinic acetylcholine receptor can be divided into two classes based on 
localization and subunit composition. These are: 1) the muscle acetylcholine receptors 
(AChRs) found at the neuromuscular junction and 2) the neuronal AChRs which are 
localized in the peripheral and central nervous systems. The mammalian muscle AChRs 
are transmembrane glycoproteins of 290 kD, that are composed of four different subunits 
(a, ~I r/E, 0) stoichiometrically arranged as either a2~DvoI in the case of the mammalian 
embryonic sketelal muscle or a.2~bl as in the adult skeletal muscle (Noda et al., 1983; 
Tanabe et aI., 1984; Takai et ai., 1984; Kubo et ai., 1985; Shibahara et ai., 1985; LaPolla, 
Mayne and Davidson, 1984; Boulter et al., 1985). It is also possible that naturally 
occurring receptors which characterize distinct channel classes in embryonic muscle may 
be formed from only three different subunits, where the 'Y subunit is absent from the 
complex (Charnet, Labarca, and Lester, 1992, Liu and Brehm, 1993). Alternative-splicing 
of the human muscle AChR a subunit mRNA generates two isoforms which differ by an 
additional exon of 25 base pairs, within the proposed extracellular domain (Beeson et al., 
1990). In the adult muscle, the AChR is present predominantly at the neuromuscular 
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junction, whereas in fetal muscle, as well as in denervated adult muscle, the AChR is also 
found in the non-junctional membrane (Mishina et ai., 1986). The junctional and non-
junctional types of AChR channels differ in conductance and gating properties and these 
differences are attributable to the differences between the primary sequences of the 'Y and £ 
subunits (Mishina et ai., 1986). 
The small area of a mature muscle fibre that is contacted by motor nerve terminals is 
highly specialized. The hallmark of the synaptic region is the cluster of AChRs organized 
along the tops of the junctional folds at a packing density of about 10,000 receptors per 
square micrometer of membrane (Fertuck and Salpeter, 1976). Suppression of 
extrajunctional AChR subunit mRNA expression during development of the 
neuromuscular junction is regulated by muscle activity induced by the innervating axon 
(Klarsfeld and Changeux, 1985; Goldman, Brenner, and Heinemann, 1988). The gene 
encoding the £ subunit of adult-type receptors, however, is unique in that it is induced in 
endplate-associated nuclei as a result of muscle innervation (Brenner, Witzemann and 
Sakmann, 1990), but is not regulated by muscle activity. In this situation it has been 
proposed that the basal lamina serves as a type of memory for the muscle, conferring 
nerve-dependent properties on a noninnervated fiber (Goldman, Carlson and Staple, 1991). 
The £ subunit also plays a key role in the assembly of the AChR complex. Chimaeric ~ 
receptor subunits in which the N-terminal and C-terminal extracellular domains are derived 
from the £ subunit have demonstrated that a heterodimer with an a subunit, which is part 
of the pathway for subunit assembly, could only form when an extracellular domain of the 
£ subunit was present (Yu and Hall, 1991). 
The muscle AChR from Torpedo is the only hetero-oligomeric ion channel receptor 
where diffraction electron microscopy has successfully resolved a 0.9 nm structure 
(Unwin, 1993, Unwin, 1995). This structure is consistent with a quasi-symmetrical 
arrangement of the five subunits around the central channel. Three rods, presumed to be 
a-helices, are evident in the extracellular domains of each subunit. The three helices in 
each a-subunit were hypothesized to form an ACh-binding site. A single, kinked rod is 
seen in the membrane-spanning domain of each subunit and is hypothesized to be a kinked 
a-helix formed by the M2 transmembrane domain. 
Neuronal nAChRs are either homologous (as demonstrated in the expression of the a7 
subunit in Xenopus oocytes) or heterologous pentamers. with a predicted conformation of 
a2~P (Cooper, Couturier, and Ballivet, 1991). To date eight a and three ~ neuronal 
subunit cDNAs have been cloned and sequenced, and through in situ hybridization shown 
to have complex overlapping patterns of expression (reviewed by Deneris et ai., 1991; 
Sargent 1993; McGehee and Role, 1995). The a4~2 combination is the most common in 
the mammalian central nervous system (Sargent 1993). Although, the neuronal AChR a 
and ~ subunit polypeptides show 40 to 50 percent sequence identity to the muscle AChR 
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subunit polypeptides (Boulter et al., 1990), the two types of receptor display different 
pharmacological and functional properties (Reviewed by Deneris et al., 1991 and Lena and 
Changeux, 1993), the most significant being the differences in o.-bungarotoxin binding. 
Recently isolated neuronal subunits 0.7, a8 and 0.9 do however show o.-bungarotoxin 
sensitivity. Mutagenesis studies have identified key residues important in the binding of 0.-
bungarotoxin as prolines 194 and 197 and aromatic residues at 187-189 (Kachalsky et al., 
1995). 
1.3.3 Glutamate Receptor 
Glutamate mediates fast excitatory neurotransmission by activating cation-selective 
channels with distinct gating kinetics, ionic permeabilities and conductances, and 
pharmacological properties (Wisden and Seeburg, 1993). The vertebrate glutamate 
receptors have been classified into three general groups: 1) AMP Alkainate receptors, 
which are transmitter-gated, ionotropic ion channels; 2) the NMDA receptor, another 
ionotropic receptor type, which has multiple and specific allosteric modulatory sites and 3) 
the metabotropic glutamate receptor, a G-protein coupled receptor, which can be activated 
by glutamate and quisqualate to stimulate inositol phospholipid metabolism (Monaghan, 
Bridge and Cotman, 1989) (reviewed by Barnard, 1992). Cloning of the corresponding 
cDNA forthe metabotropic glutamate receptor (Masu et al., 1991) has demonstrated that it 
is a single polypeptide with seven hydrophobic transmembrane domains and with no 
structural relationship to the ionotropic glutamate receptors. 
A different class of glutamate-binding proteins was isolated from the CNS of the frog 
Rana pipiens (Hampson and Wenthold, 1988) and from chicken cerebellum (Gregor et aI., 
1989). The cDNAs (Wada et al., 1989; Gregor et aI., 1989) encoding these proteins were 
isolated and expressed in transfected cells. The expressed protein could bind kainate, but 
was not functional in terms of ion conductance, and hence was referred to as a kainate 
binding protein. The kainate binding proteins share a 20 to 40 % identity with members of 
the ligand-gated ion channel superfamily. These receptors were originally proposed to 
maintain the four transmembrane topology of the family, but do not conserve the cysteine 
loop, M 1 proline and M2 threonine/serine-rich domains characteristic of this family 
(family characteristics are discussed in the GABA section 1.4.5) (Barnard, 1992; Gasic and 
Heinemann, 1991). New evidence suggests that AMPNkainate receptors may have a three 
transmembrane topology. 
AMPA receptors, which consist of GluR -A to -D (GluR-l to -4) subunits constitute a 
high affinity AMPAIlow affinity kainate receptor type (Wisden and Seeburg, 1993; Gasic 
and Hollmann, 1992). In patch clamp experiments most native neurons exhibit AMPA 
receptor-mediated currents with linear or outwardly rectifying current-voltage relationships 
(Jonas and Sakmann, 1992). In a transient expression system, the native characteristics of 
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the AMPA-receptor mediated currents is only achieved if GluR-B is co-expressed with the 
GluR-A, -C or -D subunits, suggesting that the GluR-B subunit dominates the properties of 
ion flow and that most native AMPA receptors are heteo-oligomeric assemblies of these 
subunits (Jonas and Sakmann, 1992; Hollmann, Hartley and Heinemann, 1991; Verdoorn, 
et ai., 1991). The GluR-B transcript is thought to undergo an RNA editing event which 
changes the conserved glutamine found in the other receptors to an arginine at the QRN 
site and represents the first demonstration that RNA editing occurs in the brain (Sommer et 
aI., 1991). GluR-5 and GluR-6 are subject to RNA editing in the M2 transmembrane 
domain and in the case of GluR-6 also at two sites in the Ml transmembrane domain 
(Sommer and Seeburg, 1992; Sommer et aI., 1991, Kohler et ai., 1993). In this case, 
however, conversion of an arginine(R) to glutamine(Q) in M2 leads to low calcium 
permeability. Mutations in homolgous regions of M 1 for AMPA receptors does not lead to 
changes in calcium permeability. RNA-editing at other sites in the AMPA receptor leads to 
changes in kinetic properties (Lomeli et ai., 1994). 
GluR-A,-B,-C and -D subunit also exist in one of two molecular forms, that differ in 
the sequence of a segment preceding the most C-terminal transmembrane region. These 
segments arise through alternative use of two exonic sequences present in the primary 
transcripts of members of this gene family and are designated Flip and Flop (Sommer et 
ai., 1990). Another subfamily of excitatory amino acid receptors, the high-affinity kainate 
receptors can consist of KA-l or -2 and/or GluR-5, -6 or -7 subunits. In a transient 
expression system, the homomeric GluR-5 (Q) channel, functionally resembles the native 
kainate receptor found on dorsal root ganglia (DRG) cells, (Sommer et ai., 1992; Huettner, 
1990) suggesting that these subunits may occur naturally as homomeric proteins (Wisden 
and Seeburg, 1993). 
Expression cloning and homology screening have identified five subunits of the 
NMDA receptor (NMDA-Rl and NMDA-R2A, -R2B, -R2C and -R2D) (Yamazaki, et ai., 
1992; Monyer et al., 1992; Meguro et al., 1992; Kutsuwada et al., 1992; Ikeda et ai., 
1992). NRI mRNA is found in virtually every neuron, and hence it has been suggested 
that this subunit should be viewed as a common constituent of all NMDA receptor 
channels (Wisden and Seeburg, 1993). The NRI subunit also has at least seven distinct 
splice forms which are derived from alternative-splicing events in the large amino-terminal 
extracellular domain, and in the amino-terminal hydrophilic moiety (Anantharam et al., 
1992; Durand et aI., 1992; Hollmann et aI., 1993; Nakanishi, Axel, and Schneider, 1992; 
Sugihara et al., 1992). Subunit switching, as in the case of the muscle nicotinic 
acetylcholine receptor may also playa role in the progressive changes in the properties of 
NMDA receptor channels in the developing nervous system (Carmignoto and Vicini, 
1992; Hestrin, 1992; Laurie & Seeburg 1994). 
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1.4 SYNAPTIC INHIBITION 
Synaptic inhibition in the central nervous system of vertebrates is primarily mediated 
by ligand- and voltage-gated K+ channels, and two amino acid neurotransmitter gated 
chloride channels, the GABA and glycine receptors (Krnjevic, 1974). Glycine is the major 
inhibitory neurotransmitter in spinal cord and brain stem, whereas GABA predominates in 
other parts of the brain. Binding of these two amino acids to specific ligand-gated 
receptors increases the chloride conductance of the post synaptic membrane, and thus 
produces hyperpolarization and hence inhibition of neuronal firing (Coombs, Eccles and 
Fatt, 1955). GABA can also activate a G-protein coupled GABAB receptor that is linked 
to a potassium channel (Bowery, 1989). 
1.4.1 Glycine Receptors 
The convulsive alkaloid strychnine selectively antagonizes glycine, but not GABA-
mediated inhibitory responses (Aprison, Lipkowitz and Simon, 1987). Glycine-
displaceable 3H-strychnine binding has been widely used to investigate and localize the 
glycine receptor in different regions of the CNS (Young and Snyder, 1973; Zarbin, 
Wamsley and Kuhar, 1981; Probst, Cortes and Palacios, 1986). From 3H-strychnine 
binding data, glycine receptor deficiencies have been implicated in the pathogenesis of 
spasticity (Hall et ai., 1979; White and Heller, 1982; Becker et ai., 1992) and the loss of 
motor control. Recently mutations in the glycine receptor have been implicated in 
spasticity (Kingsmore et ai. 1994; Ryan et ai., 1994). 
The glycine receptor has been purified from the spinal cord of various mammalian 
species by affinity chromatography on aminostrychnine-agarose, and shown to be a large 
glycoprotein containing polypeptides of relative molecular masses (Mr) 48,000(48 kD), 
58,000 (58 kD), and 93,000 (93 kD). The cDNA sequences of four a subunits (48 kD) and 
one ~ (58 kD) glycine receptor subunit have been determined (Grenningloh et ai., 1987, 
1990; Langosch, Becker and Betz, 1990), and share from 47 percent to 79 percent identity 
with each other. The 93 kD polypeptide is a peripheral membrane protein, which is not 
glycosylated and which by immuno-electron microscopy is seen to be cytoplasmic and 
separate from the receptor/channel structure. Photo-affinity labeling demonstrated that the 
a subunit contained the strychnine binding site (Graham, Pfeiffer and Betz, 1983), and 
from antibody immunoprecipitation of the native receptor complex, a pentameric structure 
of a3 ~2 has been proposed (Langosch, Becker and Betz, 1990). 
Homo-oligomer glycine-activated chloride channels are produced when either ~ or a 
subunits alone are expressed in Xenopus oocytes (Grenningloh et at., 1990). An expressed 
a~ combination shows no difference in function from a alone (Grenningloh et ai., 1990), 
although the ~ subunit transcript is more widely distributed in the adult nervous system, 
and during development than the mRNA for any of the a isoforms, suggesting that a 
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constant ~ is combined alone (strychnine-insensitive, glycine-gated) or with one or more a 
subunits (strychnine-sensitive, glycine-gated) to form a receptor complex. A strychnine-
insensitive glycine binding site also exists on the NMDA receptor and must be occupied by 
glycine to enable activation of the complex by NMDA. 
The expression of genes encoding the a subunits is both regionally and 
developmentally regulated. a 1 glycine receptor subunit mRNA is present in the adult 
eNS, whereas the a3 glycine receptor subunit transcript is present predominantly, in the 
eNS, during postnatal development (Becker, Hoch and Betz, 1988; Kuhse, Schmieden, 
and Betz,1990a). a2 glycine receptor subunit mRNAs are the principal glycine receptor 
subunit transcripts present during embryonic eNS development (Kuhse, Schmieden, and 
Betz, 1990b). Further glycine receptor subtype diversity, in the CNS, occurs through 
alternative splicing of glycine receptor al- and a2-subunit transcripts (Kuhse et al., 1991; 
Malosio et al., 1991). Two al- subunit transcripts are generated by the use of alternative 
3' acceptor splice sites within the proposed intracellular loop (Malosio et al., 1991). The 
longer transcript, designated a 1 ins, has 8 additional amino acids that encode a potential 
phosphorylation site. Preliminary experiments have shown that both subunit variants are 
expressed in similar regions of the nervous system, but whether they are contained within 
the same receptor complex is not known (Malosio et al., 1991). Alternative splicing of the 
. glycine receptor a2 subunit (a2 and a2*) occurs by alternative exon usage (Kuhse et al., 
1991). The two alternative exons both encode 22 amino acids, of which 20 are identical, 
within the putative extracellular loop region. The function of these two polypeptides is 
unclear although it has been suggested that these variants may play a role in 
synaptogenesis (Kuhse et al., 1991) and in the immunity of neonatal rats against strychnine 
poisoning. In vitro mutagenesis has demonstrated that a single amino acid change from a 
glycine to glutamate residue results in the low affinity binding of strychnine to the a2* 
variant (Kuhse, Schmieden, and Betz, 1990b). 
1.4.2 GAllA Receptors 
The amino acid GABA acid is the major inhibitory neurotransmitter in the vertebrate 
central nervous system, and is present at 30 percent of all synapses (Bloom and Iversen, 
1971). The brain content of GABA is also 200- to WOO-fold greater than that of other 
neurotransmitters such as dopamine, noradrenaline, ACh, and serotonin. As such, the 
GABA neuronal network is probably the largest in the central nervous system (Squires, 
1988). Receptors that bind GABA can be divided into three categories, GABAA, GABAB 
and GABAc, based on pharmacological distinctions (Table 1.2). The GABAA receptor 
complex forms an ion channel permeable to both chloride and to a lesser extent 
bicarbonate anions (Bormann, Hamill, and Sakmann 1987; Kaila and Voipio, 1987). The 
GABAA receptor complex has binding sites for at least five different classes of 
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pharmacological agent, including bicuculline (BIC), a competitive antagonist of GABA 
(reviewed by Olsen and Venter, 1986; Stephenson, 1988). The GABAA receptor is 
insensitive to baclofen (BAC), an analogue of GABA, active at the GABAB receptor 
(Enna, 1988). 
A second receptor type, termed the GABAB receptor, although widespread, is 
generally less abundant than the GABAA type in mammalian brain (Bowery, Hudson and 
Price, 1987) and appears to be coupled to Ca2+ and K+ channel conductances (reviewed 
by Bowery, 1989). GABAB receptors are insensitive to bicuculline, selectively activated 
by baclofen (Hill and Bowery, 1981) and are thought to be members of the G-protein 
coupled, seven transmembrane domain, receptor superfamily. Whereas GABAA receptors 
are thought to be predominantly postsynaptic, GABAB receptors are found both pre- and 
post-synaptically (reviewed by Sivilotti and Nistri, 1991) and appear to be involved with 
presynaptic events such as neurotransmitter release (Curits et al., 1970; Enna and Snyder, 
1977). In the lethargic mouse model of absence epilepsy, an increased number of GABAB 
binding sites have been observed suggesting that GABAB receptors may playa role in the 
expression of absence seizures in this animal model (Lin, Cao, and Hosford, 1993). 
Recently, Kaupmann et al., (1997) have reported the expression cloning of a GABAB 
receptor cDNA that shares sequence similarity with metabotropic glutamate receptor 
cDNAs. 
An additional class of GABA receptor sites, which is both bicuculline- and baclofen-
insensitive, has been suggested from binding studies (Drew, Johnston and Weatherby, 
1984; Drew and Johnston, 1992). Electrophysiological experiments have shown that this 
third class, denoted GABAC, is present in rodent retina, frog optic tectum and homologous 
regions of the guinea pig brain. Like the GABAA receptor, the GABA responses mediated 
by this receptor appear to be dependent on extracellular Cl- (Sivilotti and Nistri, 1991). 
1.4.2.1 GABAA Receptors 
The GABAA receptor has binding sites for several pharmacological agents (for reviews 
see Olsen and Venter, 1986; Schumacher and McEwen, 1989; Sivilotti and Nistri, 1991), 
and their actions and clinical use reflect the importance of inhibitory pathways for normal 
function. In addition to the recognition site for GABA, the natural ligand, the receptor has 
a number of modulatory binding sites for the anxiolytic benzodiazepines (Enna, 1988), the 
convulsant channel blockers picrotoxin (Olsen, 1982) and t-butyl 
bicyclophospharothionate (TBPS) (Squires et aI., 1983), the anti-convulsant barbiturates, 
such as pentobarbital (Barnard, 1988) and steroids (Callachan et al., 1987). Each of these 
sites behaves in an allosteric manner and hence as a consequence, binding at one site will 
affect the binding affinity at another. However, not all GABAA receptors appear to exhibit 
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all the modulatory sites (reviewed in Schumacher and McEwen, 1989; and Sivilotti and 
Nistri, 1991). 
Receptor GABAA- GABAA- GABAB GABAC 
competitive benzodiazepine 
site modulatory site 
Selective isoguvacine flunitrazepam L-baclofen muscimol 
Agonist muscimol zolpidem 3-aminopropyl GABA 
GAB A CGS9896 -phosphinic acid cis-4-
GABA aminoacro-
tonic acid 
Inverse N/A DMCM N/A N/A 
Agonist 
Selective bicuculline flumazenil (Ro 15- saclofen 
Antagonist SR95531 1788) CGP35348 
2-hydroxy 
-saclofen 
Radio-ligand [3H]muscimol [3H] fl uni trazepam [3H]L-baclofen 
[ 3H]SR95531 [3H]zolpidem [3H] 3-amino-
[3H]flumazenil propyl-phosphinic 
acid 
Channel TBPS TBPS 
Blocker Picrotoxin Picrotoxin 
Subunit ex, ~ ex, y G protein-coupled pl,2 
Involvement 
Effector integral facilitates cAMP +1-
Pathway membrane Cl- GABAA -gated Cl- K+ channel + 
channel channel opening Ca2+ channel -
Table 1.2 GABA Receptor Pharmacology 
GABA receptors can be divided into 3 groups based on pharmacological characterization. 
1.4.2 GABAA Pharmacology 
Agonist binding to the GABAA receptor increases the neuronal membrane conductance 
to chloride ions, generally resulting in membrane hyperpolarization and reduced neuronal 
excitability, a phenomenon termed synaptic inhibition. Ligand binding studies of GABA 
and GABA receptor agonists have described at least two distinct binding sites differing in 
14 
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affinity for the agonist ligand (reviewed in Sivilotti and Nistri, 1991). The high affinity 
binding site has an equilibrium constant (kD) between 3 to 30 nM while the kD of the low 
affinity site ranges from 100 to 300 nM. GABA binding sites from different brain regions, 
different mammalian species, and animals of different ages all show this heterogeneity in 
affinity. It was believed that these sites represent different affinities of the ligands to 
different conformational states of the receptor (de BIas, Vitorica, and Friedrich, 1988; 
Olsen et al., 1984). Since it is known that micromolar concentrations of GABA are 
required to produce physiological responses (Barker and Mathers, 1981; Segal and Barker, 
1984), this would correspond to activation of the channel by the binding of GABA to the 
low affinity site. Moreover, the concentration of GABA in the brain is such that all the 
high affinity sites are occupied in the resting state. The high affinity state may correspond 
to a desensitized or inactive form of the receptor (Agey and Dunn, 1989), as has been 
observed for the nicotinic AChR (Changeux, Devillers-Thiery and Chemouilli, 1984). 
Benzodiazepine agonists bind at a location removed from the GABA binding site and 
potentiate the GABA induced neuronal inhibition by increasing the frequency of channel 
opening (MacDonald and Barker, 1977). Benzodiazepine agonist binding to the 
benzodiazepine sites modulates the interaction of GABA agonists at the GABA site by 
increasing the affinity of the GABA binding site for agonists (Tallman et aI., 1978). The 
binding of the benzodiazepine antagonist Ro 15-1788 (flumazenil) is not affected by 
GABA (Mohler and Richards, 1981). Inverse agonists (imidazopyridines, 
triazolopyridazines and ~JcarbolinesF have revealed a heterogeneity of benzodiazepine 
binding. In general, BZI sites bind ~Jcarbolines and CL218872, and predominate in the 
cerebellum, while BZII sites show little affinity for these drugs (reviewed by Doble and 
Martin, 1992), and are found primarily in the cortex, hippocampus and spinal cord 
(Braestrup and Nielsen, 1981). Recently it has been postulated that this pharmacological 
classification of benzodiazepine binding is an oversimplification and that at least three 
SUbtypes are required to explain the GABA-benzodiazepine interactions in vitro. The 
benzodiazepine Ro 5-4868 binds to a distinct class of receptor site in the kidney, and other 
tissues, including the brain. Interestingly, a peripheral benzodiazepine receptor (PKBS) 
has been cloned (Sprengel, Werner, and Seeburg 1989), although the physiological 
importance of these sites is unknown. There also exists a population of GABAA receptors 
that lack benzodiazepine binding sites (Unnerstall et ai., 1981) and yet are 
immunologically similar to benzodiazepine-coupled GABAA receptors (de BIas, Vitorica, 
and Friedrich, 1988). 
Recently a binding site for the benzodiazepine GYKI 52466 has been found on an 
AMPA-type glutamate receptor (Zorumski et al., 1993). This benzodiazepine has muscle 
relaxant and anticonvulsant properties not attributable to a GABAA receptor-mediated 
mechanism. Zorumski and coworkers demonstrated that GYKI 52466 acts 
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noncompetitively to block ion currents and associated excitotoxicity, including ischemic 
neuronal degeneration, mediated through AMP A receptors. This inhibition is antagonized 
by drugs that inhibit AMP A receptor desensitization and further demonstrates that not all 
benzodiazepine receptors are GABAA receptors. 
Barbiturates modify the binding of GABA agonists to the GABAA receptor causing 
increased mean channel open time (Study and Barker, 1981) and increasing the maximal 
number of binding sites (Bmax) for GABA (Schumacher and McEwen, 1989). Barbiturates 
have further been shown to increase the affinity of benzodiazepine agonists and reduce the 
binding of inverse agonists at the benzodiazepine site (Wong et ai., 1984). Inverse 
agonists show a lower affinity in the presence of GABA (Braestrup and Nielsen, 1981), 
antagonise the sedative effects of the benzodiazepines and act as convulsants. 
Picrotoxin and TBPS are competitive inhibitors of one another (Lawrence and Casida, 
1983) and the binding of these channel blockers can inhibit and be inhibited by barbiturate 
binding (Squires et aI., 1983). TBPS binding is additionally inhibited by GABA, in the 
presence of chloride ions (Abel, Blume, and Garrett, 1989), and steroids (Harrison et al., 
1987). 
Steroid hormones such as oestrogens, progesterones, corticosteroids, androgens 
(reviewed by Schumacher and McEwen, 1989) and neurosteroids (Puia et ai., 1990) 
modulate GABAA receptor neurotransmission by increasing the affinity of GABA agonists 
for the GABA site (Harrison et al., 1987). Steroids prolong the duration of channel open 
time in a manner similar to barbiturates. Neuroactive steroids are natural or synthetic 
steroids that rapidly alter the excitability of neurons and can have positive or negative 
modulatory effects on GABAA-activated chloride conductance. Neurosteroids are 
classified as agonists, such as allopregnanolone and alfaxalone, or antagonists such as 
sulphate esters of pregnenolone (Paul and Purdy, 1992). 
1.4.3 Biochemistry of the GABAA Receptor 
The GABAA receptor protein has been solubilized from bovine cerebral cortex in the 
zwitterionic derivative of cholic acid, CHAPS (Stephenson, Watkins, and Olsenl982) and 
purified on a benzodiazepine affinity column (Schofield et al., 1987; reviewed by 
Stephenson, 1988). The purified complex had both high and low affinity sites for GABA 
and binding sites for benzodiazepines. When the GABA receptor protein was analyzed by 
SDS-PAGE (polyacrylamide gel electrophoresis), two polypeptide bands of 53kDa (a) and 
57kDa E~F were observed (Sigel et al., 1983; Sigel and Barnard, 1984). The mobility shifts 
observed after endoglycosidase F treatment and SDS-PAGE analysis (Mamalaki, 
Stephenson, and Barnard, 1987) indicated that both the a and ~ subunits were 
glycosylated. In membrane preparations, PH] flunitrazepam specifically photoaffinity 
labels polypeptides of 50kDa (Mohler, Battersby and Richards, 1980; Sieghart and 
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Karobath, 1980). In the purified receptor preparations, it is the a.-subunit that is 
specifically photoaffinity-Iabelled with flunitrazepam and is thus considered to carry the 
benzodiazepine binding site (Stephenson et aI., 1986). However, in experiments where 
higher concentrations of flunitrazepam were used, some incorporation of radioactivity was 
also found in the ~ subunit of purified bovine and porcine cerebral cortical receptors (Sigel 
et at., 1983; Kirkness and Turner, 1986). [3H]muscimol photoaffinity labels a polypeptide 
from rat cerebellar membrane preparations with an apparent molecular size similiar to that 
photoiabelled by flunitrazepam (Cavalla and Neff, 1985). Photoaffinity labelling studies 
with [3H] muscimol on purified GABAA receptor preparations, however, have shown that 
it is the ~Jsubunit that is specifically labeled with [3H] muscimol (Casalotti, Stephenson, 
and Barnard, 1986; Deng, Ransom, and Olsen 1986). As reviewed by Stephenson in 1988, 
this ambiguity may have arisen due to the slight (4kDa) difference between the a. and ~ 
polypeptides, and the sometimes poor resolution of these bands by SDS-PAGE analysis. It 
was in part this poor resolution by SDS-PAGE of large polypeptides with small differences 
in molecular size, which resulted in the initial observation that the GABAA receptor was 
composed of only two types of subunits. Later studies which incorporated higher 
resolution SDS-PAGE revealed that these two bands could be resolved further (Sieghart, 
1989; Fuchs and Sieghart, 1989), displayed differing affinities for various ligands (Fuchs, 
Mohler, and Sieghart, 1988), and could be detected in different brain regions or 
developmental stages. 
Full and partial purification of the GABAA receptor enabled the production of 
monoclonal and polyclonal antibodies (Schoch et at., 1985; Haring et at., 1985; 
Stephenson et at., 1986; Mamalaki, Stephenson, and Barnard, 1987). Monoclonal 
antibodies raised against a partially purified GABAA receptor from bovine cerebral cortex 
(Schoch et aI., 1985) distinguished four epitopes of the receptor which were defined by a 
combination of immunoblotting, species specificity and competition in a solid phase 
antibody binding assay (Haring et at., 1985). In particular, western blot analysis indicated 
that monoclonal antibody bd-17 was ~ subunit-specific and monoclonal antibody bd-24 
was ex. subunit-specific. Both bd-17 and bd-24 co-immunoprecipitated [3H]muscimol and 
[3H]flunitrazepam binding sites from partially purified receptor preparations, thus 
demonstrating that the a. and ~ subunit were integral to the same oligomeric structure 
(Schoch et at., 1985). Antibody cross-reactivity between human and bovine brain 
preparations was demonstrated and generated identical patterns of distribution throughout 
the central nervous system (Richards, Mohler and Haefly, 1986; Richards et al., 1987; 
Schoch et al., 1985). These observations suggested that the GABAA receptor population 
was homogeneous, however on comparison of the bd17 and [3H]muscimol binding and 
[3H]Ro 15-1788 labeling in the rat brain, areas of the thalamus and cerebellum showed an 
inverse correlation between antibody and benzodiazepine labelling (Schoch et at., 1985; 
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Richards, Mohler and Haefly, 1986; Richards et al., 1987). Antibody bd-28, which can 
recognize a, ~ and 'Y polypeptides, labeled three polypeptides of 51, 53 and 59 kDa on 
western blots of [3H]flunitrazepam photolabeled purified receptors, suggesting that bd-28 
recognized at least three different a polypeptides, which shared a common epitope (Fuchs, 
Mohler and Sieghart, 1988). Further studies with bd-17 also found that the antibody could 
recognize three distinct polypeptides of 51, 53 and 55 kDa, two of which were previously 
labeled with bd-28. Taken together, these results indicated a limited 
biochemical/molecular heterogeneity consistent with the previously described 
pharmacological heterogeneity. 
1.4.4 Isolation of GABAA Receptor cDNAs 
The GABA receptor was purified using a benzodiazepine affinity column, and cleaved 
with cyanogen bromide. The HPLC-isolated peptide fragments were then gas-phase 
micro sequenced, and the resulting amino acid sequences were used to design synthetic 
oligonucleotide probes. Bovine brain and calf cerebral cortex cDNA libraries were 
screened with these probes, resulting in the isolation of cDNAs encoding an a and a ~ 
subunit (Schofield et al., 1987). The deduced amino acid sequences shared 35% sequence 
identity and their predicted hydropathy profiles exhibited similarities with the proposed 
topologies of the nicotinic acetylcholine and glycine receptors, suggesting a common 
evolutionary origin. This shared sequence and organizational identity indicated that the 
GABAA receptor was part of a ligand-gated ion channel superfamily (Barnard, Darlison, 
and, Seeburg,1987; Grenningloh et al., 1987; Schofield et al., 1987). 
The sequence identity shared between the a and ~ subunits of the GABAA receptor, 
and the concurrent application of molecular biology to the study of the vertebrate brain 
GABAA receptor, has resulted in a rapid increase in the identification of a number of 
different subunits and subunit isoforms. Degenerate oligonucleotides and GABAA 
receptor subunit cDNAs have been used as probes to identify new and species-related 
sequences. As a result of these experiments, several distinct subunit classes EaI~IDvI and 0), 
and subunit isoforms (al-6, ~NJ4I ,,(1-4,51, pl-3, el and 'tlI) of the vertebrate GABAA 
receptor have been identified (Bateson et al., 1990, 1991 a: Bateson, Lasham and Darlison, 
1991; Garrett et al., 1988; Glencorse, Bateson and Darlison, 1990, 1991, 1992; Kato, 1990; 
Keir, Deitech and Sikela, 1991; Kirkness et al., 1991; Kofuji et al., 1991; Levitan et al., 
1988a; Ltiddens et aI., 1990; Montpied et al., 1989; Pritchett, Ludden and Seeburg, 1989; 
Pritchett and Seeburg, 1990; Schofield et al., 1987, 1989; Sommer et al., 1990a; Whiting, 
McKernan, Iversen 1990; Wilson-Shaw et al., 1991; Ymer et al., 1989a, b, 1990; Cutting 
et al., 1991; Wang, T.L., Guggino, W.B. and Cutting, G.R., 1994; Ogurusu, T. and 
Shingai, R., 1996; Davies et ai., 1997; Hedblom and Kirkness, 1997). 
18 
Chapter 1 Genera/Introduction 
• Variable 
Figure 1.3 Schematic Model of the Proposed Secondary Structure of the Rat at 
GABAA Receptor Subunit 
The amino acids are numbered according to Krestchatisky et al... 1989. The colour 
code indicates the identity shared among the al. a2, a4. {31, {33. '}'QS. and 8 rat GABA A 
receptor subunits. White represents an identity common to all the subunits mentioned 
above, gray represents an amino acid in a position common to several subunits, black 
indicates amino acid identity shared by only the alpha subunits, and red indicates the 
variable positions for amino acid identity among the subunit sequences. The four putative 
transmembrane domains (Ml to M4) are represented as a-helices (for current views refer 
to Chapter 6). The NH2- and COOH- termini are shown as "N" and "c" respectively. N-
linked glycosylation sites in the NH2-terminus are indicated by small branched black 
circles. (Reproduced from Olsen and Tobin. 1990) 
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The subunit rho with isoforms pI, p2 and p3, is highly expressed in the human retina 
and shares 30 to 38 percent identity with other GABAA receptor subunits (Cutting et al., 
1991, 1992). Pharmacological characterization of the p class of receptors suggests a novel 
type of bicuc1ine-, baclofen-, and benzodiazepine-insensitive GABA receptor that might 
represent the GABAc (non-A, non-B) class (Cutting et al., 1991; Shimada, Cutting and 
Uhl, 1992). Invertebrate forms of the GABAA receptor have been identified in Lymnaea, 
Drosophila and C. elegans (Harvey et al., 1991; Mcintire, Jorgensen and Horvitz, 1993). 
1.4.5 A Ligand-Gated Ion Channel Superfamily 
As mentioned previously, the GABAA receptor subunits share topology and sequence 
similarities with the nicotinic AChR, 5-HT3, and glycine receptors, and a more limited 
identity with subunits of the AMP Nkainate glutamate receptor. Within the lipid bilayer 
the GABAA receptor subunit polypeptides, like the acetylcholine receptor subunit 
polypeptides, are believed to form a heteropentameric structure. Figure 1.3 outlines the 
predicted topology of the al subunit polypeptide of the rat GABAA receptor. In common 
with other members of the superfamily, the GABAA receptor polypeptides contain a signal 
sequence, suggesting that the amino-terminus is likely to be extracellular. The mature 
subunits contain four hydrophobic sequences that are proposed to be membrane-spanning 
domains, termed MI-M4. The intracellular region between M3 and M4 is the area of 
greatest diversity among the GABAA receptor subunits. Consensus sequence sites for 
protein phosphorylation are located within the cytoplasmic domains of the 12, an a and 
several ~ GABAA receptor subunits (Moss et al., 1992; Whiting, McKernan, Iversen 1990; 
Sweetnam et al., 1988; Browning et al., 1990). The extended hydrophilic extracellular 
region features several potential sites for N-linked glycosylation. and a proposed loop 
structure formed by disulphide bonding between two cysteine residues. NMDA, AMPA 
and kainate receptors differ significantly from other members of the ligand-gated ion 
channel superfamily. The differences include, overall length, lack of dicysteine loop 
structure, absence of conserved M 1 proline, and fewer threonine/serine residues in the M2 
region. 
1.4.6 Further GABAA Receptor Subunit Diversification 
Alternative-splicing of primary gene transcripts has been demonstrated for the human. 
bovine. chick, rat and mouse "(l and the chick ~4 GABAA receptor subunit mRNAs 
(Whiting, McKernan, Iversen, 1990; Kofuji et al .• 1991; Glencorse, Bateson and Darlison, 
1992; Bateson, Lasham and Darlison, 1991). The GABAA receptor Y2-subunit gene 
transcripts are alternatively spliced to generate two mRNAs that differ by the presence or 
absence of 24 base pairs. The subunits that are encoded by these mRNAs are termed y2L 
and "(lS. Analysis of the gene structure of the 12 subunit revealed that the 24 base pair 
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sequence is encoded in a separate exon contained within the cytoplasmic loop domain. 
The alternatively-expressed exon carries 8 amino acids (Leu-Leu-Arg-Met-Phe-Ser-Phe-
Lys) which encode a consensus site for protein kinase C phosphorylation. At present it is 
unclear whether this exonic sequence acts as a modulatory site for the action of ethanol on 
the GABAA receptor complex (Wafford et al., 1991; Sigel, Baur and Malherbe, 1993). 
The chick P4-subunit variants are generated by the differential choice of 5' -donor splice 
sites in the P4-subunit gene and differ by the presence (P4') or absence (\34) of four amino 
acids in the proposed intracellular loop (Bateson, Lasham and Darlison, 1991). 
1.4.7 Subunit Homology 
All GABAA receptor polypeptide sequences identified to date share sequence identity 
to each other and to other members of the superfamily (Barnard, Darlison, and Seeburg, 
1987). The a, ~I yand S subunit polypeptides exhibit about 30 to 45% sequence identity at 
the amino acid level (Figure 1.4), which is increased to 50% with the inclusion of 
conservative amino acid residue substitutions. The percentage identity between each of 
two of the four subunits is shown in Table 1.3. 
~t y2 S 
at 33% 47% 29% 
~l - 34% 37% 
y2 
- -
35% 
Table 1.3. Percentage of amino acid sequence identity between the rat GABAA receptor 
aI-, /31-, ~JI and 8-subunit polypeptides. 
The percentage identities were determined using the alignment shown in Figure 1.4. 
The rat aI-subunit polypeptide is from Lolait et aI., (1989) , the rat PI-subunit polypeptide 
sequence is from Ymer et al., (1989b) and the rat 12- and S- subunit polypeptide sequences 
are from Shivers et al., (1989). 
The percentage identity comparison reveals that a- and y-subunit sequences are more 
closely related to each other than either is to ~J or s..subunit sequences. This may reflect 
the evolutionary origins of the genes encoding each of the subunits. It has been suggested 
that the members of the superfamily of ligand-gated ion channels originated from a 
common ancestor (Schofield et al., 1987). Arbas et al., (1991) proposed the ancestor of 
the superfamily to be a ligand-gated membrane ion channel which evolved preferences for 
acetylcholine, GABA and glycine. In support of this idea, other members of the 
superfamily, for example the glycine receptor al subunit (Grenningloh et al., 1987), and 
the nicotinic AChR al subunit (Noda et al., 1983), exhibit approximately 34% and 20% 
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Figure 1.4 
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Figure 1.4 Amino acid sequence comparisons ofral GABAA receptor aI, {31, ~ and 8 
subunits. 
Alignment of the deduced amino acid sequences of the al (A 1) (Lolait et al., 1989), 131 
(B 1) (Ymer et aI., 1989), y2 (G2) and 0 (Dl) (Shivers et al., 1989) subunits was performed 
using the computer program MULTALIGN (Barton and Sternberg, 1987). Gaps are 
introduced into the sequences to maximise the alignment and negative numbers refer to 
signal peptide residues. Identical residues, at the same position in all four sequences, are 
highlighted. The proposed transmembrane domains (MI-M4) are indicated by solid lines 
above the sequences. The proposed disulphide bonded loop region is shown by the dashed 
line. 
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identity, respectively , to the GABAA receptor subunits. Arbas et ai., ( 199 1) believe that 
the first to diverge , and therefore the most anc ient member of thi s family, was the 
acety lcholine-gated ion channe l. Thi s was followed by GABAA/glycine receptor 
divergence. 
The amino ac id identity of different sUbtype polypeptides is generall y greater than 70% 
(rev iewed by Betz, 1990). Subtype-specific sequences are mainly within the proposed 
intracellular domain of the mature polypeptide. Subtype-specific functions or structure are 
assoc iated with the highly conserved amino ac ids among polypeptides of a particular 
subtype, located on the cytoplasmic sides of transmembrane domains, M3 and M4 (Kato, 
1990; Ymer et ai., 1990; Wil son-Shaw et aI. , 1991 ). Although the extracellular domains of 
GABAA receptor isoforms of a spec ific sUbtype exhibit a high degree of amino ac id 
ide ntity, within this reg ion, it is the nonhomol ogous s ites w hich contribute to the 
differences in allosteric modulation exhibited by the subunit variants. 
1.4.8 GABAA Receptor Subunit Gene Chromosomal Localizations 
The chromosomal localizations of several human GABAA receptor subunit genes have 
been dete rmined and are li sted in Table 1.4 with the mouse syntology. The a3 GABAA 
receptor subunit gene is on the mouse X chromosome and has been mapped near the 
spontaneous X-linked mouse mutant, trembl y (Ty) (Tay lor et aI., 1978) . The trembly 
males develop tremors at two weeks of age and later experience seizures . In humans, one 
form of inheritable manic depression (MAFD 2) is X-linked and has been mapped close to 
co lor-blindness and G6PD genetic markers (Baron el ai., 1987; Del Zompo et ai., 1984; 
Mendlewicz el al., 1987), in the region of the human a3 gene . Other neurological 
disorders which map within the Xq28 reg ion include adrenoleukodystrophy , Emery-
Dre ifuss muscul ar dystrophy , spastic parapleg ia, myotubul ar (centronuc lear) myopathy 
and hydrocephalus (Rowl and , 1992). GABAA receptor subunit genes, ~ I and a2, with 
locali zations that encompass p 12-p 13 bands on human chromosome 4, map onto mouse 
chromosome 5, in a region that contains a neurological mutant mouse locus, tilted (tIt) 
(Buckle et ai., 1989). The susceptibility locus for schizophrenia is located on the Sq arm 
(Sherrington et ai. , 1988), as are the 12 and a 1 GABAA receptor subunit genes (Buckle et 
ai., \989). The ~PI as , a4 and 13 GABAA receptor subunit genes map to human 
chromosome 15 (Wagstaff et ai., 1991 ; LaLande and Sike la, unpubli shed re ults; 
Danciger, Farber and Kozak, 1993; Brilliant et aI., 1994). Recently a spontaneous mouse 
mutant locus on chromosome 7 was shown to be a deletion of the "(3, as, and ~P GABAA 
receptor subunit genes (Brilliant et ai. , 1994). The locus is sy ntenic with human 
chromosome ISq II-q 13. Prader-Willi sy ndrome and Angelmann syndrome genes 
localized in the area of 15q II , on chromosome 15 (Wagstaff et ai., 1991). Another murine 
neonatally lethal mutation of the p locus, includes only the GABAA receptor ~P subuni t 
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Subunit Chromosome Species Location Reference Mouse 
Equivalent 
al S Human Sq31.1- Buckle, et 11 
q33.2 al., 1989 
a2 4 Human 4pI2-p13 Buckle, et S 
al.. 1989 
a3 X Human Xq28 Buckle, et N.D. 
al.,1989 
a4 IS Human ISqll-13 Danciger, 7 
Farber, 
Kozak, 
1993 
as IS Human near ~P Marc 7 
LaLande, 
James M. 
Sikela, 
Un-
~ublished 
~N 4 Human 4p12-p13 Buckle, et 5 
al.,1989 
~P 15 Human ISqll-13 Wagstaff, 7 
et al., 
1991 
yl 4 Human 4p14- Wilcox, et [3,5,19] 
-.9.2 1.1 al., 1992 
y2 5 Human 5q31.1- Wilcox, et 11 
q33.2 ai., 1992 
Bl 1 Human Ip Sommer, [1,3,4,5] 
et aI., 
1990a 
Table 1.4 Localization of Human GABAA Receptor Subunit Genes 
Locations of GABAA receptor subunit genes on human chromosomes are listed. The mouse 
chromosomal localizations are abased on known syntologies with human chromosomes. 
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gene (Culiat et al., 1993). Complementation and RNA expression data suggest that the 
deficiency in the ~P GABAA receptor subunit gene contributes to the elefting defects 
observed in mice homozygous for this mutation and is consistent with earlier observations 
that GABA or its agonist diazepam interfer with normal palate development in mice (Wee 
and Zimmerman, 1983). 
The co-localization of aI, "(2 GABAA receptor subunit genes to chromosome 5, a2, ~ 1 
and yl GABAA receptor subunit genes to chromosome 4 and ~PI as, a4 and "(3 to 
chromosome 15 suggests coordinated expression, possibly through shared regulatory 
regions for these co-localised subunits. 
1.4.9 Functional Properties Conferred by Specific Subunits 
GABAA receptors may be constructed in vitro by the transient expression of 
combinations of a, ~I y, 0, E and 1t subunits in Xenopus oocyte or mammalian cell 
expression systems. Both the pharmacological and electrophysiological properties of these 
subunit combinations, and the specific contribution of different subunits to these 
parameters, have been studied, and the results from several labs are discussed below. 
1.4.9.1 a Subunit 
The greatest diversity among GABAA receptor subunit isoforms is observed for the a 
subunit. It has been suggested that these subunit isoforms determine different functional 
SUbtypes of the GABAA receptor in the brain (Seeberg et al., 1990). The GABAA receptor 
subtypes are defined by their subunit composition and by their affinities for various 
allosteric ligands (reviewed by Loddens and Wisden, 1991; Doble and Martin, 1992). 
Initial studies using Xenopus oocytes demonstrated that expression of bovine aI, 2 or 3 
GABAA receptor subunits with the bovine ~ Isubunit produced receptor SUbtypes which 
could be distinguished by their apparent sensitivity to GABA (Levitan et al., 1988a, b). 
Transient expression experiments using a human kidney 293 cell line demonstrated that 
ax~ 1"(2 recombinant receptors, where x is 1, 2 or 3 displayed unique affinities for the 
triazolopyridazine CI218-872, and the ~JcarbolineI BCCE (Pritchett, Luddens, and 
Seeburg, 1989). The high affinity of the a 1 ~ 1"(2 receptor complexes for C1218-872 and 
~CCb is characteristic of a benzodiazepine (BZI) type-pharmacology, whereas the low 
affinity of the a2~ 1"(2 and aP~ 1"(2 receptor complexes for these ligands resembled a BZII 
type-pharmacology. Receptors containing the a3 subunit exhibited greater GABA 
potentiation of benzodiazepine binding than did the receptors containing the a2 subunit, 
thereby demonstrating the existence of subtypes within the BZII class of GABAA 
receptors (Pritchett, Luddens and Seeburg, 1989). 
The presence of the as GABAA receptor subunit in a coexpression experiment with 
~ 1"(2 subunits conferred a BZII l~keJpharmacology different to that seen for the other type 
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II variants. These receptors displayed a higher affinity for C1218-872 than receptors 
containing either the a2 or a3 subunits, but a lower affinity for CI218-872, when 
compared with al containing receptor complexes (Pritchett and Seeburg, 1990). Further 
heterogeneity within the BZII class of receptors occurs in the pharmacological profile of 
the imidazopyridin, zolpidem. GABAA receptors containing the as isoform have a much 
lower affinity to zolpidem than do receptor complexes containing either the a2 or a3 
subunits (Pritchett and Seeburg, 1990). 
Recombinant receptors containing the a4 or a6 subunits exhibit a disparate 
pharmacology from GABAA type I and type II receptors. These novel receptors bind the 
benzodiazepine 'alcohol antagonist' Ro 15-4513 with high affinity, but fail to bind 
benzodiazepine agonists (Luddens et aI., 1990; Wisden et aI., 1991 b). In addition, the 
Ro 15-4513 binding is poorly, if at all, displaced by diazepam indicating that these 
receptors may be similar to the previously described GABAA receptors that lack 
benzodiazepine binding sites (Unnerstall et ai., 1981). However, approximately one-third 
of the a6 subunit containing receptor complexes were shown to be diazepam sensitive and 
may therefore represent a pharmacologically distinct class of GABAA receptors (Luddens 
et al., 1990). 
1.4.9.2 ~ Subunits 
Ligand binding studies have implicated the ~ subunit as the GABA agonist binding 
site(Casalotti et ai., 1986). However, in both Xenopus oocyte and mammalian expression 
systems, some bovine and rat a, yand () homomeric channels have been shown to be gated 
by GABA, implying that the GABA agonist binding site is not unique to p subunits (Blair 
et al., 1988; Ymer et ai., 1989a; Shivers et al., 1989). Mutational analysis suggests that 
certain substitutions in the a subunit can have a much more dramatic effect on GABA 
affinity than alteration in homologous residues in the p subunit (Sigel et al., 1992). 
Interestingly these mutations also decreased the affinity of the a subunit for competitive 
antagonists, such as bicuculline, while homologous substitutions in p or 'Y subunits did not. 
Initial studies in Xenopus oocyte system with coexpression of al py, where y is 1, 2 or 3, 
bimeric receptor combinations suggested that the beta subunits were functionally 
interchangeable and that substitution of either the P2 or p3 subunit for the PI subunit did 
not change the qualitative properties of the expressed GABAA receptors (Lolait et al., 
1989; Ymer et al., 1989b). However, later studies using suggest that the replacement of P2 
or the PI subunit in a given recombinant receptor results in a decreased affinity for GABA 
and in an increased sensitivity to diazepam (Sigel et al., 1990). In addition, it has been 
suggested that natural GABAA receptors containing either P2 or p3 subunits differ in their 
affinity to GABA analogues, and pentobarbital (Bureau and Olsen, 1990). 
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1.4.9.3 ySubunits 
Recombinant receptors expressed in heterologous systems using a and ~ subunit 
combinations were found to display many of the properties of native GABAA receptors, 
but to lack consistent benzodiazepine potentiation (Schofield et at., 1987, Levitan et ai., 
1988b; Pritchett et al., 1989; Malherbe et ai., 1990a). 
Coexpression of the 12 subunit with al and ~ 1 subunits, in an Xenopus oocyte system 
produced GABAA receptors displaying high affinity binding for the central 
benzodiazepine receptor ligands (Pritchett et ai., 1989). Thus, although the a subunits 
determine the different affinities of the benzodiazepine ligands in GABAA receptor 
subtypes, the y subunit is proposed to contribute to the formation of the benzodiazepine 
allosteric site, or to induce a conformational change on the receptor complex, making the 
binding site more accessible to benzodiazepine ligands (Pritchett et aI., 1989; Stephenson, 
Duggan, Pollard, 1990). Targeted disruption of the 12 gene in mice leads to animals with a 
94% reduction in benzodiazepine binding sites, and GABA receptors that are insensitive to 
benzodiazepines (Gunther et ai., 1995). Additionally, the y subunits have been shown to 
reduce sensitivity to a non-competitive block of channel conductance by zinc ions 
(Draguhn et al., 1990; Herb et at., 1992; Smart et al., 1991). 
The "/ subunit variants have been shown to differ in the extent to which they modify the 
functional properties of GABAA receptors. Specifically, when recombinant receptors are 
expressed in Xenopus oocytes, the yl subunit confers a markedly reduced affinity for the 
benzodiazepine antagonist RoI5-1788, and the inverse agonist DMCM, compared to those 
containing y2 (Ymer et al., 1990). This loss in affinity may be linked to the increase in 
GABA evoked current produced in ax~ 1,,/1 complexes. Thus the positive modulation 
conferred by these compounds define the unusual pharmacological profile of a~IILN 
receptors (Y mer et aI., 1990; Puia et al., 1991). 
In contrast, recombinant receptors containing the "f3 subunit are sensitive to DMCM, as 
are y2 containing receptors, but differ in their responses to diazepam and zolpidem 
(Knoflach et al., 1991; Herb et ai., 1992). Therefore, replacement of the "(l subunit with 
either the yl or y3 subunits, in recombinant receptors, results in disparate pharmacological 
profiles (Ymer et ai., 1990; Herb et ai., 1992). 
1.4.9.4 B subunit 
Homo-oligomeric recombinant receptors with the B subunit have been shown to form 
GAB A-gated bicuculline and picrotoxin sensitive channels. In one study, replacement of 
the y2 subunit in recombinant a 1 ~ 1"(l receptors with the B subunit, resulted in the abolition 
of benzodiazepine sensitivity (Shivers et aI., 1989). From these results it has been 
suggested that the B subunit may contribute to the formation of GABAA receptors that lack 
benzodiazepine binding sites (Shivers et al., 1989; Wisden et aI., 1992). HEK-293 cells 
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co-transfected with a, ~ and 0 GABAA receptor subunit cDNAs exhibit GABA evoked 
chloride currents that are not potentiated by anaesthetic steroids (Zhu et al., 1996). 
1.4.9.5 P subunits 
A novel class of receptors for GABA, termed GABAc have been identified in the 
retinae of a variety of species including white perch, catfish, hybrid bass, salamander, rat 
and cow (Polenzani, Woodward and Miledi, 1991; Feigenspan, Wassle, Bormann, 1993; 
Qian and Dowling, 1993; Lukasiewicz, Maple and Werblin, 1994; Takahashi, Miyoshi and 
Kaneko, 1994; Qian and Dowling, 1995). Retina GABAc receptors are present on rat and 
tiger salamander bipolar cells (Feigenspan, Wassle, Bormann, 1993; Feigenspan and 
Bormann, 1994) and on horizontal cells of the white perch (Qian and Dowling, 1993, 
1994). Recent cloning experiments have identified 3 novel GABA receptor subunits that 
when expressed in Xenopus oocytes form functional homo- and hetero-oligomeric CI-
channels, with unique pharmacologcial properties that correlate with the bicuculine- and 
baclofen-insensitive GABAc receptors characterized in retinae. The p subunits share a 30 
to 38 percent identity with GABAA receptor subunits (Cutting et aI., 1991; 1992). 
Contrary to the initial view that p represented a retinal-specific GABA receptor 
isoform, Boue-Grabot et al., (1998) have demonstrated by in situ hybridization analysis the 
co-localise of p 1-3 mRNAs in the superficial gray layer of the superior coliculus and in 
cerebellar Purkinje cells. Although p subunits can form homomeric GABA-activated 
chloride channels that are bicuculline-barbiturate- and benzodiazepine-insensitive in 
Xenopus oocytes, the co-localisation of these subunits suggest that p subunits may form 
either homomeric or heteromeric GABAc receptors in vivo. Homo-oligomeric pI and p2 
receptors are less sensitive to muscimol and picrotoxin and desensitize slower than 
GABAA receptors. Like GABAA receptor complexes composed of ex. and ~ subunits only, 
GAB A-activated chloride currents generated by pI and p2 homo- and hetero-oligomer 
expression in Xenopus oocytes are reversibly inhibited by ZnCl2 (Wang, Guggino and 
Cutting, 1994). 
The pI subunit mRNA is alternatively-spliced in the amino terminal extracellular 
domain resulting in either a non-functional receptor (150 amino acid deletion) or a 
functional GABAc-like receptor (17 amino acid deletion) when expressed in Xenopus 
oocytes (Martinez-Torres et al., 1998). Co-immunoprecipitation studies with truncated 
versions of the pi subunit have demonstrated that the N-terminal regions of p subunits 
contain signals for both homo- and hetero-oligomeric assembly (Hackam et aI., 1997). 
The generation of chimeric receptors consisting of glycine receptor a 1 subunit and 
GABAc pI subunit sequences has lead to the identification of two amino acid residues in 
transmembranes 2 and 3 that are critical for allosteric modulation of both GABAA and 
glycine receptors by alcohols and two volatile anaesthetics (Mihic et al., 1997). 
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1.4.9.6 e Subunit 
A novel GABAA receptor gene (e) has recently been identified on human chromosome 
Xq28 (Wilke et at., 1997). The e subunit is clustered with the a3 and /34 GABA A receptor 
subunit genes in an approximately 0.8 megabase interval on Xq28 and in candidate regions 
for early onset parkinsonism (Waisman syndrome) (Lax ova et ai., 1985; Gregg et ai., 
1991) and X-linked mental retardation (MRX3) (Gedeon et al., 1991; Nordstrom et al., 
1992). The e subunit shares the highest amino acid identity (49 percent) with the 14 
GABAA receptor subunit and therefore represents a new class of GABAA receptor subunit. 
The genomic organization of the e subunit gene differs from other GABAA receptor genes 
due to the loss of the third intran/exon boundary that is otherwise highly conserved among 
GABAA receptor subunit genes (Wilke et ai., 1997). The position of the last intron of the e 
subunit gene is conserved with the deduced position of an intran in 12 subunit genes. 
Northern blot analysis indicates that the e GABAA receptor subunit transcript is 
abundant in heart and placenta, but is not detectable in whole brain RNA (Wilke et ai., 
1997). The e subunit transcript is alternatively spliced at several positions that yield 
truncated protein sequences in most tissues. This form of alternative splicing may function 
to down-regulate expression of the £ subunit in these tissues or to create truncated protein 
variants with unknown function. in another study, Davies et ai., (1997) used Northern blot 
analysis of dissected brain regions to demonstrate an enrichment of the e subunit transcript 
in amygdala, thalamus and subthalamic nucleus. The subthalamic nucleus receives major 
GABA-mediated inputs, with particularly dense projections from the globus pallidus. 
HEK-293 cells transfected with the e subunit only did not express binding sites for [3H] 
muscimol or esS] TBPS and failed to exhibit chloride currents in response to GABA or 
glycine. HEK-293 cells transfected with a combination of a, ~ and e subunits exhibited 
GAB A-activated chloride currents, that were not potentiated by benzodiazepines, 
pregnanolone or intravenous anaesthetic agents such as pentobarbital and propofol (Davies 
et al., 1997). In contrast, the activating effects of pregnanolone, propofol and 
pentobarbital were unaffected by the presence of the e subunit and supports the view that 
the two responses (potential and activation) are mediated by different anaesthetic binding 
sites on the GABAA receptor complex (Davies et ai., 1997). 
1.4.9.7 1t Subunit 
Recently a sixth class of GABAA receptor subunit has been cloned ,1t, that shares a 30 
to 40 percent amino acid identity with known GABAA receptor family members and is 
most closely related to the ~ subunits. Both rat and human 1t subunits have been 
characterised and share a 93 percent amino acid sequence identity (Hedblom and Kirkness, 
1997). The 1t subunit polypeptide has a predicted four transmembrane spanning topology, 
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with five sites for potential N-linked glycosylation in the extracellular loop that also 
includes the putative cysteine loop which is a characteristic of all other GABAA receptor 
subunits. 1t transcripts are localized in the hippocampus and temporal cortex as well as in 
peripheral tissues including the uterus, prostate, ovaries, placenta, gall bladder, lung, and 
small intestine (Heblom and Kirkness, 1997). The transcript for the 1t GABAA receptor 
subunit was particularly enriched in uterine tissue. 
Expression of the 1t subunit alone in REK-293 cells resulted in no discernible binding 
sites for [35S]TBPS, eH] muscimol, and eH] Ro 15-1788 demonstrating an inability of the 
1t subunit to form homo-oligomers. Expression of the GABAA receptor p3 subunit, whieh 
can assemble homomerie chloride channels that bind [35S] TBPS with high affinity, with 
the 1t subunit had no significant effects on the Kd and Bmax values for [35S] TBPS binding to 
transfected cell membranes. Displacement of e5S] TBPS binding by pentobarbital yielded 
similar K j values for the two membrane preparations, however displacement of [35S] TBPS 
binding by pregnanolone demonstrated a significant reduction in sensitivity to 
pregnanolone in the receptor population containing the 1t subunit (Hedblom and Kirkness, 
1997). Since the actions of pregnanolone at GABAA receptors have been proposed to 
regulate uterine motility by inhibiting contractions (Majewska and Vaupel, 1991; Putnam 
et al., 1991), the identification of a novel class of GABAA receptors in the uterus may 
provide new insights into the role of GABAA receptors in this process. 
1.4.9.7 Null Mutations in GABAA Receptor Subunits 
Genetic modification of GABA A receptor subunit genes by the introduction of null 
mutations into the germline have provided insight into the functional roles of these genes 
in vivo. To date null mutations have been generated in genes for the a6, 12, p3 and 0 
GABAA receptor subunits and a GABA synthesising enzyme GAD 67 (Jones et ai., 1997; 
Romanies et al., 1997a; Gunther et al., 1995; Romanies et al., 1997b; Romanies et al., 
1998; Condie et ai., 1997). Knockout of the a6 gene results in animals that are grossly 
normal in motor skills and cerebellar cortical cytoarchitecture. Analysis of cerebellar 
granule cells from these mice demonstrates a severe deficit in high affinity [3H] muscimol 
and [3H] SR 95531 binding to GABA sites and inverse agonist binding of [3H]Ro 15-4513 
(Makela et al., 1997). In a similar animal model of an a6 GABA A receptor null mutation, 
Jones et al., (1997) demonstrated that loss of a6 GABAA receptor gene expression had a 
profound influence on the expression of the 0 GABAA receptor subunit polypeptide. In the 
mutant animals, wild-type levels of 0 subunit mRNA were present, but there was an almost 
complete loss of 0 subunit immunoreactivity, suggesting that there is an association of the 
a6 and 0 subunits whieh may aid in trafficking of this receptor complex to the cell surface, 
as well as provide protection against proteolytic degradation of the 0 subunit monomer. 
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When a null mutation was introduced into the 0 subunit gene, there was a reduction in 
high affinity binding of [3H] muscimol in the forebrain and cerebellum, confirming the 
high affinity of GABA sites in the 0 subunit-containing receptors. In contrast to the a6 
null mutation, there was an increase in [3H] Ro 15-4513 binding in the forebrain and 
cerebellum suggesting that either 0 subunits normally prevent the assembly of y2 subunits 
with the a6 subunit or that in the presence of the 0 subunit, the y2 subunit is unable to form 
normal benzodiazepine sites (Homanics et ai., 1998). Most of the increase in [3H] Ro 15-
4513 binding was diazepam insensitive indicating the presence of a4 subunits (Homanics 
et aI., 1998). 
A null mutation in the y2 GABAA receptor subunit gene resulted in a 94 percent loss of 
benzodiazepine binding sites in neonatal brain, although there was only a slight reduction 
in the number of GABA sites (Gu nther et al., 1995). The single channel main 
conductance level and Hill coefficient were reduced to values consistent with recombinant 
GABAA receptors composed of a and ~ subunits. The GABA response was potentiated by 
pentobarbital but not by flunitrazepam in neonatal DGR neurons. Loss of the 12 GABAA 
receptor subunit demonstrated no obvious embryonic phenotype, however during postnatal 
development reduced GABAA receptor function was associated with retarded growth, 
sensorimotor dysfunction and a drastically reduced life span (Gunther et aI., 1995). 
The ~P subunit is an essential component of the GABAA receptor in many brain 
regions and especially during development. Generation of a null mutation in the ~P 
subunit gene by homologous recombination results in an approximately fifty percent 
reduction in eH] muscimol binding in the cortex and thalamus (Homanics et al., 1997). 
eH] Ro 15-4513 binding was decreased in the hippocampus, thalamus, basal nuclei, and 
frontoparietal cortex and demonstrates that another subunit such as ~2 is unable to 
substitute for the ~P subunit. Electrophysiological analysis of DRG neurons from the 
homozygous null ~P mutant mouse demonstrated a dramatic eighty percent reduction in 
the maximal amplitude of GAB A-activated chloride currents and suggests that the majority 
of the GABAA receptors on the cell somas of isolated DRG sensory neurons in the neonatal 
mouse contain the ~P subunit and is consistent with in situ hybridization studies in the 
neonatal rat (Homanics et aI., 1997). Most ~PJdeficient mice die as neonates and some 
neonatal mortality is accompanied by cleft palate. The ~P null mutant mice that survive 
are runted until weaning but achieve normal body size by adulthood, although with a 
reduced life span. The adult ~P mutant mice are hyperactive and hyperresponsive to 
human contact and other sensory stimuli. The mice have difficulty swimming, walking on 
grids and fall off platforms and rotarods, although they do not have a jerky gait. The ~PJ
deficient mice display frequent myoclonus and occasional epileptic seizures. 
Hyperactivity, lack of coordination, and seizures are consistent with reduced presynaptic 
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inhibition in spinal cord and impaired inhibition in higher cortical centers (Homanics et al., 
1997). 
Mice with a homozygous null mutation in the Gad67 gene, which encodes an enzyme, 
responsible for GABA synthesis, glutamic acid decarboxylase, have defects in the 
formation of the palate, a phenotype which is also evident in ~PJdeficient mice (Condie et 
ai., 1997). 
1.4.11 Subunit Composition of GABAA Receptors In vivo 
Unlike the muscle acetylcholine receptor, the quaternary structure of the GABAA 
receptor has not been elucidated. It is, however, possible to construct putative subunit 
combinations, through in situ histochemical localisation of mRNA and 
immunocytochemical data. 
The significant sequence identity among the GABAA receptor subunits and to an even 
greater extent among subunit variants has encumbered the preparation of subunit-specific 
antibodies. It is only recently that subunit-specific antibodies have been available for 
immunocytochemical studies (Benke et al., 1991 a, 1991 b; Zimprich et aI., 1991), which so 
far have only implicated the existence of one possible GABAA receptor complex, a 1 ~2y2 
(Benke et al., 1991 b). Immunoprecipitation studies have shown that the a 1 subunit 
together with either ~2 or ~P subunits are constituents of 80% of the native GABAA 
receptors in bovine and rat brain, and that these aI, ~2 or ~P combinations co-exist with 
the y2 subunit in 20% to 30% of native receptors (Benke et al., 1991b). The results of 
immunoprecipitation studies have also described several other possible GABAA receptor 
subtype combinations: xl]al~ly2I [2] a2~Ny2I [3] aP~Ny2I and [4] aR~Ny2 (McKernan et 
ai., 1991). Although the majority of receptors immunoprecipitated from membranes 
contain only one a subunit isoform, a minority have been shown to contain more than one 
a subunit per receptor complex (Duggan, Pollard, Stephenson, 1991; Lilddens, Killisch 
and Seeburg, 1991; McKernan et al., 1991b). 
mRNA localization studies represent an indirect approach for addressing the question 
of GABAA receptor subunit composition. Where the mRNA expression patterns of two or 
more genes coincide, the receptor complex is presumed to co-assemble from the subunits 
present. Whether the mRNA abundance and distribution correlates with protein levels and 
localization has yet to be determined. 
In situ hybridization studies have demonstrated the differential distribution of the 13 
isolated rat GABAA receptor transcripts in embryonic, postnatal and adult brain (Wisden et 
al., 1992; Laurie et aI., 1992; Mohler et al., 1991; Killisch et al., 1991). mRNA 
localization studies of rat GABAA receptor transcripts have also implicated the existence 
of several possible GABAA receptor subtype subunit combinations in specific brain 
regions: [1] al ~2y2 (Laurie, Wisden, Seeburg, 1992; Lilddens and Wisden, 1991; 
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Gambaran et al., 1991; Pritchett et al., 1989; Shivers et aI., 1989; Wisden et al., 1992), [2] 
0.1 ~ 1 y2 (Malherbe et ai., 1990b), [3] 0.1 ~2yP (Herb et ai., 1992), [4] a2~Pyx (Persohn, 
Malherbe and Richards, 1991; Wisden et ai., 1992), [5] aR~lyx (Wisden et ai., 1992), [6] 
ala4~28 (Wisden et al., 1992), [7] ala4~2 (Wisden et ai., 1992), [8] aS~xy2 and [9] 
0.1 aS~x8 (Laurie, Wisden and Seeburg, 1992a). 
A more direct approach has been recently developed that uses a combination of 
transcriptional amplification and PCR amplification to measure RNA levels in single 
neurons (Sheng et ai., 1994). While this method still does not provide evidence of 
functional assembly it does greatly increase the sensitivity of RNA detection. 
The immunoprecipitation, in situ histochemical and immunocytochemcial studies 
described above have all identified the 0.1 ~2y2 combination, as the major receptor subtype 
in the adult brain. Co-expression experiments with 0.1, ~2 and y2 subunits have resulted 
in GABAA receptors which display high-affinity type 1 benzodiazepine binding (Pritchett 
et aI., 1989) and have channel properties similar, but not identical, to a subset of native 
GABAA receptors (Verdoorn et aI., 1990). Two of the other proposed subtypes, al~ly2 
and aR~lyxI are common to two of the three approaches used to investigate the in vivo 
GABAA receptor subunit composition. The 0.1 ~ 1 y2 sUbtype exhibits a pharmacologically 
and functionally similar profile to the 0.1 ~2y2 subtype (Malherbe et al., 1990b; Pritchett et 
al., 1989), while the aR~ 1 yx subtype produces GABAA receptors which display sensitivity 
to benzodiazepine receptor ligands but differ in their functional properties (Herb et al., 
1992; Knoflach et aI., 1991; Pritchett and Seeburg, 1990). 
1.S Conclusions 
This chapter has attempted to outline a small part of the elaborate communication 
network required by the mammalian central nervous system to enable responses to 
environmental stimuli. Pre- and post-synaptic receptors are responsible for the accurate 
transmission of information between cells. The diversity of responses required for such 
communication among cells is accomplished by heterogeneity within receptor classes. 
Receptor heterogeneity can be derived from several sources: [1] the number and types of 
subunits available to form the receptor complex, [2] different combinations of subunits and 
hence the emergence of SUbtypes of receptors, [3] alternative-splicing of subunit mRNAs, 
[4] RNA editing of subunit mRNA and [5] allelic variation, as has been demonstrated for 
the 04 subunit of the human dopamine receptor (Van Tol et al., 1992). The regulation of 
heterogeneity is controlled predominantly through the developmental and co-ordinated 
expression of receptor subunits and subunit variants (Schofield, Shivers, Seeburg. 1990). 
1.6 Research Project 
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GABAA receptor mediated responses are a classical example of the diversity that can 
be generated through the number of subunit genes and the possible combinatorial 
arrangements of these subunits within the receptor complex. As GABA is the major 
inhibitory neurotransmitter in the adult mammalian eNS (Bloom and Iversen, 1971) and 
may also playa neurotrophic role during development, the elucidation of temporal patterns 
of subunit mRNA expression is central towards an understanding of the development of 
system heterogeneity and hence neuronal plasticity. 
The aims of this project are: [1] to investigate the temporal patterns of GABA receptor 
subunit mRNA expression in the murine central nervous system and [2] to study the 
structure-function relationship of subunit amino acid conservation in ligand binding 
studies. The mouse was chosen because it is currently the only mammalian system in 
which both in vitro and in vivo genetic manipulations can be performed. Although the 
scope of this project concerns in vitro studies only, the information derived from these 
experiments should provide a useful reference for future in vivo studies where the 
generation of null mutants or the over-expression of specific subunit genes may be 
considered. 
GABAA receptor subunit genes exhibit a 30 to 40 percent amino acid sequence identity 
between subunits and a 70 to 90 percent sequence identity among subunit variants. When 
GABAA receptor subunit sequences are compared in a broader context with subunit 
sequences from other ligand-gated ion channels belonging to the ligand-gated ion channel 
superfamily, sequence identity decreases. There are however, specific amino acids in the 
putative cytoplasmic loop and transmembrane domains Ml and M2, which are conserved 
throughout the ligand-gated ion channel superfamily. We have chosen several of these 
highly conserved amino acids as positions for site-directed mutagenesis, and subsequent 
ligand binding analysis. We hypothesize that these sites may play key roles in subunit 
interactions involved in; pentameric subunit receptor assembly and in the formation of 
cooperative ligand binding domains. The results of these experiments may provide 
important insights into the structure-function relationship of the ligand-gated ion channel 
superfamily. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 Bacterial Strains 
The strains of bacteria used in this work are listed below. They are discussed in greater 
depth and referenced in Sambrook et al., (1989). 
TG·l: 
supE,hsd a5, thi a(lac-proAB)F'[traD36proAB+lacNlacUMI5] An EcoK-
derivative of JMIOI that neither modifies or restricts transfected DNA and supports 
growth of vectors carrying amber mutations. Used for the propagation of M13 
recombinants. 
CJ236: 
dut 1 ,ung 1, thi-I, relA IIpCJ 105 ( caml}") A dur ung- strain used to prepare uraciI-
containing DNA for site-directed mutagenesis experiments (Kunkel, Roberts and 
Zakour, 1987). pCJlO5 carries F' and camr; growth of CJ236 in the presence of 
chloroamphenicol selects for the retention of F. 
MCI0611p3: 
ara139, a(ara,leu)7696, galU, glaK, alacX74, hsr-, hsrm+, strA, deoR+, {p3:amber 
ampr, amber tetr, Kmr} A P3 containing strain designed to support replication of 
plasmid DNA's which encode the tyrosine tRNA suppressor (synthetic supF gene). 
All strains were grown in 2YT (l.6%bacto-tryptone, 1.0% bacto-yeast extract, 0.09 M 
NaCI, pH7.0), at 370 C . 
2.1.1.2 Mammalian Cell Line 
Human embryonic kidney 293 cells (ATCC CRL 1573) were a generous gift of Karen 
Haddington. The 293 cells were grown in Dulbecco's MEMlNutrient Mix, F12(l: 1) 
supplemented with 1 % L-Glutamine, 1 X StreptomyciniPenicillin and 10% fetal calf serum, 
at 370 C in 8% C02. 
Media for growth of bacteria and tissue culture were prepared by staff of the media kitchen 
in the MRC Laboratory of Molecular Biology. 
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2.1.2 Enzymes, Chemicals, Radioisotopes and Vectors 
2.1.2.1 Enzymes 
All enzymes were purchased from New England Biolabs with the following exceptions. 
T4 DNA ligase, RA V2 reverse transcriptase, S 1 nuclease and terminal transferase (used in 
the direct sequencing protocol, Lasham et al., 1992) were purchased from Boehringer 
Mannheim. T4 gene32 protein was purchased from United States Biochemical Corp. 
Terminal transferase (used to label probes for Northern blots and in situ hybridization), 1'7 
DNA polymerase and the Pharmacia oligo labelling kit were purchased from Pharmacia 
LKB. SP6 RNA polymerase, T7 RNA polymerase, T3 RNA polymerase, RNasin, Reagent 
kit for in vitro transcription and Taq DNA polymerase were purchased from Promega. Taq 
DNA polymerase was also purchased from Perkin Elmer Cetus. DNaseI, RNaseA and 
lysozyme were purchased from Sigma. All enzymes were used according to manufacturers 
specifications. 
2.1.2.2 Chemicals 
All chemicals were BDH analytical grade with the following exceptions. Acrylamide and 
bisacrylamide were BDH electrophoresis grade and sodium dodecyl sulphate (SDS) and 
diethylpyrocarbonate (DEPC) were BDH biochemcial grade. The Prep-A-Gene, DNA 
purification matrix kit was purchased from Biorad. Ethidium bromide (EtBr), putrescine, 
polyethylene glycol (PEG) 4000, polyvinylpyrrolidone (PVP), sorbitol, isopropylJ~Ja­
thiogalactopyranoside (lPTG), RJbromoJ4JchloroJPJindoylJ~JaJgalactopyranoside (X-gal), 
heparin, poly-L lysine, poly A and trypsin, tissue culture grade were purchased from Sigma. 
Water-saturated phenol was purchased from Rathburn Chemicals Ltd. Deoxynucleotide 
triphosphates (dNTPs), dideoxynucleotide triphosphates (ddNTPs), adenosine 
ribonucleotide triphosphate (rATP), random hexamers (pd(N)6) and Sephadex G-25 were 
purchased from Pharmacia LKB. Formamide and guanidine thiocyanate were purchased 
from Fluka. Dulbecco's MEMlNutrient Mix, F 12(1 : 1) with L-glutamine. lOX 
streptomycin/penicillin and fetal calf serum were purchased from GmCO BRL. The dGTP 
reagent kit for sequencing with Sequenase was purchased from United States Biochemical 
Corporation. Ultra pure grade reagents purchased from BRL were agarose, low melting 
point (LMP) agarose, cesium chloride, and urea. Dithiothreitol (DTT), N,N-bis-(2-
hydroxyethyl)-2-aminoethanesulfonic acid (BES), spermidine and spermine were purchased 
from Calbiochem. Yeast tRNA and glycogen were purchased from Boehringer Mannheim. 
K5 emulsion was purchased from Ilford Scientific Products. D19 developer was purchased 
from Kodak. Chloroform, methanol and N-butanol were purchased from R.P. Normapur. 
95% and 100% absolute ethanol (EtOH) was purchased from Hayman Ltd. 
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2.1.2.3 Radioisotopes 
a 32p dCTP (3000 Cilmmol), 'Y_32p ATP (>5000 Cilmmol) and a 35S dATP (800 
Cilrrunol) were purchased from Amersham. a-35S dATP (1200 Cilmmol) and a_32p dATP 
(6000 Cilmmol) were purchased from New England Nuclear. [3H] mu sci mol (23 
Cilmmol), [3H] flunitrazipam (83 Cilmmol), [3H] Ro15-1788 (78 Cilmmol), isoquavine, 
GABA, CL2I8 828, clonazepam, and flunitrazipam were generous gifts from I.L. Martin. 
2.1.2.4 Vectors 
M13mp18: M13 is a filamentous, F-pilus-specific, E. coli bacteriophage. A polylinker 
for the subcloning of DNA fragments with blunt, 3' or 5' overhangs resulting from 
restriction endonuclease cleavage has been introduced 5' of the ~Jgalactosidase sequence. 
Insertion of DNA into the poly linker results in inactivation of the ~Jgalactosidase a-fragment 
coding sequence which renders the resulting transformed colony or plaque unable to utilize 
the X-gal chi orogenic substrate and hence remains white. 
Bluescript KS+: pBluescript KS+ is a 2,961 base pair phagemid derived from 
PUCI9. The vector possesses an f1 phage origin, a colEl origin and T3 and T7 promoters 
flanking a novel polylinker containing 21 unique restriction sites. The fl phage origin 
allows single strand rescue, via helper phage infection, which produces a single-strand DNA 
which can be used for site-directed mutagenesis or DNA sequencing. The vector was 
purchased from Stratagene. 
pSP65: pSP65 is a 3,005 base pair plasmid containing an SP6 RNA polymerase 
promoter, 5' of a polylinker containing 11 unique restriction sites. Other features of this 
vector are described by Melton et ai., (1984). The vector was purchased from Promega. 
pCDM8: pCDM8 is a 4,500 base pair eukaryotic expression for cDNA cloning analysis 
in E. coli and eukaryotic systems. pCDM8 has a human CMV promoter and enhancer for 
transient expression in mammalian cells, SV40 and polyoma viral origins of replication for 
expression in mammalian cell lines which have been infected with SV40 or Polyoma viruses 
or in cell lines which carry the large T antigen, a ColEI-like origin of replication for 
expression in E. coli., the supF gene for the rescue of amber mutations which acts as a 
selectable marker for transformed E. coli cells, an M13 origin for single strand rescue via 
helper phage infection and T7 and SP6 RNA promoters. pCDM8 was a generous gift of Bill 
Wisden. 
37 
Chapter 2 Materials and Methods 
pRc/CMV: pRc/CMV is a 5,400 base pair eukaryotic expression vector designed for 
high level stable expression in eukaryotic cells. pRc/CMV has a human cytomegalovirus 
promoter and enhancer for the expression of cloned cDNAs in mammalian cell lines, a 
neomycin gene for the selection of stable transfectants, a ColE 1 origin of replication for 
expression in E. coli, an M13 origin for single strand rescue via helper phage infection and 
T7 and SP6 RNA promoters. pRc/CMV was purchased from British Biotechnology, a 
United Kingdom distributor for Invitrogen. 
2.1.2.5 Oligonucleotide probes and PCR primers 
All oligonucleotides (Tables 2.1, 2.2, 2.3 and 2.4) were synthesised on a 
Pharmacia:LKB Gene Assembler Plus. 
Probe Sequence Ammo Acid References 
Name/Subunit Change 
Cys loop 
MGD 1079/alpha 1 5' agggcaggcatgggcat Asp149-Asn149 Schofield et al .• 
tcatagggaaatcctc'3 (1987) 
MGD 1 085lbeta 1 5'cgaagatatcctctgaat Asp146-Asn146 " 
gaacaaaactgcacc'3 " 
MGD 1 0821beta 1 5'c gaagatatcctctg&l!.& Asp146-Glu146 " 
TMI 
gaacaaaactgcacc'3 
MGDl154/alphal 5'aactgtcattatgcaa i: cc Pro233-Ala233 Schofield et al., 
aggtatgtttgaat'3 (1987) 
MGD1149lbetai 5'ttgcaaacctacatgitlt Pro228-Ala228 " 
ccacactgattaca'3 
Table 2.1 Oligonucleotides designed for mutagenesis of bovine GABAA 
receptor subunit cDNA sequences. 
The oligonucleotides were used for in vitro mutagenesis as described by Kunkel, Roberts 
and Zakour, ( J 987). The nucleotides involved in the amino acid change are underlined and 
highlighted in bold print. 
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Probe Sequence Amino Acids Reference 
N arne/S ubunit 
MNU1479 5' ggggtcacccctggctaagttaggg 342-356 Khrestchatisky 
alphal gtatagctggttgctgtagg'3(A) et al., (1989) 
MNU1502 5' ggcaacggctacagcataggcgttgttct 340-344 Khrestchatisky 
alpha2 gtatcatgacggagcc'3(A) et al., (1991) 
MNU1503 5' aggtggttcccactatgttgaaggtggtg 361-375 Malherbe et al., 
alpha3 cttgttttcttggttg'3 (A) (1990a) 
MNU1577 5' gagtggtttcagaagactcctgggcagc 380-395 Wisden et al., 
alpha4 ggtggtcttgctggaat'3(A) 1991b 
MNU1480 5'attcccagtccc gcctggaagctgctcctt 355-369 Khrestchatisky 
alphaS tgggatgtttggagg'3(A) et al., (1989) 
MNU1505 5'agctgattctcttcttcagatggtacttgga 342-356 Malherbe et al., 
alpha6 gtcagagtgcacaac'3(A) (1990a) 
MNU1506 5' gcctgtccagccctcgtccgaagccctc 382-396 Luddens et al., 
beta 1 acggctgctcagtggtt'3(A) (1990) 
MNU1509 5'tcgttccagggcgttgcggccaaaactat 382-396 Ymer et al., 
beta2 gcctaggcaacccagc'3(A) (l989b) 
MNU1512 5'tctgtctcccatgtaccgcccatgcccttc 380-394 Ymer et al., 
beta3 cttgggcatgctctg'3( A) (l989b) 
MNU1515 5'catgggaatcagagtagatccagcatgg 340-354 Ymeretal., 
gamma 1 agacctggggataccgaagt'3(A) (1989b) 
MNU1516 5'gttcatttggatcgttgctgatctgggac g 339-353 Ymer et al., 
gamma2T gatatcaatggtagg'3(A) (1990) 
MNU15 5'ttagagggtgcttgaaggcttattcgatca 343-358 Shivers et al., 
gamma3 ggaatccatcttgtt'3(A) (1989) 
Herb etal., 
(1992) 
Table 2.2 Oligonucleotides designed to rat GABAA subunit cDNA 
sequences. 
The oligonucleotides were used for Sl protection experiments and as subunit specijic-
probes for Southern blot analysis. The gamma2T oligonucleotide can recognize both the 
long and short forms of the gamma2 subunit. The oligonucleotides are in an antisense 
configuration (A). 
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Probe Sequence Amino Acid Reference 
Name/Subunit 
MLS4000 5'gggtcacccctggctaagttaggggtat 369-383 Keir, et al., 
alphal agctggttgctgtagga'3( A) (1991) 
MNU16161 5' aggatctttggaaagattcggggcatagt 340-355 Chapter 3 and 
alpha2 tggcaacagctaccgc'3(A) Burt, 
unpublished 
results 
MNU16171 5'gagaactcagtatccttggccagattgat 373-385 Chapter 3 and 
alpha3 aggataggtggtaccc'3( A) Burt, 
unpublished 
results 
MLS40011 5' ggcctcagaagatggaacgatgggcaa 383-398 Kato, (1990) 
alpha6 agtcagagagctgattct'3(A) 
MNU15081 5'tggcactctggtcttgtttgctcgctcccttt N/A Chapter 3 
beta 1 ttctgagggcctt'3(A) 
MNU15071 5'acgatcattcttggccttggctgtcttctcc N/A Chapter 3 
beta3 gcaagcttcttctgcc'3(A) 
MNU15261 5'ccctccaaacactggtagccataatcatct N/A Chapter 3 
gamma 1 tccccttgtggcaaa3' (A) 
MGD7401 5'tagccatattcttcatccctctcttgaaggt 351-367 Kofuji et al., 
gamma2T gggtggcattgttcatt'3(A) (1991) 
MGD12731 5'atggtaggggccttgaaggaaaacatcc 334-341 " 
gamma2L gaagaagagggtttttc'3( A) 
MGD12741 5'ggacgaatatcaatggtaggggcaggg 330-345 " 
gamma2S tttttcttctttttgtct'3( A) 
MGD13521 5'ggaattgtttaacgtgatcatcacaggtg 363-377 Knoflach et al., 
gamma3 gtgggggcctcatgtc'3( A) (1991) 
MLS40021 5'acccatgaggttcccagggacccggcct 352-366 Sommer et al., 
delta! tgacgacgggagatagc'3(A) (1990a) 
Table 2.3 Oligonucleotides designed to mouse GABAA subunit cDNA 
sequences. 
The oligonucleotides were used for in situ hybridization experiments. The gamma2T 
oligonucleotide can recognize both the long and short forms of the gamma2 subunit. The 
oligonucleotides are in an antisense configuration (A). 
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Degenerate Sequence GAllA cDNA Reference 
Oligos coding region 
Name/Subunits 
MNU1455 5 'tagagtggatccatgac( ac )ac( tca)( t TM2 Chapter 3 
alpha 1,2,3,4,5,6 c)t (gac )ag( tc )atcagtgc'3 
MNU1491 5'ctagatgagctctt( tc )a( ac )ata( ct )gt TM4 Chapter 3 
al pha 1,2,3,5 (gt) gccca( ag)ta( ag)ac'3 
MNU1489 5'ctagatgagctcga( at )a( ag)gtaaac TM4 Chapter 3 
alpha4,6 (at)a(tc)cca(ag)ta(gc)ac'3 
MLS4004 5'tagagtggatccgt(gca)ct(gc )ac( c TM2 Chapter 3 
betal,2,3 ga)atgac( act )ac( ac )atca'3 
MLS4oo3 5'ctagatgagctc(ga)t( tg)( atc )acata TM4 Chapter 3 
betal,2,3 gta( ca)a(ga)cca( ag)ta(ga)ac'3 
MNU1494 5'tagagtggatccatcac( tc )ac(gt) gt( TM2 Chapter 3 
gammal,2,3 ctg)( ct )t(ga)ac( tc )atgac'3 
MNU1495 5'ctaactgagctc( ca)(ga)accca( ag)t TM4 Chapter 3 
gammal,2,3 a(ga)ac(ac )ag(ga)ttgaaca'3 
Table 2.4 Base-degenerate oligonucleotide sequences based on known rat 
GA BAA cDNA sequences. 
The oligonucleotides are degenerate at the positions indicated by brackets and were used in 
PCR amplification experiments to identify corresponding mouse sequences. The design and 
rationale of these degenerate nucleotide sequences is outlined in Chapter 3. 
2.2 METHODS 
2.2.1 DNA Preparation 
2.2.1.1 Plasmid DNA Mini Preparation 
This procedure is briefly outlined below and can be found in greater detail in Sambrook et 
al., (1989). 2 millilitres (mt) of 2 IT with the appropriate antibiotic were inoculated with a 
single colony and grown overnight at 300 revolutions per minute (rpm), 37oC, in a New 
Brunswick incubator. Cells were harvested by centrifugation for 5 minutes in a Beckman 
microfuge. The pellet was resuspended in 100 microlitres CI.d) of lysis buffer (50 mM 
glucose, 10 mM EDT A) and incubated at room temperature for 5 minutes. 200 J.1l of 0.2 M 
NaOH, 0.1 % SDS was added and the reaction was gently mixed by inversion of the tube 
several times. 150 J.1l of 5M potassium acetate, pH 4.5 was quickly added and the solutions 
were briefly mixed by inverting the tubes and vortexing. The reaction was then centrifuged 
in a Beckman microfuge for 10 minutes. 400 J.1l of supernatant was removed and extracted 
once with an equal volume of phenoVchloroform (50:50). The DNA was pelleted by the 
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addition of 1 ml of 95 % EtOH, placed in dry ice for 10 minutes followed by centrifugation 
for 10 minutes in a Beckman microfuge. The DNA pellets were washed with 70 % EtOH, 
dried under vacuum and resuspended in 25 JlI of dH20. 
This procedure gave plasmid DNA of a quality which could be restriction digested, 
sequenced. 
2.2.1.2 Large Scale Plasmid DNA Preparation 
This procedure is a modification of the methods of Birnboim and Doly (1979) and Ish-
Horowicz and Burke (1981). A single colony was inoculated into 500 m1 of 2YT with the 
appropriate antibiotic (100 Jlglml ampicillin for Bluescript KS+, pSP65 and pHEI with CAT 
and 100 Jlglml ampicillin, 12.5 Jlglml tetracyclin, and 50 Jlg/ml kanamycin for pCDM8) and 
shaken at 300 rpm in a New Brunswick incubator at 370 C, overnight. The cells were 
harvested by centrifugation at 40 C in a GSA rotor at 6K rpm for 10 minutes. The cell 
pellets were resuspended in 10 ml of lysis solution (10% sucrose, 5 mM EDTA, 50 mM 
Tris, pH 7.5 and 2 mglml of lysozyme) and placed on ice for 5 minutes. 20 ml of O.2M 
NaOH, 0.2% SDS was added and the suspension was vortexed briefly before 15 m1 of 3M 
NaOAc, pH 4.5 was added. The suspension was again vortexed briefly and then 
centrifuged at 8K rpm, 40 C for 10 minutes in a GSA rotor. The supernatant was collected 
and 0.6 volumes of isopropanol were added. This suspension was centrifuged at 8K rpm, 
40 C for 10 minutes in a GSA rotor. The pellet was resuspended in 9 m1 of TE (10 mM 
Tris, pH 7.5 and 1 mM EDT A) and 1 gram of cesium chloride per gram of solution. 200 JlI 
of 10 mglm1 ethidium bromide (EtBr) was added and the solution was transferred to 
Beckman Quick Seal tubes, prior to centrifugation in a NVT65 rotor at 60K rpm, 180 C for 
8 hours. Plasmid bands were extracted with an 18 gauge needle. Et Br was removed with 3 
to 4 butanol extractions. The plasmid was collected by suspension in 8 ml of dH20, 0.8 m1 
of 3M NaOAc, pH 5.2 and 16 ml of 95% EtOH, followed by a 30 minute incubation on ice, 
then a 30 minute incubation in dry ice and finally centrifugation for 30 minutes in a SS34 
rotor at 8K rpm, 4°C. The DNA pellet was washed twice with 70% EtOH and resuspended 
in dH20. The OD260 was determined and the purity of the DNA was checked by 
electrophoresis on an 0.7% agarose gel. 
The quality of this DNA was suitable for restriction endonuclease digestion, sequencing, 
in vitro transcription and mammalian cell transfection. 
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2.2.1.3 Single-Strand DNA Preparation 
2.2.1.3.1 Single-stranded M13 DNA Preparation 
Single-strand DNA from M13 phage was prepared as described by Vieira and Messing 
(1987). 
2.2.1.3.2 Single-stranded Bluescript KS+ DNA Preparation 
A single colony was inoculated into 2 mls of 2YT containing 100 Ilglml of ampicillin and 
approximately Ix 109 pfu/ml of M 13K07 helper phage (prepared as described by Vieira and 
Messing, (1987» and shaken in a New Brunswick incubator at 370 C for 1 hour. 
Kanamycin was then added to a final concentration of 5 Ilglml and the culture was grown 
overnight with aeration at 370 C. The cells were harvested by centrifugation in a Beckman 
microfuge for 10 minutes. The supernatant was transferred to a fresh tube with 10% 
PEG6000, 2.5 m NaCI, and 15 mM EDTA, pH 8.0 and incubated on ice for 2 hours. The 
phage were pelleted by centrifugation in a Beckman microfuge for 15 minutes. The 
supernatant was carefully removed and the inner walls of the microfuge tube were wiped 
prior to resuspending the pellet in 100 III of single strand extraction buffer (5 mM NaCI, 10 
mM TrisHCl, pH 8.0, 1 mM EDTA, 0.2% Sarkosyl and 50 Ilg/ml of Proteinase K). The 
reaction was incubated at 550 C for 30 minutes followed by phenoVchloroform (50:50) 
inactivation. The aqueous phase was removed and EtOH precipitated. The DNA pellet was 
washed with 70% EtOH, vacuum dried and resuspended in 30 III of TE. 
2.2.2 RNA Preparation 
2.2.2.1 Small Scale RNA Preparation 
For RNA preparation from less then 0.5 grams of tissue or from 106 cells the following 
method was used and is a modification of the method described by Chomczynski and Sacchi 
(1987). 100 III of solution D (4 M guanidine thiocyanate, 12.5 roM EDTA, 50 mM 
TrisHCI, 2% sodium N-lauryl sarcosinate and 140 mM ~JmercaptoethanolF was added to an 
eppendorf tube with cells or tissue and vortexed. In the case of large embryos, the tissue 
and solution were syringed to obtain a homogeneous suspension. 10 III of 2M Na acetate, 
pH 4.0 was added and the suspension was phenol extracted by adding 100 III of H20-
saturated phenol (no pH adjustment), 100 III of chloroformIIAA (isoamyl alcohol) 49: 1, 
vigourously mixed, placed on ice for 15 minutes and spun in a microfuge at 40 C for 15 
minutes. The aqueous phase was placed in a new tube and if dealing with less then 105 cells 
or 1 mg of tissue, 1 III of RNase-free glycogen at 20 Ilg/ml was added prior to EtOH 
precipitation. The RNA pellet was washed in 70% EtOH, dried and resuspended in 10 to 
100 III of DE PC-treated H20. 
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2.2.2.2 Tissue Isolation and Large Scale RNA Preparation 
This protocol is a modification of methods described by Glisin et al., (1974) and Ullrich et 
al., (1977) and is outlined in greater detail in Sambrook et al., (1989). Whole brains were 
removed from freshly killed animals, immediately placed in liquid nitrogen and then stored at 
-700 C. 1 to 5 grams of frozen tissue was ground under liquid nitrogen using a mortar and 
pestle. The ground tissue was suspended in 12 ml of guanidine thiocyanate solution (4M 
guanidine thiocyanate, 12.5 mM EDTA, pH 8.0, 50 mM TrisHCI, 2% sodium N-Iauryl 
sarcosinate and 140 mM 2-mercaptoethanol), briefly homogenised with a Brinkman polytron 
homogeniser and then centrifuged at 5K rpm, for 10 min in a Sorvall SS34 rotor, at 4° C. 
The supernatant was carefully layered over a 5.7M cesium chloride, O.1M EDTA, pH8.0 
cushion and spun for 18 hours, at 32K rpm, in a Beckman SW40 rotor at 4° C. The RNA 
pellet was washed twice with 95% EtOH and suspended in 1 rnl of HES buffer (10 mM 
Hepes, 5 mM EDTA, pH 8.0 and 0.1 % SDS). The RNA was EtOH precipitated, phenol 
extracted, reprecipitated and finally suspended in DEPC (diethylpyrocarbonate)-H20, at a 
concentration of 1 mg/ml. Total RNA was used for Northern blot analysis and S 1 nuclease 
protection. For 1 st strand synthesis, poly A+ mRNA was prepared by the method of 
Sambrook et ai., (1989) with the following modifications. Total RNA was heated at 650 C 
in elution buffer (10 mM Hepes, 1 mM EDT A and 0.1 % SDS) for 5 minutes, at which time 
5 M NaCI was added to a final concentration of 0.4 M NaCI. The RNA solution was 
repeatedly applied to an oligo dT cellulose column (up to 6 times). The column was washed 
with 25 ml of binding buffer (10 mM Hepes, 1 mM EDT A, pH 8.0, 0.1 % SDS and 0.4 M 
NaCl) and the RNA was eluted from the column with eight 0.5 rnl volumes of elution 
buffer, which had been preheated to 650 C. The 260 nm absorbance of the 0.5 ml aliquots 
was measured and the appropriate aliquots were pooled and EtOH precipitated. 
2.2.2.3 In Vitro Transcription of cRNA 
10 J..lg of plasmid DNA containing various bovine GABAA subunit cDNAs were digested 
with the appropriate restriction endonuclease, following the manufacturer's instructions, for 
at least 6 hours. Complete linearisation of the plasmid was checked by electrophoresing an 
aliquot on an 0.7% agarose (BRUultrapure) lXTAE (0.04 M Tris-acetate and 0.001 M 
EDT A, pH 8.0) gel. The linearised plasmid was phenol/chloroform (50:50) extracted, EtOH 
precipitated, washed in 70% EtOH, vacumm dried and resuspended in dH20 at a final 
concentration of 11lg/J..l1. 1 to 2 J..lg of DNA were added to a 60 J..lI reaction containing IX 
transcription buffer, 10 mM DTT, 2.0 units of RNasin, 1 mM of each rNTP (ribonucleotide 
triphosphate), 50 J..lM of pGppG, and 60 units of T7, T3 or SP6 RNA polymerase. The 
reaction was incubated at 370 C for 90 minutes to 2 hours. 1.5 units of RNasin and 3 units 
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of RNase-free DNase was added and the reaction was allowed to incubate at 370 C for a 
further 5 minutes. At this time the reaction was stopped by phenol/chlorofonn (50:50) 
extraction, followed by EtOH precipitation. The RNA pellet was washed with 70% EtOH, 
air dried and resuspended in 20 J!l of DEPC-treated H20. 5 J!l of this RNA was 
electrophoresed on a 1.5% agarose, 2.2 M fonnaldehyde, IX MOPS (3-(N-
morpholino )propanesulfonic acid gel, as described by Sambrook et al., (1989), to check the 
quantity and integrity of the sample. If a poly A tail was to be added to the RNA, then the 
remaining 15 J!l of the RNA sample was added to a 85 J!l reaction containing 100 J!M rATP, 
2.5 units of RNasin, 5 mM DTT, IX Poly A buffer (50 mM Tris-HCI, pH 7.9, 10 rnM 
MgCI2, 2.5 mM MnCI2, 250 mM NaCl) and 5 units of E. coli poly A polymerase (BRL) 
and incubated at 370 C for 2 hours. The reaction was terminated by phenol/chlorofonn 
(50:50) extraction. The aqueous phase was precipitated with 0.1 volumes of 3M K acetate, 
pH 5.2 and 3 volumes of EtOH. After centrifugation in a microfuge for 15 minutes at 40 C, 
the RNA pellet was washed with 70% EtOH, air dried and resuspended in 15 J!l of DEPC-
treated H20. This procedure routinely produced between 10 to 15 J!g of cRNA, which 
could be used for Xenopus oocyte injection or for in vitro translation. 
2.3 DNA MANIPULATION 
2.3.1 PCR Applications 
2.3.1.1 First-Strand cDNA Synthesis 
Five micrograms of poly A+ mRNA. which had been heat denatured at 650 C for 10 
minutes and then snap cooled, was added to a 25 J!l reaction containing IX transcription 
buffer (50 mM Tris-HCl, pH 8.3, 140 mM KCl, 10 mM MgCI2), 1 mM of each dNTP, 4 
mM DTT (dithiothreitol) 13 units of RNasin, 1 nM of random hexanucleotides (Phannacia) 
and 40 units of RA V -2 (avian myeloblastosis virus) reverse transcriptase. The reaction was 
incubated at 420 C for 2 hours followed by heat inactivation at 700 C for 10 minutes. The 
1st strand eDNA was separated from the remaining hexanucleotides by adding 65 J.lI of 
DEPC-treated H20, 0.1 volumes of 3 M Na acetate, pH 5.2 and 0.6 volumes of isopropanol 
to the reaction. followed by incubation on ice for 15 minutes and finally centrifugation in a 
microfuge for 20 minutes. This precipitation was repeated. The 1st strand eDNA pellet was 
washed in 70% EtOH, vacuum dried and resuspended in 25 J.lI of DEPC-treated H20. 
2.3.1.2 peR (Polymerase Chain Reaction) Amplification 
PCR reactions were routinely conducted in a 50 J!l volume containing IX PCR buffer (50 
mM KCI, 20 mM Tris-HCl, pH 8.4), 10 to 20 pmoles each of a forward and reverse primer, 
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2 mM MgCI2, 200 J.lM dNTPs, 1 to 5 J.lI of template and 0.3 units of Taq polymerase 
(Promega for degenerate PCR and Perkin Elmer Cetus for 3' and 5' termini modification). 
Templates used in the PCR reaction were: 
1. First strand cDNA 
2. Plasmid DNA containing cloned GABAA receptor subunit cDNAs 
2.3.1.3 Southern Blotting 
Four J.lI of 6X agarose gel loading buffer (0.25% bromophenol blue, 0.25% xylene 
cyanol, 15% Ficoll 400) was added to 10 J.lI of PCR product prior to loading onto 1.0% 
agarose gels containing 0.5 J.lglml of EtBr. Following electrophoresis the gels were 
photographed, denatured in 1.5 M NaCI, 0.5 M NaCI for 30 minutes, rinsed briefly in 
dH20 and neutralized for two 15 minute intervals in 1.5 M NaCl, 0.5 M Tris-HCI, pH 7.5. 
The DNA was transferred onto Hybond-N filters (Amersham International) in lOX SSC (IX 
SSC: 150 mM NaCI, 15 mM Na citrate) overnight according to the method of Southern 
(1976). After transfer the well positions were marked and the filter was washed briefly in 
2X SSPE, air dried and UV cross-linked using a Statagene UV Stratalinker™2400 (120 
loules/254 nm). 
2.3.1.4 Filter Hybridisation 
50 to 100 pmoles of oligonucleotide was labeled in a 50 J.lI reaction containing IX kinase 
buffer (50 mM Tris-HCI, pH 7.6, 10 mM MgCI2. 5 mM DTT, 100 J.lM spermidine-HCI, 
100 uM EDTA), 30 J.lCi of [y_32p]ATP and 10 units of T4 polynucleotide kinase (New 
England Biolabs). The reaction was incubated at 370 e for 2 to 3 hours and heat inactivated 
at 700 C for 10 minutes. The unreacted isotope was removed by spinning the sample 
through a Sephadex G25 column as outlined in Sambrook et aI., (1989) and the specific 
activity of the sample was determined by Cerenkov counting. The labeled probe was added 
to the hybridization solution (5X Denhardt's, 6X sse, ) at a concentration of 2 x 106 
dprnlml and the hybridization was continued at 420 C for 24 hours. After hybridisation was 
completed, the filter was washed 2 times in 500 ml of 2 x sse, 0.1 % SDS, at room 
temperature, followed by two washes for 30 minutes each in I X SSC, 0.1 % SDS, at 550 
C. The filters were exposed to preflashed Fuji-RX X-ray film, with an intensifying screen, 
at -700 C for 2 to 24 hours. 
2.3.2 Cloning 
2.3.2.1 Preparation of Vectors 
Bluescript KS+ constructs: 3 J.lg of vector was digested with either 10 units of EcoRl 
or 10 units of both BamH I and Xba 1 for 6 hours at 370 C, following the manufacturers 
specifications for the enzymes. The enzymes were heat inactivated by incubation at 700 C 
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for 10 minutes followed by calf alkaline phosphatase (CIP) (Boehringer Mannheim) 
treatment as outlined by Sambrook et al., (1989). The CIP was inactivated by 
phenol/chloroform (50:50) extraction and the vector DNA was EtOH precipitated, washed 
with 70% EtOH, vacuum dried and resuspended in 20 III of H20. The bovine alpha (ex) 1 
and beta E~F 1 cDNAs were isolated from the pSP65 constructs described by Schofield et 
al., (1987), by restriction digestion of the alpha 1 construct with EcoRI and restriction 
digestion of the beta 1 construct with BamHI and XhaI. The fragments were isolated from a 
0.8% TAE agarose gel and further purified using a Biorad Prep-a-gene kit, as outlined by 
the manufacturer. 100 ng of vector and approximately 50 to100 ng of eDNA insert were 
added to a ligation reaction containing 1 X ligase buffer (50 mM Tris-HCl, pH 7.6, 10 mM 
MgCI2, and 10 mM DIT), 1 mM rATP and 1 unit of T4 DNA ligase (Boehringer 
Mannheim). The reaction was incubated at 140 C for 24 hours. One quarter to one half of 
the reaction was transformed in to competent E. Coli TG 1 cells and after incubation at 370 C 
for 30 to 60 minutes, with gently shaking, the transformed cells were plated onto 2YT agar 
plates containing 100 Jlg/ml of ampicillin and the plates were incubated overnight at 370 C. 
Mini prep plasmid DNA was prepared as outlined in section 2.2.1.1 and the products were 
analysed by electrophoresis on a 0.8% agarose gel containing 0.5 Ilg/rnl of ethidium 
bromide and visualized under UV illumination. 
pCDM8 and pRcCMV constructs: The vector DNA was prepared as described above, 
with the following exceptions. 3 Jlg of vector DNA was digested with either 10 units of 
HindlII or 10 units of Xbal, at 370 C for 8 hours. The 5' and 3' termini of mutant and 
wild-type bovine alpha 1 and beta 1 cDNAs cloned into Bluescript KS+ were modified by 
PCR amplification with forward and reverse primers containing a HindlII restriction 
endonuclease site. lOng of template and 10 pmoles of each primer were included in a PCR 
reaction as outlined in section 2.3.1.2. The reaction was phenol/chloroform (50:50) 
extracted and isopropanol precipitated. An aliquot of the products was checked on a 0.8% 
IX TAE agarose gel, prior to purification of the remaining products with a Prep-a gene kit 
(Pharmacia), as specified by the manufacturer. The products were then incubated in a 50 Jll 
reaction with 40 units of HindlII, overnight at 370 C. The enzyme was heat inactivated by 
incubation at 700 C for 10 minutes. One fifth of the digested product was added to a ligation 
reaction as outlined above. In the case of pCDM8 the ligated products were transformed into 
competent MC1061 cells and the transformed cells were plated onto 2YT agar plates 
containing 100 Jlg/rnl of ampicillin and 12.5 Jlg/ml of tetracycline. 
M13mp18 constructs: Vector DNA was prepared as described above with the following 
exception. M13mp19 DNA was digested with 10 units each of BamHI and Sad for 6 hours 
at 370 C. 5 III of 1st strand cDNA and 20 pmoles of both forward and reverse degenerate 
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primers were included in a PCR reaction as outlined in section 2.3.1.2. 10 JlI of each PCR 
reaction was run on a 0.8% LMP agarose gel and the products were excised under UV 
illumination. The resulting gel slices were incubated at 700 C for 15 minutes and 5 JlI of the 
melted slices was added to a 15 JlI restriction reaction containing 10 units of both BamHI 
and Sad. This reaction was incubated at 370 C, overnight. The enzymes were heat 
inactivated and 5 JlI of this reaction was added to 15 JlI of a ligation reaction as outlined 
above. After 24 hours at 140 C one half of the ligation reaction was transformed into 
competent TO 1 cells and the transformed cells were pipetted into 3 rnl of prewarmed top 
agar (500 C) containing 20 JlI of 20mglrnl IPTO (isopropylthio-p-D-galactoside) and 20 JlI 
of20 mglml Xgal (5-bromo-4-chloro-3-indolyl-p-D-galactoside). The 3 ml of top agar was 
then poured onto 2YT agar plates, which were incubated at 370 C overnight. 
2.3.2.2 Competent Cells 
A single colony of cells was inoculated into 100 ml of 2YT and grown at 370 C in a New 
Brunswick incubator to an OD600 of 0.6 to 0.8. The cells were harvested by centrifugation, 
at 40 C in a Centronix clinical centrifuge at 3,000 rpm for 10 minutes. The cell pellet was 
resuspended in 20 ml of ice cold 50 mM CaCl2 and left on ice for 2 hours. The cells were 
again harvested by centrifugation at 40 C in a Centronix clinical centrifuge at 3,000 rpm for 
10 minutes and then resuspended in 7 rnl of ice cold 50 mM CaCI2. After preparation the 
competent cells could routinely be used for up to 5 days. 
2.3.3 Site-Directed Mutagenesis 
A single colony of E. coli CJ236 transformed cells was inoculated into 10 mls of 2IT 
medium containing 100 Jlglrnl ampicillin and 30 Jlglrnl chloramphenicol and shaken in a 
New Brunswick incubator at 300 rpm. After three hours, the culture was inoculated with 2 
X 107 pfu of K07 helper phage and incubated at 37°C for a further 8 hours. Single-
stranded DNA was prepared as described in section 2.2.1.3.2. The single-stranded DNA 
was analyzed on a 0.8% TAE agarose gel and quantitated by measuring the absorbance at 
260 nm. Primers for mutagenesis were phosphorylated at the 5' terminus. 100 pmoles of 
mutagenic oligonucleotide (10 pmoles/ml) was added to ImM rATP, 5mM DIT, 50 mM 
Tirs-HCI, pH 8, 10 mM MgCl2 and 10 units of T4 polynucleotide kinase (Biolabs) and 
incubated for 30 minutes at 370 C. The enzyme was heat inactivated at 700 C for 10 
minutes. To anneal template to primer, 1 to 2 Ilg of template and 5 pmoles of primer in 20 
mM Tris-HCI, pH 7.4,2 mM MgCl2 and 50 mM NaCl (final volume 10 Jll) were heated in 
a 0.5 rnl eppendorf tube placed a water-filled 15 m1 polypropylene culture tube at 700 C. 
One microlitre of dH20 replaced the 5 pmoles of primer as the control to determine the 
amount of unsubstituted template present in the reaction. After two minutes the culture tube 
was removed and the reaction was allowed to cool to room temperature. After cooling, the 
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eppendorf tubes were removed from the culture tubes, spun briefly in an eppendorf 
centrifuge and placed on ice. One microlitre of lOX synthesis buffer (5 mM of each dNTP, 
10 mM rATP, 100 mM Tris-HCI, pH 7.4,50 mM MgCl2 and 20 mM DIT), 10 units of T4 
DNA polymerase (Biolabs), and 5 units of T4 DNA ligase (Boehringer Mannheim) were 
added to the annealed reaction and left on ice for 5 minutes prior to incubation at room 
temperature for 5 minutes and finally at 370 C for 90 minutes. The reaction was stopped by 
the addition of 90 J.lI of dH20 and freezing at -200 C. Ten microliters of the mutagenesis 
reaction was used to transform competent E.coli TG2 cells prepared as described in section 
2.3.3.2. The transformed cells were plated on 2YT agar plates with 100 J.lg/ml ampicillin 
and grown at 370 C, overnight. Only unsubstituted templates and newly synthesized 
template can be replicated in TG2 cells. 
2.3.4 DNA Sequencing 
A Sequenase II (USB) DNA sequencing kit was used to sequence PCR products cloned 
into the Bluescript KS+ vector. Direct sequencing, which is a PCR-based method 
essentially as outlined by Lasham et al., (1992) was used to verify cDNAs cloned into the 
pCDM8 and pRcCMV expression vectors. 
2.4 Transient Expression in 293 Cells 
293 cells were plated at a concentration of 4 X 106 cells per 10 centimetre plate in 10 mls 
of Dulbecco's MEM !Nutrient Mis, F12 (1: 1), supplemented with 1 % L-glutamine, 1 X 
streptamycinJpenicillin and 10 % fetal calf serum and incubated overnight at 370 C in a 5 % 
C02 incubator. After overnight incubation, plates of cells which had reached approximately 
80 % confluence were used for transfections. 15 J.lg of each cDNA construct was added to 
0.5 ml of 250 mM CaCl2 and mixed gently prior to the addition of 0.5 ml of 2X BBS 
buffer, pH 6.95 (50 mM N-NBis(2-hydroxy-ethyl)-2-amino-ethanesulfonic acid, 280 roM: 
NaCI, 1.5 mM Na2HP04). After incubation at room temperature for 15 minutes, 1 ml of 
the calcium phosphatelDNA was added per plate of cells and incubated for 48 hours at 370 C 
in a 3% C02 incubator. 
Transfected 293 cell were harvested after 48 hours by washing the cell 2X in ice cold TBS 
(25 mM Tris-HCI, pH 7.4, 150 mM NaCl, 2.6 mM KCl).The cells were transferred into 10 
ml of TBS and collected at 40 C by centrifugation, for 10 minutes at 5K rpm in a clinical 
centrifuge. The cells were lysed by homogenisation in 25 mM Tris buffer. The membranes 
were collected by centrifugation in a Sorvall SS34 rotor at 20K rpm for 20 minutes at 40 C. 
The membrane pellet was washed 3X in ice cold TBS and resuspended to a final 
concentration of 1 mg/ml in ice cold IBS. 
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2.5 SI Nuclease Protection 
The S 1 nuclease protection assay is essentially as outlined by O'Donovan et aI, (1991). 
2.5.1 Oligonucleotide Preparation 
Oligonucleotides used for S 1 nuclease protection were gel purified. Approximately, one 
third of an oligonucleotide synthesis was suspended in formamide loading buffer, without 
bromophenol blue or xylene cyanol and heated at 850 C for 10 minutes prior to loading onto 
a prerun 10% polyacrylamide gel. The gel was run until the bromophenol blue dye was 
approximately two thirds of the distance from the top of the gel. The major product was 
visualized by VV shadowing and excised from the gel. The oligonucleotide was eluted from 
the gel slice by soaking the slice in 3M ammonium acetate, pH 504, for 3 to 8 hours. The 
eluted oligo was desalted over a C18 sep-pack, which had been pretreated with 100 percent 
acetonitrile and washed with 10 mls of H20. The bound oligonucleotide was eluted from 
the column with a 60:40 mixture of acetonitrile:H20, dried in a Speedvac and resuspended in 
50 JlI of DEPC-treated H20 prior to quantitation at 260 nm. 
2.5.2 S 1 Nuclease Reaction 
10 pmoles of purified oligonucleotide were end labelled with polynucleotide kinase and 
y2p-ATP in a reaction outlined in section 2.3.3.1 for 1 hour, at 370 C. 5 to 40 Jlg of total 
RNA and an equal amount of tRNA were ethanol precipitated and the pellets after 
centifugation were air dryed. The pelleted RNA was resuspended in 30 JlI of hybridization 
buffer (probe concentration: 1 pmolelrnl in OAM NaCI, 40 mM Hepes, pH 604 and 1 mM 
EDT A), heated at 900 C for 3 minutes and incubated at 700 C for 2 hours. Excess probe 
was removed by the addition of 300 JlI of S 1 nuclease buffer (S 1 nuclease 120 Vlml, 4.5 
mM zinc sulphate, 50 mM sodium acetate, pH 5.2. 0.3 M sodium chloride and 10 Jlglml 
single stranded DNA) and digestion at 370 C for 15 minutes. 300 JlI of the reaction was 
transferred to a fresh tube and inactivated with 48 JlI of 4 M ammonium acetate, 0.1 M 
EDT A. Double-stranded hybrids were precipitated with ethanol, resuspended in 20 JlI of 
formamide running buffer and denatured at 900 C for 2 minutes. The denatured samples 
were loaded onto a pre-electrophoresed 10% polyacrylamide gel and run until the 
bromophenol blue band was approximately two thirds of the distance from the top of the gel. 
The gels were fixed and dryed prior to exposure to Kodak X-Omat film from one to twenty 
four hours, at -700 C, with an intensifying screen. 
2.6 Localization of mRNA distribution in mouse brain 
Messenger RNA (mRNA) hybridization (in situ hybridisation) was performed essentially 
as in Wisden et al., (1992). 
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2.6.1 Section preparation 
Mice were killed by spinal dislocation and their brains were rapidly removed, frozen on 
dry ice, wrapped in parafilm (Fisons) to prevent freeze-drying, and stored at -700 C until 
sections were ready to be prepared. Horizontal serial sections (I2Jlm) were cut, using a 
cryostat, and thaw-mounted onto poly-L-Iysine-coated slides. Sections were dried for 30 
min at room temperature before being fixed for 5 min in 4% (w/v) paraformaldehyde in 1 x 
phosphate-buffered saline (PBS; 130 mM sodium chloride, 7 mM disodium hydrogen 
orthophosphate, 3 mM sodium dihydrogen orthophosphate). After washing twice for 2 min 
in 1 x PBS, sections were dehydrated for 5 min in 70% (v/v) ethanol and 5min in 95% (v/v) 
ethanol, and stored in 95% (v/v) ethanol at 40 C until use. 
2.6.2 Oligonucleotide probes 
Transcript-specific, antisense, 45-base oligonucleotide probes (Table 2.3) were 3' end-
labelled using terminal deoxynucleotidyl transferase (Pharmacia) and [a-35S]dATP (1300 
Cilmmol, New England Nuclear) to a specific activity of -109 dprnlmg. Labelled probes 
were purified on a I-ml Sephadex G-25 spun-column (Sambrook et al., 1989) prior to use, 
to remove unincorporated radiolabelled nucleotides. 
2.6.3 mRNA localization 
All hybridisations were standardized such that each contained 2.0 x I 03 dprnlml 
hybridization buffer (50% (v/v) formamide, 4 x SSC, 25 mM sodium phosphate (pH 7.0), I 
mM sodium pyrophosphate, 20 mM dithiothreitol, 5 x Denhardt's solution, 10% (w/v) 
dextran sulphate, 200 Jlglml acid-alkali hydrolyzed salmon sperm DNA, 100 Jlglml 
polyadenylic acid, 120 Ilglml heparin). Sections were hybridized in 200JlI buffer, under 
parafilm coverslips, overnight at 420 C. Control sections were hybridized in the presence of 
a 30-fold molar excess of the appropriate unlabelled oligonucleotide. After hybridisation, 
coverslips were removed in I x SSC at room temperature, and the sections were washed in 
O.3x SSC for 60 min at 550 C. They were rinsed at room temperature in Ix SSC, followed 
by a rinse in O.lx SSC, dehydrated sequentially in 70% (v/v) and 95% (v/v) ethanol and air-
dried. All wash solutions contained 10 mM dithiothreitol. Sections were exposed to Kodak 
X-Omat film at room temperature for 15 days before being dipped in Ilford K-S emulsion. 
After exposure for 50 days at 40C, sections were processed in Kodak DI9 developer for 2 
min at 170 C, briefly rinsed in distilled water, fixed in 30% (w/v) sodium thiosulphate for 4 
min, and finally washed in distilled water for 10 min. Sections were dried overnight at room 
temperature before being counterstained with 0.05% (w/v) thionin, differentiated in an 
ascending ethanol series (70%, 95% and 100% (v/v)), cleared in Histo-clear (National 
Diagnostics), and mounted in DPX (BDH). 
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2.6.4 Photography 
Autoradiographic images generated on X-ray film were printed with an enlarger directly 
onto Kodak Kodabrome II RC photographic paper (grade F5 M), giving reverse images. 
All sections were photographed onto Kodak Tech-Pan film using a Leitz microscope and 
35rnm camera with lightfield and darkfield condensers at 200 ASA and 1600 ASA settings 
respectively. Negatives were processed using Kodak HC-IID developer at 200 C for 4.5 
minutes. Both lightfield and darkfield negatives were printed onto Kodak Kodabrome II RC 
photographic paper (grade F5 M). Scale bars were determined using a precalibrated 
graticule. 
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3.1 Introduction 
Development of the mouse nervous system begins during embryogenesis and is 
completed during early postnatal development. During the postnatal period, activity-
dependent processes playa critical role in cell migration, differentiation and division, and 
synapse formation. Activity-dependent development has been extensively investigated in 
cortical structures where the normal progression of synapse formation can be disrupted either 
by sensory deprivation or by neuropharmacological manipulations, such as tetrodotoxin 
implants or chronic treatment with NMDA receptor antagonists. During embryonic 
development, trophic factors and cell adhesion molecules play an important role in cell 
differentiation, and the growth and guidance of neuronal processes. Recently, however, 
studies on embryonic development have also focused on molecules more normally associated 
with synaptic transmission in the adult central nervous system. Ion channels, particularly 
potassium channels, have recently been implicated in the processes of neuronal 
differentiation in cultured neurons (Jones and Ribera, 1994), and in granule cell migration in 
vivo in the autosomal recessive mouse mutant weaver. Neurotransmitters and their 
appropriate receptor complexes may also play an important part in neuronal development. 
Concentration gradients of neurotransmitter can in some circumstances, play an important 
role in growth cone guidance. Since GABA is the major inhibitory neurotransmitter of the 
adult central nervous system it is reasonable to suppose that GABA might also play a role 
during nervous system development. 
Several developmental studies of the nervous system including the superior cervical 
ganglia and cerebral cortex, have' demonstrated that GABA can exhibit trophic activities 
(Wolff, Joo and Dames, 1978; Wolff, Rickman and Chronwall, 1979). Furthermore, 
studies on the effects of GABA and GABA receptor agonists and antagonists in 
neuroblastoma cell cultures and on certain neuronal cell types in the retina, cortex and 
cerebellum have demonstrated a major role for GABA in synapse formation and cell 
differentiation (Spoerri and Wolff, 1981; Spoerri, 1988; Hansen et al., 1987). GAB A-
induced chemotaxis has been demonstrated in rat embryonic spinal cord cultures where 
neurons migrate toward picomolar concentrations of NGF and femtomolar concentrations of 
GABA beginning at embryonic day 13 (Behar et at., 1994). The neurons in the 
microchemotaxis assay exhibited chemotactic responses to NGF, while GABA stimulated 
chemokinesis (increased random movement). GABA chemokinesis was mimicked by 
muscimol and inhibited by bicuculline and picrotoxin, suggesting GABA motility signals 
were mediated by GABA receptors (Behar et ai., 1994). Immunohistochemical analysis of 
GABA immunoreactivity in E 13 spinal cord sections demonstrated that GABA loclaised in 
fibers close to the target destinations of migrating neurons, suggesting diffusible gradients of 
GABA for migratory cells (Behar et ai., 1994). GABA stinulated chemokinesis involves 
both GABAA and GABAB signaling pathways (Behar et ai, 1995). In the embryonic and 
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postnatal eNS, GABAA receptors have been demonstrated using biochemical, 
electrophysiological and immunocytochemical methodologies (Meier et al., 1991; Fiszman et 
al., 1990; Killisch et al., 1991). 
Although several in situ hybridization studies have examined the expression of GABAA 
receptor subunit mRNAs during embryogenesis, the starting point for such studies has been 
E15.5 in the rat, a time point that corresponds to approximately E13.5 in the mouse (Wisden 
et al., 1992; Poulter et al., 1993). This chapter is a preliminary investigation into the 
developmental pattern of GABAA receptor subunit mRNA expression and describes the 
early embryonic detection of GABAA receptor subunit mRNAs in the mouse, using 
degenerate RT-PCR and Southern blot analysis. Quantitation of various GABAA receptor 
subunit mRNAs was accomplished using S 1 nuclease protection analysis, during late 
embryonic and throughout postnatal CNS development. 
3.2 Results 
3.2.1 Experimental Rationale 
To identify the presence of GABAA receptor subunit mRNAs during early stages of 
nervous system development, it was necessary to use reverse transcription (RT)-PCR, due 
to the very small percentage of nervous system tissue present in the embryo during early 
embryogenesis. Degenerate oligonucleotides were designed based on rat sequences and 
were used in the RT-PCR experiments because of the lack of murine sequences for GABAA 
receptor subunits at the time of the experiment. Southern blot hybridization analysis was 
used to identify specific GABAA receptor subunit sequences amplified from the PCR 
reactions. 
To identify specific GABAA receptor subunit sequences derived from PCR amplification, 
forward and reverse PCR primers were designed to amplify a region of nonhomology 
among all GABAA receptor subunit cDNAs. Among GABAA receptor subunit cDNA 
sequences, the putative intracellular loop between transmembrane domains 3 and 4 is the 
most heterogeneous and therefore an excellent target sequence for the specific identification 
of GABAA receptor subunit mRNAs. In contrast, the sequences encoding transmembrane 
domains 3 and 4 are highly conserved among GABAA receptor subunits and therefore are 
excellent regions for the design of degenerate oligonucleotide PCR primers. Degenerate 
oligonucleotides were therefore designed to sequences within transmembrane domain 3 
(forward primers) and transmembrane domain 4 (reverse primers), as illustrated in Figure 
3.1. 
3.2.2 Degenerate Oligonucleotide Design 
Oligonucleotides for PCR had temperatures of melting (Tms) between 58°C and 74°C, as 
determined by the formula (2°C x # of Aff nucleotides + 4°C x # of G/C nucleotides). The 
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difference in thermal stability between Aff and G/C base pairs is based on the higher degree 
of hydrogen bonding between G/C base pairs. The degree of degeneracy of each 
oligonucleotide is the product of the number of bases present at each degenerate site. The 
degree of degeneracy ranged from 64 to 192. As illustrated in Figure 3.1 amino acid 
alignments were used initially to determine the most homologous regions among rat receptor 
subunit sequences and then the corresponding DNA sequences were selected based on the 
above mentioned criteria (Tm and degree of degeneracy). Only one set of degenerate primers 
for each of the ~ (l,2,3) and ,),(1,2,3) subunit alignments was required to meet both the Tm 
and degeneracy guidelines. In the case of the a. subunit sequences, however, two reverse 
primers were required to maintain the limitations on the degree of sequence degeneracy for 
the PCR primers (listed in Table 2.4). As well as the GABAA receptor subunit sequences, 
each PCR primer also contains one restriction endonuclease site followed by six nucleotides. 
The six nucleotides at the end of each primer are positioned such that the restriction sites are 
not at the immediate ends of the PCR products. This positioning is based on optimization of 
cleavage (NewEngland Biolabs, technical notes) from an end with the restriction enzymes 
listed above. The restriction sites for EcoRI (forward primers) and Sad (reverse primers) 
are used for directional subcloning of PCR products into the phage vector, M13mpl8 for 
subsequent sequence analysis. 
3.2.3 RT-PCR and Southern blot analysis of GABAA receptor subunit 
mRNAs 
First strand cDNA was reverse transcribed with RA V-2 reverse transcriptase from either 
total or polyA+ mRNA preparations as described in Methods 2.3.1.1. Polymerase chain 
reactions contained 5 III of the first strand eDNA, 0.3 units of Taq polymerase (Promega), 
10 pmoles of each of a degenerate forward and reverse primer, in a volume of 50 J.lI with 
final concentrations of 2 mM MgCh, 200 J.lM dNTPs, 50 mMKCI, and 20 mM Tris-HCl. 
The reactions were heat denatured for 5 minutes prior to 30 cycles of 1 minute at 90°C, 2 
minutes at 50°C and 1 minute at 72°C. After the 30 cycles were completed, one final 
extension was performed at 72°C for 7 minutes. The PCR products were electrophoresed 
on aO.8% LMP agarose gel and subcloned into M13mpl8 as described in Methods 2.3.2.1 
and 2.3.2.2. Blue/white selection was used to choose plaques for subsequent DNA 
sequencing experiments. Introduction of foreign DNA into the multiple cloning sites of the 
M 13 vector results in interruption of complementation provided by the a. fragment of the ~ 
galactosidase gene carried by the M 13 plasmid. Single stranded M 13mp 18 template DNA 
was prepared as described by Vieira and Messing (1987) and dideoxynucleotide sequencing 
was performed using a Sequenase II DNA sequencing kit (USB) and the M13 universal 
forward sequencing primer. 
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The products of the degenerate oligonucleotide driven PCR were electrophoresed 
through 0.7% agarose gels prior to immobilisation onto Hybond N nylon filters. As 
outlined in Methods 2.3.1.3 and 2.3.1.4, the filters were UV cross-linked, prehybridised for 
2 hours in 5x Denhardts, 6x SSC, and then hybridised for 24 hours with a rat GABAA 
receptor subunit-specific p32-labeled oligonucleotide probe. After hybridisation the filters 
were washed in Ix SSC, 0.1 % SDS, at 55°C to remove nonspecific labeling, prior to 
exposure to pre-flashed Fuji RX X-ray film. 
A 
Rat y1 
Rat 12 
Rat y3 
AsmAoTpid~TTsiTMTTipT~Aoh 
AsmAoTpid~TTsiTMTTipT~Aoh 
ATmAoTTid~TTsiTMTTipT~Aoh 
B 
Ryl A v PAR T S L G ITT V L T M TTL S 
Ryl GCTGTACCTGCTAGAACATCCCTGGGTATCACTACGGTTTTGACTATGACAACCCTCAG 
Ry2 GCTGTTCCTGCCAGAACATCTTTAGGAATCACTACTGTCCTGACCATGACAACTTTAAG 
Ry3 GCGACACCAGCAAGAACAACATTAGGCATCACCACGGTGCTAACCATGACCACACTCAG 
*.*.*.***************** 
GCTGTACCTGCTAGAACATCCTTAGGTATCACTACGGTTCTGACCATGACAACCCTCAG 
ACT A C A TC G ACT CT A T C TT A 
A A C G A 
T I ARK 
Ryl TACAATCGCTAGA 
Ry2 CACCATAGCCAGA 
Ry3 CACCATTGCCAGG 
CACCATCGCCAGA 
T A A T G 
T 
2x 2x 3x2x2x2 = 96 
Figure 3.1 Amino Acid and DNA Alignments of Transmembrane Domain 2 
of Rat GABAA Receptor r Subunit Sequences. A: Amino acid alignments the 
transmembrane 2 region of the rat r1, 1-2 and r3 GABAA receptor subunits. B: DNA 
56 
Chapter 3 Developmental Expression I 
alignments of the corresponding rat cDNA sequences. The rat yl amino acid sequence is 
above the DNA alignment for codon reference. A consensus sequence is listed below the 
alignment and includes sites of degeneracy. Asterisks are placed above the sequence used in 
the peR primer and the degree of degeneracy (96X) is calculated below the consensus 
sequence. 
Figure 3.2 illustrates the peR products detected by ethidium bromide staining of the 
electrophoresed 0.7% agarose gels. As shown in Figure 3.2 the presence and amount of 
PCR product generated was dependent on the primer set used. For example, in peR 
reactions where degenerate oligonucleotides for the detection of GABAA receptor a I, a2, 
a3 and a5 subunit mRNAs were used, ethidium bromide staining detected PCR products at 
all developmental stages studied. In contrast, in peR reactions where degenerate 
oligonucleotides were used for the detection of GABAA receptor a4 and a6 mRNAs, only 
peR products from adult first strand cDNA were visualized by ethidium bromide staining. 
peR products are present at varying amounts in all developmental stages tested from peR 
reactions incorporating degenerate oligonucleotides for the detection of GABAA receptor ~ I , 
~2I ~P subunit mRNAs. There was no detectable ethidium bromide staining of peR 
products derived from the amplification of first strand templates derived from E7.5, E8.5, 
E12 and E14 total mRNAs using degenerate oligonucleotides designed for the detection of 
GABAA receptor yl, "{2, and 13 subunit mRNAs (Figure 3.2). 
Gestation Days Postnatal Days 
Subunit 7.5 8.5 9.5 12 14 1 7 14 Adult 
Table 3.1 
GABAA 
al + + + + + + + + + 
a2 + + + + - + - + -
a3 + + + + + + + + + 
a4 
- - + - - + + + + 
a5 
- - - - - + + + + 
a6 - - + + + + + + + 
~N - - + + + + + + + 
~2 - - - - - + + + + 
~P - - - - + - + + + 
yl 
- - - - - + - + + 
"{2 + + + + + + + + + 
y3 
- - - - - - - + + 
Southern blot analysis of RT·PCR detection experiments for 
receptor subunit mRNA expression during murine C N S 
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development. Hybridisation signals were obtained from Southern blot analysis with 
oligonucleotide probes specificfor the GABAA receptor al-, a2-, a3-, a4-, as-, a6-, /31-, 
/32-, /33-, yl-, '}Q-, and y3-subunit cDNAs and are scored as positive (+) or negative (-). 
Further analysis of the DNA products generated from degenerate-oligonucleotide driven 
PCR are shown in Figures 3.3 through 3.6 and results are summarized in Table 3.1. Figure 
3.2 shows that although there was abundant product from each amplification reaction, as 
evidenced by ethidium bromide staining, not all subunit cDNAs to which the degenerate 
oligonucleotides were designed, are detectable at each stage in development. In Figure 3.3, 
the a 1 GABAA receptor subunit mRNA was represented throughout development, while 
Southern blot analysis failed to detected the a2 subunit mRNA of the GABAA receptor in 
E14, P7 and adult first strand cDNA templates. The a3 subunit mRNA of the GABAA 
receptor was detected throughout embryonic and postnatal development, by Southern blot 
analysis. In Figure 3.4, a p32-labeled rat a4 GABAA receptor subunit oligonucleotide 
probe detected specific murine a4 subunit mRNA amplified from the E8.5, PO, P7, P14 and 
adult first strand templates. The a6 rat GABAA receptor subunit oligonucleotide probe 
detected mRNAs amplified from the E9.5, E12.5, E14.5, PO, P7, P14 and adult first strand 
templates (Figure 3.4), while the as GABAA receptor subunit oligonucleotide probe only 
detected a5 subunit mRNA amplified from postnatal and adult first strand templates (Figure 
3.4). 
In Figure 3.5, Southern blot analysis detected murine ~ 1 GABAA receptor subunit 
mRNA amplified from E12.5, E14.5, PO, P7, P14 and adult first strand cDNA templates. A 
~2 specific subunit mRNA was amplified from postnatal and adult first strand templates 
(Figure 3.5), while a ~P specific GABAA receptor subunit mRNA was identified from the 
amplification of E14, P7, P14 and adult first strand cDNA templates (Figure 3.5). 
Southern blot analysis with a rat yl GABAA receptor subunit probe identified murine 
yl subunit specific mRNA from amplification of PO, P14 and adult first strand cDNA 
templates (Figure 3.6). Murine 12 GABAA receptor subunit mRNA was detected in all first 
strand cDNA templates amplified (Figure 3.6), while a y3 GABAA receptor subunit mRNA 
was detected in DNA amplified from P14 and adult cDNA first strand templates, only 
(Figure 3.6). Southern blot analysis with rat a6 and ~2 GABAA receptor subunit 
oligonucleotide probes detected more than one PCR product in DNA amplified from P14 
(a6) and adult (a6, ~2F first strand cDNA templates (Figures 3.4 and 3.5). 
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3.2.4 Sequence Analysis of Embyronic peR products 
Partial Mouse al GABAA receptor subunit cDNA sequences 
L I K K N N T YAP TAT S Y T P N L 
AI.I TCTCATTAAGAAAAACAACACATATGCTCCTACAGCAACCAGCTATACCCCTAACTTA 
AI.2 TCATTAAGAAAAACAACACATATGCTCCTACAGCAACCAGCTATACCCCTAACTTA 
AI.3 TCATTAAGAAAAACAACACATATGCTCCTACAGCAACCAGCTATACCCCTAACTTA 
AI.4 TCTCATTAAGAAAAACAACACATATGCTCCCACAGCAACCAGCTATACCCCTAACTTA 
AI.S TCTCATTAAGAAAAACAACACATATGCTCCTACAGCAACCAGCTATACCCCTAACTTA 
A R G D P G L A T I A K SAT I E P K E 
Al.l GCCAGGGGTGACCCCGGCTTGGCAACTATTGCTAAAAGTGCGACCATAGAACCGAAAG 
AI.2 GCCAGGGGTGACCCCGGCTTGGCAACTATTGCTAAAAGTGCGACCATAGAACCGAAAG 
AI.3 GCCAGGGGTGACCC GGCTTGGCAACTATTGCTAAAAGTGCGACCATAGAACCGAAAG 
Al.4 GCCAGGGGTGACCCCGGCTTGGCAACTATTGCTAAAAGTGCGACCATAGAACCGAAAG 
AI.S GCCAGGGGTGACCCCGGCTTGGCAACTATTGCTAAAAGTGCGACCATAGAACCGAAAG 
Y K PET K P PEP K K T F N S V S K 
AI.I AAGTCAAGCCTGAGACAAAACCACCAGAACCCAAGAAAAC TTTAACAGCGTCAGCAA 
AI.2 AAGTCAAGCCTGAGACAAAACCACCAGAACCCAAGAAAACCTTTAACAGCGT AGCAA 
AI.3 AAGTCAAGCCTGAGACAAAACCACCAGAACCC 
AI.4 AAGTCAAGCCTGAGACAAAACCACCAGAACCCAAGAAAACCTTTAACAGCGTCAGCAA 
AI.S AAGTCAAGCCTGAGACAAAACCACCAGAACCCAAGAAAACCTTTAACTGCGTCAGCAA 
I DRL SRI A F 
AI.I AATCGACCG CTG T AAGAATAGC TT 
AI.2 AATCGACCGACTG TCAAGAATAGCCTT 
AI.3 
AI.4 AATCGACCGACTGCTCAAGAATAGCCTTTCG 
AI.S AATCGACCG CTG T 
Partial Mouse a3 GABAA receptor subunit cDNA sequences 
M TTL SIS A R N S L P K V A Y A T A 
A3.l ATGACAACGCTGAGTATCAGTGCCAGAAACTCTTTACCTAAAGTGGCATACGCGACGG 
M D W E M A V C Y A F V F SAL I E F 
A3.I CCATGGACTGGTTCATGGCCGTCTGTTATGCCTTTGTATTTTCTGCACTGATTGAATT 
A T V N Y F T K R S W AWE G K K 
A3.1 TGCTACTGTCAACTACTTCACCAAGCGGAGTTGGGCTTGGGAAGGCAAGAAGG 
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Partial Mouse ~N GABAA receptor subunit cDNA sequences 
K I PYV K A I DIY L M G C F V F V 
BI.I GAAGATCCCTTACGTCAAAGCGATTGACATCTATCTCATGGGCTGTTTTGTGTTTGTG 
BI.2 GAAAGCGATTGACATCTATCTCATGGGCTGTTTTGTGTTTGTG 
B1.3 
F L ALL E Y A F V N Y IFF G K G P Q 
BI.I TTCCTGGCTCTACTGGAATATGCTTTTGTCAATTACATTTTCTTCGGAAAAGGCCCTC 
BI.2 TTCCTGGCTCTACTGGAATATGCTTTTGTCAATTACATTTTCTTCGGAAAAGGCCCTC 
BI.3 TTCTTCGGAAAAGGCCCTC 
K K GAS K Q D Q SAN F K N R L E M 
BI.I AGAAAAAGGGAGCGAGCAAACAAGACCAGAGTGCCAATGAAAAGAACAGACTGGAGAT 
BI.2 AGAAAAAGGGAGCGAGCAAACAAGACCAGAGTGCCAATGAAAAGAACAGACTGGAGAT 
BI.3 AGAAAAAGGGAGCGAGCAAACAAGACCAGAGTGCCAATGAAAAGAACAGACTGGAGAT 
N K V Q V D 
BI.l GA CAAAGTC AGTTGTGCCACGCA TATCTCT 
BI.2 GAAACACAGTCCAAGTTGACCCACGCAATATCTCTCA 
BI.3 GAA CAAAGTC AGTTGACGCACGCAATATCTCTCA 
Partial Mouse ~P GABAA receptor subunit cDNA sequences 
K I PYVKA I DM YLMGC FV FV 
B3.I AAAATTCCCTATGTCAAAGCCATCGACATG TACCTGATGGGCTGCTTTGGTCTTTGT 
B3.2 AAAGCCATCGACATGATACCTGATGGGCTGCTTTG TCTTTTG 
B3.3 AAAATTCCCTATGTCAAAGCCATCGACATG TACCTGATGGGCTGCTTTG TCTTTGT 
B3.4 AAAATTCCCTATGTCAAAGCCATCGACATG TACCTGATGGGCTGCTTTG TCTTTGT 
B3.5 AAAATTCCCTATGTCAAAGCCATCGACATG TACCTGATGGGCTGCTTTG TCTTTGT 
F I ALL E Y A F V N Y IFF G R G P 
B3.I ATTCCTGGCACTTCTGGAGTATGCCTTTGTCAACTACATTTTCTTTGGAAGAGGTTC 
B3.2 TATTCCTGGCACTTCTGGAGTACGCCTTTGTCAACTACATTTTCTTTGGAAGAGGTCC 
B3.3 ATTCCTGGCACTTCTGGAGTACGCCTTTGTCAACTACATTTTCTTTGGAAGAGGTCC 
B3.4 ATTCCTGGCACTTCTGGAGTATGCCTTTGTCAACTACATTTTCTTTGGAAGAGGTCC 
B3.5 ATTCCTGGCACTTCTGGAGTATGCCTTTGTCAACTACATTTTCTTTGGAAGAGGTCC 
Q R Q K K L A E K T A K A K N DRS K 
B3.I CCCAAAGGCAGAAGAAGCTTGCGGAGAAGACAGCCAAGGCCAAGAATGATCGTTCTA 
B3.2 CCAAAGGCAGAAGAAGCTTGCGGAGAAGACAGCCAAGG AAGAATGATCGT 
B3.3 CAAAGGCAGAAGAAGCTTGCG AGAAGACAGCCAAGGCCAAGAATGATCGT CTA 
B3.4 CAAAGGCAGAAGAAGCTTGCGGAGAAGACAGCCAAGGCCAAGAATGATCG 
B3.5 CAAAGGCAGAAGAAGCTTGCGGAGAAGACAGCCAAGGCCAAGAATGATGCTTCTA 
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S E I N R V D A H G N 
B3.1 AGAGTGAAATAAACCGGGTGGATGCTCACGGGAAT 
B3.2 
B3.3 AGAG 
B3.4 
B3.5 AGAGTGAAATAAAC GGTGGATGCTCACGG AATA 
Partial Mouse yl GABAA receptor subunit cDNA sequences 
T LIP M N TIS L P Q G F D D Y G Y 
Gl.l ACT CTCATTCCCATGAACACCATTTCTTTGCCACAAGGGGAAGATGATTATGGCTAC 
Gl.2 ACTTCTCATTCCCATGAACAGCATTTCTTTGCCACAAGGGGAAGATGATTATGGCTAC 
Gl.3 ACT CTCATTCCCATGAACAGCATTTCTTTGCCACAAGGGGAAGATGATTATGGCTAC 
Gl.4 ACT CTCATTCCCATGAACAGCATTTCTTTGCCGCAAGGGGAAGATGATTATGGCTAC 
Q C LEG K D C T S F FCC F D G CRT 
Gl.l CAGTGTTTGGAGGGCAAAGACTGTACTAGCTTTTTCTGTTGCTTGCATGACTGCAGAA 
Gl.2 CAGTGTTTGGAGGGCAAAGACTGTACTAGCTTTTTCTGTTGCTTCGATGACTGCAGAA 
Gl.3 CAGTGTTTGGAGGGCAAAGACTGTACTAGCTTTTTCTGTTGCTTCGATGACTGCAGAA 
Gl.4 CAGTGTTTGGAGGGCAAAGACTGTACTAGCTTTTTCTGTTGCTTCGATGACTGCAAAA 
G S W REG R I H I R I A KID S Y S 
Gl.l C GGGTCCTGGAGGGAAGGGCGGATACACATACGCATTGCAAAAATTGACTCCTACTC 
Gl.2 CTGGGTCCTGGAGGGAAGGGCGGATACACATACGCATTGCAAAAATTGACT CTACTC 
Gl.3 CTGGGTCCTGGAGGG 
Gl.4 CTGGGTCCTGGAGGG 
R IFF Q Q L C L F N W 
Gl.l CAGAATCTTTTTCCAACAGCTTT GC TTGTTCAACTGG 
Gl.2 CAGAATCTTTTTCCAACAGCTTTTGCCTTGTTCACCT 
Figure 3.7 Partial Sequences of Murine GABAA receptor Subunit cDNAs. 
First strand cDNAs synthesised/rom total RNA isolated/rom 9.5 and 14 day embryos were 
used in PCR amplications with degenerate oligonucleotide primers. The PCR products were 
subcloned into the M 13mp 18 vector and templates were sequenced using a Sequenase II 
DNA sequencing kit (USB) and the universal M 13 forward sequencing primer. Single letter 
amino acid classification is shown above the first nucleotide 0/ each codon. Underlined 
sequences were used in the design o/probes/or in. m.u hybridisation. 
To verify that the results from Southern blot analysis, peR products from the 
amplification of sequences between TM2 and TM4 were identified for the mouse 0.1, 0.3, 
~ 1, ~P and yl GABAA receptor subunit cDNAs (Figure 3.7) and previously reported 
sequences for 0.2, 0.6, y2, 13 and at mouse GABAA receptor subunit cDNAs. In this 
sequencing analysis, sequences for 0.4 , 0.5 and ~2 GABAA receptor subunit cDNAs were 
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not detected. The absense of sequences for the a4, a5, ~2I were confirmed by Southern 
blot analysis of the PCR products from the amplification of first strand cDNAs synthesised 
from 9.5 and 14 day embryonic total RNA. 
Several M13 clones were obtained for each of the a2, a3, ~NI ~2I ~PI yl and 01 partial 
GABAA receptor subunit cDNA sequences and amino acid alignments showed that the 
amino acid code remained constant. However, at the third position in several codons 
variability in the nucleotide sequences was observed. This variability in DNA sequence 
probably reflects allelic variation, rather than PCR artefacts, since the same amino acid and 
nucleotide positions were always affected. 
3.2.5 81 Nuclease Analysis of Developmental Murine GABAA Receptor 
Subunit mRNA Expression 
Although RT-PCR with degenerate oligonucleotide primers and subsequent Southern 
blot analysis can identify the presence of specific GABAA receptor subunit mRNAs during 
development, it is not a quantitative method. S 1 nuclease protection was therefore used to 
quantitate 4 a, 2 ~ and 3 y GABAA receptor subunit mRNAs during embryonic and 
postnatal stages of CNS development. Total RNA was prepared as described in Chapter 2: 
Materials and Methods (Section 2.2.2.2) from whole embryos or whole brain. Three to four 
early stage embryos were required for the preparation of quantities of RNA necessary for the 
S 1 experiments. Oligonucleotides listed in Table 2.2 were gel purified and p32-labeled as 
outlined in Method 2.5.1. S 1 nuclease reactions were performed as outlined in Chapter 2: 
Materials and Methods (Section 2.5.2) and run on non-denaturing pre-electrophoresed 10 
percent polyacrylamide gels. After electrophoresis, the gels were dried and exposed to pre-
flashed Fuji RX X-ray film (Figures 3.8, 3.9 and 3.10). S 1 nuclease experiments were 
repeated three times for each oligo and RNA sample used and quantified by densitometry of 
audioradiograms of the GABAA receptor subunit and ~Jactin mRNA products. pince~­
actin mRNA levels are not developmentally regulated, ratios of the densitometric values of 
GABAA receptor subunit mRNA to ~Jactin mRNA were used to calculate the changes in 
GABAA receptor subunit mRNAs through development. Use of the GABAA receptor 
subunit mRNA to f3-actin mRNA ratio accounts for differences which may exist in the 
amount of total RNA used in each S 1 nuclease reaction. The ratios of GABAA receptor 
subunit mRNA to ~Jactin subunit mRNA were plotted throughout embryonic and postnatal 
CNS development and are summarized in Figure 3.11. 
Ratios of a 1 GABAA receptor subunit mRNA to f3-actin subunit mRNA were 
consistently higher than those for the a2, a3 and a6 GABAA receptor subunit mRNAs, 
throughout the stages of eNS development studied and in the adult brain. a 1 GABAA 
receptor subunit to ~Jactin subunit mRNA ratios were lowest at E14 and peaked around PO 
before decreasing to the adult level. The ratio of a2 GABAA receptor subunit mRNA to ~J
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actin subunit mRNA was highest at E14 and decreased throughout postnatal development to 
adult levels. Both a3 and a6 GABAA receptor mRNA to ~Jactin subunit mRNA ratios 
were low in the 14 day embryo and throughout CNS postnatal development. 
Ratios of ~P GABAA receptor subunit rnRNA to ~Jactin subunit rnRNA were 
consistently higher than the ratios of ~ 1 GABAA receptor subunit mRNA to ~Jactin subunit 
mRNA, throughout CNS postnatal development and in the adult brain. ~P GABAA receptor 
subunit rnRNA to p-actin ratios increased incrementally from E14 to the adult level. After 
birth, ratios of PI GABAA receptor subunit rnRNA to l3-actin subunit mRNA peaked at P7 
and decreased by P14 to the level of ~N mRNA present in the adult. 
Ratios of y2 GABAA receptor subunit mRNA to ~Jactin subunit mRNA were 
consistently higher than the ratios of yl and 13 GABAA receptor subunit mRNAs to p-actin 
subunit mRNA, throughout CNS development and in the adult murine brain. After birth, 
ratios of yl, y2 and 13 GABAA receptor subunit mRNAs to ~Jactin subunit mRNA 
increased incrementally to adult levels. 
3.3 Discussion 
During mouse embryogenesis, rapid morphological changes occur between embryonic 
days 7.5 and 14.5 (Figure 3.12). Beginning at about 7.5 days of gestation the mouse 
embryo shows signs of organ differentiation (Figure 3.12A), including the thickening of the 
ectoderm overlaying the notochord and paraxial mesoderm, which fold to form the neural 
tube, the rudiments of the mouse CNS. Closure of the neural tube begins at about E8.5 
(Figure 3.12B) along with the development of somites and neuromeres, which indicate the 
beginning segmentation of the muscles, skeleton, brain and spinal cord. Closure of the 
neural tube continues in an anterior to posterior direction and is completed by about ElO 
(Rugh, 1991). At 9.5 days of gestation (Figure 3.12C) four major divisions of the brain 
(prosencephalon, mesencephalon, metencephalon, and myelencephalon) are apparent, with 
the prosencephalon and tail in close approximation. In fact, the head of the 9.5 day mouse 
embryo has developed well in advance of the rest of the body. Twenty-one to 25 somites 
are apparent through the skin surface (Figure 3.12C), with the more anterior somites always 
the most developed. By 14.5 days of gestation (Figure 3.12D), the skeletal and nervous 
systems are still in a stage of rapid development. The susceptibility of the nervous system 
during this stage of embryogenesis is due to rapid cell division, differentiation and migration 
To investigate the presence of GABAA receptor subunit mRNAs during this early period 
of nervous system development, degenerate oligonucleotides were designed to known rat 
GABAA receptor subunit cDNA sequences within the highly conserved regions of putative 
TM2s and TM4s. First strand eDNA templates were prepared from various whole embryo 
stages and postnatal and adult whole brain total mRNAs. At E7.5, before closure of the 
neural tube, a I, a2, a3, a6 and y2 GABAA receptor subunit mRNAs were detected by 
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PCR with degenerate oligonucleotides and subsequent Southern blot analysis. In vitro 
transient expression studies in HEK293 cells have demonstrated that co-expression of a 1 
and y2 GABAA receptor subunit cDNAS can result in functional GABAA receptors with 
unique pharmacological properties. At E8.5, when closure of the neural tube has begun, as 
well as early rhombomere organization, a, ~ and y GABAA receptor subunit mRNAs were 
detected by PCR with degenerate oligonucleotides and subsequent Southern blot analysis. 
Neither 13 nor yl GABAA receptor subunit mRNAs were detected during embryogenesis 
using this method. 
The very early detection (E7.5) of GABAA receptor subunits supports the hypothesis that 
during CNS development, GABAA receptors may participate in trophic activities. This 
trophic activity of GABAA receptors is believed to correlate with carrier-mediated release of 
GABA through a reverse uptake mechanism present in the plasma membranes of specialized 
growth cones (Gordon-Weeks, Lockerbie and Pearce, 1984). Growth cones are highly 
motile expansions at the ends of growing axons and dendrites and play key roles in 
synaptogenesis by making the initial contact with the postsynaptic neuron and by themselves 
becoming the presynaptic terminal. Recognition of an appropriate synaptic partner 
transforms the growth cone into either a presynaptic terminal, in the case of axonal growth 
cones (Rees, 1978) or into a postsynaptic element, in the case of dendritic growth cones 
(Vaughn et ai., 1974). Taylor and Gordon-Weeks, (1991) have demonstrated that a major 
portion of the K+-stimulated, Ca+-independent release of GABA from growth cones is 
mediated by a reversal of the GABA transporter, using uptake inhibitors to demonstrate this 
mechanism. During the transformation from a highly motile growth cone to a sessile 
synaptic element, the biochemical machinery for neurotransmission must develop. 
Electrical activity plays an important role in synaptogenesis and neuronal differentiation 
(Nelson et ai., 1990). The excitation level depends on the temporal activation of both 
excitatory and inhibitory pathways. However, stimulation of immature inhibitory pathways 
can evoke excitation rather than inhibition (reviewed by Cherubini, Gaiarsa and Ben Ari, 
1991). Cl- -mediated depolarizing potentials have been recorded in spinal motoneurons of 
newborn rats (Fulton et ai., 1980; Takahashi, 1984; Jahr and Yoshioka, 1986) and 
embryonic chicks (Obata, Oide and Tanaka, 1978; Velumian, 1984; O'Donovan, 1989). In 
motoneurons ofE16-E17 embryos, both strychnine and bicuculline were capable of blocking 
dorsal root ganglia evoked potentials. These GABA and glycine induced, CI- -mediated 
depolarizing responses gradually decrease during embryonic development and hence may be 
attributable to temporal changes in the expression of glycine and GABAA receptor subunit 
mRNAs, since suppression of this response results from neither a decrease in neuronal 
excitability nor the inhibition of glutamate receptors (Wu, Ziskind-Conhaim and Sweet, 
1992). The chemotropic response of microdissected rat E13.5 cortical plate cells (95% 
neurons) and immature ventricular zone cells (60% percursors) was differentially modulated 
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by micromolar and femtomolar concentrations of GABA, respectively (Behar et al., 1998). 
Behar et aI., (1998) demonstrated that GABA could promote motility via G-protein activation 
(response blocked by pertussis toxin) and arrest attractant-induced migration via GABAA 
receptor mediated depolarization. 
Degenerate oligonucleotide derived PCR results reported in this chapter demonstrate the 
rapidly changing temporal expression of GABAA receptor subunit mRNAs during 
embyronic development and support the role potential embryonic GABAA receptor 
complexes (E7.5-9.5: aly2, a3y2, a2y2, a4y2, a6')'2; EI2.5-14.5: al~fy2I aP~Ny2I 
aS~ 1 y2), may play in elicitation of network excitability. At E 15 in the rat, in situ 
hybridization anat),sis has demonstrated that transcripts for GABAA receptor 0.3, ~PI and y2 
subunits were found eXClUsively in fu~ m~~~ Du~yyey while those for 0.4, ~ 1 and "(\ were 
predominantly detected in the inner half of th . It" \\. \" tJ."fy~ '-l M\' ~Df e gerrruna or ven nCUlar zone \Nl.a au\l D ~y. \-"'\'\, 
1995). In the E 15 germinal matrix of the lumbar spinal cord, a4 subunit mRNA was much 
more abundant in the receding intermediate plate, which contains mostly postmitotic cells, 
that in the alar plate comprised of DNA . . . many -synthesIsIng cells and suggests that cells In the 
ventricular zone may express GABAA receptor a4, /31 and y1 subunit mRNAs at the 
premigratory stage, just after completing cell division (Ma and Barker, 1995). 
The results of S 1 nuclease protection experiments indicate that during postnatal CNS 
development, ai, ~ 1 and 12 subunits are the most abundant of the GABAA receptor subunit 
mRNAs examined. At postnatal day 1 and postnatal day 7, the abundance of a GABAA 
receptor subunit mRNA was 0.1> 0.2> 0.3 >0.6, whereas at postnatal day 14 and in the adult 
brain, the abundance of a GABAA receptor subunit mRNA was 0.1> a2~ 0.6> 0.3. 
Throughout postnatal development the abundance of ~ and "( GABAA receptor subunit 
mRNAs was ~P> ~N and ')'2> yl> y3. The predominance of ~P and y2 GABAA receptor 
subunit mRNAs are in agreement with Northern blot analysis of mRNA levels by 
MacLennan et al., 1991. Autoradiographs of Northern blot analysis also indicate that rat and 
bovine p2 and p3 mRNAs are considerably more abundant than ~ 1 mRNA in the adult 
brain, and P2 mRNA was considerably more abundant than ~P mRNA in the adult CNS 
(Y mer et al., 1989b). Bovolin et al., (1992) demonstrated by competitive PCR analysis with 
mimic DNA as an internal standard, that during postnatal development, the levels of 0.5 
mRNA are considerably lower than those of 0.1 mRNA and decrease from 0.08 fmos~g 
total RNA at PO to less than 0.02 fmolL~g of total RNA in the adult rat cerebellum. In 
contrast 0.1 mRNA in the PO rat cerebellum starts at about 0.1 fmolL~g of total RNA and 
increases to 2 fmolL~g of total RNA in the adult. When looking at primary cultures of rat 
cerebellar granule cells, Bovolin et al., (1992) observed that the GABAA receptor subunit a.5 
mRNA peaked later in the development (8 days) of the primary cultures. 
In this chapter, differences exist between RT -peR and S 1 nuclease protection assay in the 
detennination of the presence or absence of 0.2, "(1 and 12 GABAA subunit mRNAs at 
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EI4.S. RT-PCR analysis failed to detect mRNA for the a2, "(1, and y2 GABAA receptor 
subunits, whereas S 1 nuclease analysis detected the presence of all three GABAA receptor 
subunit transcripts at EI4.S. These discrepancies are probably due to variabilities in the 
sensitivity of the methodologies employed. The same preparation of E 14.5 total mRNA was 
used in both the RT-PCR amplification and the S 1 nuclease protection analysis. The ability 
of degenerate oligonucleotide PCR primers to detect a2, "(1 and y2 GABAA receptor subunit 
mRNAs may be dependent upon both the abundance of these specific mRNAs and the 
number and abundance of competing templates. The RT -PCR methodology also requires 
conversion of mRNA into first strand eDNA templates which again may be less efficient for 
less abundant transcripts. 
Unlike glycine and muscle acetylcholine receptors that have unique embryonic SUbtypes, 
GABAA receptor subunits demonstrate differential patterns of embryonic and postnatal 
mRNA expression. It is evident from the results presented in this chapter, that GABAA 
receptor ai, a3 and y2 subunit mRNAs are present during critical periods of CNS 
embryonic development (al was not detected during early rat embryogeneis). It further 
appears from the preliminary studies presented in this chapter, that GABAA receptor as, ~2I 
"(1 and y3 subunit mRNAs are primarily expressed during postnatal development and could 
contribute to the plasticity of the GABA response in the adult brain. Alternative-splicing of 
the GABAA receptor subunit 12 mRNA as well as variation in the embryonic and postnatal 
GABAA receptor subunit composition may account for the trophic activity of GABA during 
murine embryonic CNS development. 
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Figure 3.2 
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Figure 3.2 Gel electrophoresis and ethidium bromide staining of peR products. O.S 
percent T AE agarose gel analysis of peR products derived from the amplification of first 
strand cDNA reversed transcribed from embryonic, whole brain postnatal, adult kidney 
and cell line total RNA as well as embryonic 12 day and adult whole brain poly A+ 
mRNA. Embryonic stages lanes 1-6: 1) E7.5; 2) ES.5; 3) E9.5; 4) E12; 5) E12 poly A+ 
mRNA; 6) E14. Postnatal developmental stages lanes 7-10: 7) PI; 8) P7; 9) P14; 10) 
adult; 11) adult kidney; 12) adult liver; 13) adult retina; 14) adult spleen; M) lkb ladder; 
A) A DNA digested with restriction endonuclease Hind III; e) control reaction with H20 
as template. 3.05, 2.03, 1.02 and 0.517 kb DNA size markers. I: Degenerate 
oligonucleotides for GABAA receptor a.l,2,3,5 subunits were used in the peR reaction; 
II: degenerate oligonucleotides for GABAA receptor a.4,5 subunits were used in the peR 
reaction; III: degenerate oligonucleotides for GABAA receptor PI ,2,3 subunits were used 
in the peR reaction; IV: degenerate oligonucleotides for GABAA receptor yl,2,3 subunits 
were used in the peR reaction. 
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Figure 3.3 
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Figure 3.3 Southern blot analysis of peR products with GABAA receptor subunit 
specific oligonucleotide probes. Each lane was loaded with 10 III of a peR reaction 
containing degenerate oligonucleotide primers designed to the conserved regions of 
transmembranes 2 and 4 for GABAA receptor a.l, 2,3 and 5 subunits. First strand cDNA 
from embryonic and postnatal stages of development were used in the peR reactions. 
Prior to hybridization with 32P-Iabeled GABAA receptor subunit specific oligonucleotide 
probes, peR products electrophoresed through a 0.8% agarose gel were immobilized onto 
Hybond N membranes. peR products from embryonic stages, lanes 1-6: 1) E7.5; 2) 
E8.5; 3) E9.5; 4) E12; 5) E12 poly A+ mRNA; 6) E14. peR products for postnatal 
developmental stages, lanes 7-10: 7) PO; 8) P7; 9) P14; 10) adult. There was no signal 
observed in control lanes that represent peR reactions without a DNA template (results 
not shown). DNA size markers 0.46 0.51, 0.96 kb. 
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Figure 3.4 
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Figure 3.4 Southern blot analysis of peR products with GABAA receptor subunit 
specific oligonucleotide probes. Each lane of a 0.8% agarose gel was loaded with 10 J.11 of 
a peR reaction containing degenerate oligonucleotide primers designed to the conserved 
regions of transmembranes 2 and 4 for either GABAA receptor a4 and 6 subunits (A,B) or 
GABAA receptor a I ,2,3 and 5 subunits (e). First strand cDNA from embryonic and 
postnatal stages of development were used in the peR reactions. Prior to hybridization 
with 32P-Iabeled GABAA receptor subunit specific oligonucleotide probes, peR products 
electrophoresed through a 0.8% agarose gel were immobilized onto Hybond N 
membranes. peR products from embryonic stages, lanes 1-6: 1) E7.5; 2) E8.5; 3) E9.5; 
4) E12; 5) E12 poly A+ mRNA; 6) E14. peR products for postnatal developmental 
stages, lanes 7-10: 7) PO; 8) P7; 9) P14; 10) adult. There was no signal observed in control 
lanes that represent peR reactions without a DNA template (results not shown). DNA size 
markers 0.41, 0.44,0.7,0.9 kb. 
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Figure 3.5 Southern blot analysis of peR products with GABAA receptor subunit 
specific oligonucleotide probes. Each lane of a 0.8% agarose gel was loaded with 10 JlI of 
a peR reaction containing degenerate oligonucleotide primers designed to the conserved 
regions of transmembranes 2 and 4 for GABAA receptor ~NI 2 and 3 subunits. First strand 
cDNA from embryonic and postnatal stages of development were used in the peR 
reactions. Prior to hybridization with 32P-Iabeled GABAA receptor subunit specific 
oligonucleotide probes, peR products electrophoresed through a 0.8% agarose gel were 
immobilized onto Hybond N membranes. peR products from embryonic stages, lanes 1-
6: 1) E7.5; 2) E8.5; 3) E9.5; 4) E12; 5) E12 poly A+ mRNA; 6) E14. peR products from 
postnatal developmental stages, lanes 7-10: 7) PO; 8) P7; 9) P14; 10) adult. There was no 
signal observed in control lanes that represent peR reactions without a DNA template 
(results not shown). DNA size markers 0.51, 0.64, 0.76, 1.2 kb. 
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Figure 3.6 Southern blot analysis of peR products with GABAA receptor subunit 
specific oligonucleotide probes. Each lane of a 0.8% agarose gel was loaded with 10 Jll of 
a peR reaction containing degenerate oligonucleotide primers designed to the conserved 
regions of transmembranes 2 and 4 for GABAA receptor 11, 2 and 3 subunits. First strand 
cDNA from embryonic and postnatal stages of development were used in the peR 
reactions. Prior to hybridization with 32P-labeled GABAA receptor subunit specific 
oligonucleotide probes, peR products electrophoresed through a 0.8% agarose gel were 
immobilized onto Hybond N membranes. peR products from embryonic stages, lanes 1-
6: I) E7.5; 2) E8.5; 3) E9.5; 4) E12; 5) EI2 poly A+ mRNA; 6) E14. peR products from 
postnatal developmental stages, lanes 7-10: 7) PO; 8) P7; 9) P14; 10) adult. There was no 
signal observed in control lanes that represent peR reactions without a DNA template 
(results not shown). DNA size markers 0.50, 0.59,0.98 kb 
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Figure 3.8 S1 nuclease protection analysis of GABAA receptor subunit mRNA 
abundance during embryonic and postnatal development. 32P-Iabeled GABAA receptor 
aI, 2, 3 and 6 subunit-specific antisense oligonucleotide probes (45mers) were hybridized 
with postnatal whole brain or embryonic total RNA in the presence of a 32P-Iabeled p 
actin-specific antisense oligonucleotide probe (24mer). S 1 nuclease was used to remove 
excess 32P-Iabeled oligonucleotide prior to electrophoresis on 12% denaturing 
polyacrylamide gels. al: 5 Jlg of total RNA (A,B,C,D,E); 30 Jlg of total RNA (F,G,H,I,J). 
a2: 5 Jlg of total RNA (K,L,M,N,O); 30 Jlg of total RNA (P,Q,R,S,T). a3: 30 Jlg of total 
RNA (A,B,C,D,E). a6: 5 Jlg of total RNA (F,G,H,I,J); 30 Jlg of total RNA (K, L, M, N, 
0). Developmental stages: al and a2 El4 (A,F,K,P), PO (B,G,L,Q), P7 (C,H,M,R), Pl4 
(D,I,N,S), Adult (E,J,Q,T); a3 and a6 El4 (A,F,K), PO (B,G,L), P7 (C,H,M), Pl4 
(D,I,N), Adult (E,J,O). +, oligonucleotide in the absence of template with S 1 nuclease 
treatment. -, oligonucleotide in the absence of template without S 1 nuclease treatment. 
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Figure 3.9 S1 nuclease protection analysis of GABAA receptor subunit mRNA 
abundance during embryonic and postnatal development. 32P-Iabeled GABAA receptor 
~ 1 and 3 subunit-specific antisense oligonucleotide probes (45mers) were hybridized with 
postnatal whole brain or embryonic total RNA in the presence of a 32P-Iabeled ~ actin-
specific antisense oligonucleotide probe (24mer). S 1 nuclease was used to remove excess 
32P-labeled oligonucleotide prior to electrophoresis on 12% denaturing polyacrylamide 
gels. ~NW 30 J.Lg of total RNA (A,B,C,D,E). ~PW 5 J.Lg of total RNA (F,G,H,I,J); 30 J.Lg of 
total RNA (K,L,M,N,O). Developmental stages: ~ 1 and ~P E14 (A,F,K), PO (B,G,L), P7 
(C,H,M), P14 (D,I,N), Adult (E,J,O). +, oligonucleotide in the absence of template with 
S 1 nuclease treatment. ., oligonucleotide in the absence of template without S 1 nuclease 
treatment. 
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Figure 3.10 S1 nuclease protection analysis of GABAA receptor subunit mRNA 
abundance during embryonic and postnatal development. 32P-labeled GABAA receptor 
rI, 2 and 3 subunit-specific antisense oligonucleotide probes (45mers) were hybridized 
with postnatal whole brain or embryonic total RNA in the presence of a 32P-labeled ~ 
actin-specific antisense oligonucleotide probe (24mer). S 1 nuclease was used to remove 
excess 32P-labeled oligonucleotide prior to electrophoresis on 12% denaturing 
polyacrylamide gels. rl: 5 ~g of total RNA (F,G,H,I,J); 30 ~g of total RNA (K,L,M,N,O). 
"(2: 5 ~g of total RNA (F,G,H,I,J); 30 ~g of total RNA (A,B,C,D,E). "(3: 30 ~g of total 
RNA (A,B,C,D,E). Developmental stages: "{2 E14 (A,F), PO (B,G), P7 (C,H), P14 
(D,I,N,S), Adult (E,J) Blank lanes (K,L); 11 and y3 E14 (A,F,K), PO (B,G,L), P7 
(C,H,M), P14 (D,I,N), Adult (E,J,O). +, oligonucleotide in the absence of template with 
S 1 nuclease treatment. ., oligonucleotide in the absence of template without S 1 nuclease 
treatment. 
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Figure 3.11 Developmental analysis of the ratio of GABAA receptor subunit mRNA 
expression to f3 actin mRNA expression. S 1 nuclease reactions were run on a 12% 
denaturing polyacrylamide gel, dried under vacuum onto Whatman 3mm paper and 
exposed to preflashed Fuji X-ray film for 2 to 24 hours. Densitometry was used to 
quantitate the signal intensity of the GABAA receptor subunit and ~ actin S 1 nuclease 
protection products for developmental stages: embryonic day 14 (14 E), postnatal day 1 (1 
PN), postnatal day 7 (7 PN), postnatal day 14 (14 PN) and adult. 
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Figure 3.12 Four Stages of Murine Embryogenesis. Rapid developmental and 
morphogenic changes occur during the second week of murine embryogenesis. A: 7.5 
day mouse embryo photographed under bright-field conditions. B: 8.5 day mouse embryo 
photographed under bright-field conditions. C: 9.5 day mouse embryo stained with 
thionin and photographed using a dark-field condenser. D: 14.5 day mouse embryo 
photographed using a dark -field condenser. 
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4.1 Introduction 
Diversity of response to chemical signals within the central nervous system is enhanced 
through several mechanisms including~ the cotransmission of neurotransmitters with 
neuropeptides, the interaction of a neurotransmitter with different receptor systems, such as 
GABAA and GABAB receptors and the interaction of a neurotransmitter with SUbtypes of 
receptor. Many channels and ligand-gated ion receptors of the mammalian central nervous 
system are able to form either homo-oligomeric or hetero-oligomeric complexes that account 
in large part for the variation in rates of activation and inactivation, toxin sensitivity, 
differences in ligand affinity, and disparate pharmacologies. 
As outlined in Chapter 1, at least fifteen different GABAA receptor subunit genes have 
been cloned in the rodent, and are known to play various roles in a receptor complex. 
Studies of combinations of GABAA receptor subunit cDNAs in transient expression systems 
have aided in the elucidation of the role of individual subunits and subunit combinations in 
the resultant pharmacologies. For example, the 'Y subunit class confers a robust 
benzodiazepine responsiveness on any aL~ subunit combination (Pritchett, Luddens and 
Seeburg, N989~ Pritchett et al., 1989), such that a minimum requirement for conventional 
GABAA receptor pharmacology would be an ax~xDFDu combination, where x is any isoform 
variant. When the 'Y subunit becomes "{2 and the combinations are then ax~x"{2I transient 
expression studies have revealed that it is the a subunit that dictates the type of 
benzodiazepine interaction and associated allosteric modulation of the GABAA receptor 
complex (Pritchett et al., 1989; Pritchett, Luddens and Seeburg, 1989; Pritchett and 
Seeburg, 1990; Luddens et al., 1990; Seeburg et al., 1990; Luddens and Wisden, 1991). 
Type I and II benzodiazepine (BZ) receptors have been identified in terms of their 
relative sensitivity to ~Jcarbolines and the triazolopyridazine CL 218872 (Braestrup and 
Nielsen, 1981; Lippa et al., 1981). Benzodiazepine binding to the cerebellar receptor is 
sensitive to these agents and is designated type I. The pharmacological and 
electrophysiological properties of GABAAIBZ type I receptors can only be mimicked by 
recombinant receptors of the al ~x"{2 type. BZ II receptors assembled in HEK293 cells 
from the a2, a3 or as variants together with the ~xy2 combination display the 
characteristics of the "classical" BZ type II receptors. BZ I and BZ II receptors distribute 
unevenly over the rat brain. BZ I receptors predominate in the cerebellum, but are rare in the 
hippocampus (Faull and Villiger, 1988; Faull, Villiger and Holford, 1987, Olsen, McCabe 
and Wamsley 1990). In contrast, BZ II receptors are strongly expressed in the hippocampus 
and nearly absent from the cerebellum. Both receptor subtypes are equally expressed in the 
cortical layers (Faull and Villiger, 1988; Faull, Villiger and Holford 1987; Olsen, McCabe 
and Wamsley 1990). BZ type II receptors are also enriched in the striatum and spinal cord 
(Lo, Strittmatter and Snyder, 1983; Olsen and Tobin. 1990, Sieghart et al., 1985). aR~2y2 
receptors have similarly low affinities for CL 218,872 and 2-oxoquazepam as a2~xy2 and 
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aP~xy2 receptors. However, the binding properties for imidazopyridines like zolpidem and 
alpidem differ from conventional GABAAIBZ II receptors (Pritchett and Seeburg, 1990), 
and hence sensitivity to these imidazopyridines constitutes a sUbtype of the BZ II receptors. 
Recombinant receptors expressing a6p2y2 in HEK293 cells bind with high affinity 
muscimol and the imidazo-l,4-benzodiazepine Ro-15-4513. Other benzodiazepines and p-
carbolines are either not recognized by this receptor or at an affinity two to three orders of 
magnitude lower than that of aI, a2, a3 or a5- containing receptors. 
During development of the CNS, changes in receptor composition play a role in the 
developmental modifications of glycine, nicotinic acetylcholine, and glutamate receptor 
function. As discussed in Chapter 3, several differences also exist between adult and 
neonatal GABA responses. These differences which are characteristics of neonatal 
responses include: 1) the depolarizing effects of GABA on neonatal neurons (Ben-Ari et aI., 
1989; Cherubini et al., 1990); 2) reduced desensitization of neonatal GABA currents 
(Cherubini et al., 1990); 3) limited outward rectification of neonatal GABA currents at 
membrane potentials more depolarized than -40 mV (Ito and Cherubini, 1991); and 4) the 
potentiation of neonatal GABA currents by barbiturates but not benzodiazepines (Rovira and 
Ben-Ari, 1991). 
In this chapter, in situ hybridization analysis has been used to investigate the onset of 
expression and the localisation of ten GABAA receptor subunit mRNAs during postnatal 
development of the murine central nervous system in order to determine if changes in 
GABAA receptor subunit mRNA expression and hence corresponding changes in GABAA 
receptor composition may account for the differences in neonatal versus adult GABA 
responses. 
4.2 Results 
GABAA receptor subunit gene expression was studied during murine postnatal CNS 
development through in situ hybridization with antisense subunit-specific oligonucleotide 
probes. Probes were designed either to sequences for GABAA receptor subunits at, ex3, 
PI, P3, and yl that were isolated as outlined in Chapter 3 or to mouse GABAA receptor 
subunit sequences a2, a6, y2, y3 and () 1 retrieved from the Genebank database. The 
regional distribution patterns of the GABAA receptor aI, a2, a3, a6, PI, P3, yl, y2, y3 
and BI subunit mRNAs in postnatal 1 day (PO), 7 day (P7), 14 day (P14) and adult (four to 
five month old) mouse brains are shown in Figures 4.1 to 4.17 and summarized in Tables 
4.1 to 4.7. After exposure to X-ray film, slides were dipped in emulsion and stored in the 
dark for 60 to 120 days at 4°C. After exposure the slides were developed, counterstained 
with thionin and viewed using a Zeiss microscope under bright-field and dark-field optics. 
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All cellular localisation of the various GABAA receptor subunit probes was determined 
using emulsion-dipped slides. 
Although the experiments were standardized such that each contained the same amount 
of radioactively labeled probe, no attempt was made to accurately quantitate the results. It 
is clear, however from these results that the levels of transcript detected, in general, 
correspond well with the relative abundance of mRNA for the various GABAA receptor 
subunits detected by S I nuclease analysis in the previous chapter. Images were virtually 
devoid of signal on parallel control sections, where each of the ten antisense oligonucleotide 
probes were competed out by a thirty-fold molar excess of the appropriate unlabelled 
oligonucleotide (Figures 4.18 and 4.19), thus confirming the specificity of the individual 
hybridization signals. 
4.2.1 GABAA Receptor a Subunit mRNA Distributions 
4.2.1.1 Cortex 
During postnatal development of the CNS, the a subunits of the GABAA receptor were 
expressed differentially among neocortical layers. At birth, for instance, distribution of the 
GABAA receptor al subunit was restricted to the outermost layers (I and II) of the cerebral 
cortex (Figures 4.1A, 4.2A). However, by P7, expression of the GABAA receptor al 
subunit transcript was abundant throughout the neocortex and then declined sometime after 
PI4 to adult levels. Emulsion-dipped slides showed silver grain distribution for the al 
subunit rnRNA in the Pl4 cortex was distributed over large pyramidal cell bodies (Figure 
21B, 2ID). The GABAA receptor a2 subunit mRNA was expressed in cerebral cortical 
layers I, II and III of the PO murine brain (Figures 4.3A, 4.4A). At P7 (Figures 4.3B, 4.4B) 
and Pl4 (Figures 4.3C, 4.4C), the a2 subunit transcript was moderately expressed in 
cerebral cortical layers I and II and weakly expressed throughout the remaining cerebral 
cortical layers. In the adult CNS, the a2 subunit mRNA of the GABAA receptor was only 
weakly expressed throughout the neocortex (Figures 4.3D and 4.4D). Of the four GABAA 
receptor a subunits studied, the a3 mRNA was the most abundant transcript in the PO 
neocortex (Figures 4.5A, 4.6A) and this level of a3 subunit mRNA expression in the 
cerebral cortex was maintained throughout postnatal development as well as in the adult 
brain (Figures 4.5, 4.6). There was no expression of the a6 GABAA receptor subunit 
transcript in the cerebral cortex during postnatal development or in the adult brain. 
4.2.1.2 Hippocampus 
The a2 subunit of the GABAA receptor was the predominant a isoform of the four 
studied in the PO hippocampus (Figures 4.3A ,4.4A). a2 rnRNA was present throughout 
the stratum pyramidale and weakly in the granule cells of the dentate gyrus. The al isoform 
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was weakly expressed in the PO CAl (Figures 4.lA ,4.2A), while the transcript for the a3 
subunit variant was weakly expressed throughout the PO hippocampal pyramidal cell layer 
(Figures 4.5A, 4.6A). At P7 (4.1B, 4.2B, 4.3B, 4.4B) and Pl4 (4.1C, 4.2C, 4.3C, 
4.4C), mRNAs for the al (Figures 4.1, 4.2) and a2 (Figures 4.3, 4.4) GABAA receptor 
subunit isoforrns were abundantly expressed in the CAl pyramidal cell layer. In the P7 
CA3, a2 was again the predominant isoforrn (Figures 4.3B and 4.4B), while the a3 mRNA 
was moderately expressed (Figures 4.5B and 4.6B) and the al transcript was weakly 
expressed (Figures 4.1B and 4.2)B. al and a2 mRNAs were moderately expressed in the 
P7 (Figures 4.1B, 4.2B, 4.3B, 4.4B) dentate gyrus, whereas by PI4 both transcripts were 
abundantly expressed in the dentate granule cells (Figures 4.1 C, 4.2C, 4.3C, 4.4C). 
Emulsion-dipped slides demonstrated that the silver grain distribution for the ex 1 subunit 
mRNA was present over granule cell bodies of the PI4 dentate gyrus and over a subset of 
cells in the hilus (4.2IF, 4.2IH, 4.22F). The transcript for a3 was not detected in the 
dentate gyrus during postnatal development or in the adult brain (Figures 4.5, 4.6). al 
(Figures 4.ID, 4.2D) and a2 (Figures 4.3D, 4.4D) transcripts were moderately expressed 
in the adult CAL In contrast, in adult CA3 pyramidal cells, the al transcript (Figures 4.1D, 
4.2D) was weakly expressed, while the ex2 subunit mRNA (Figures 4.3D, 4.4D) was 
detected at moderate levels. 
4.2.1.3 Thalamus 
In the newborn thalamus, al mRNA expression was absent (Figure 4.2B, Table 4.1), 
whereas the a2 and a3 GABAA receptor subunit mRNAs were differentially expressed 
among thalamic nuclei (Figures 4.4A, 4.6A). For example, in the PO thalamus, a2 mRNA 
was weakly expressed in the ventrolateral, anteromedial, dorsal lateral genicular, ventral 
posterior and lateral dorsal thalamic nuclei (Figure 4.4A, Table 4.1), whereas the a3 subunit 
mRNA was weakly expressed in the anteroventral, paraventricular, anteromedial, 
ventrolateral, dorsal lateral genicular, and ventroposterior lateral thalamic nuclei (Figure 
4.6A, Table 4.1 ). At PO, the a3 subunit mRNA was abundantly expressed in the reticular 
thalamic nucleus and a2 mRNA was absent (Figures 4.6A and 4.4A, respectively). By P7, 
the a 1 transcript was moderately expressed in the anteromedial, dorsal lateral geniculate, 
laterodorsal and lateroposterior thalamic nuclei (Figure 4.2B). The a2 transcript was 
present in the anteroventral, paraventricular, ventrolateral, dorsal lateral genicular, medial 
genicular, laterodorsal and lateral posterior P7 thalamic nuclei (Figure 4.4B, Table 4.1), 
whereas the a3 transcript was present in the same nuclei as the a2 subunit mRNA as well as 
the anteromedial, reticular and ventroposterior lateral thalamic nuclei (Figure 4.6B, Table 
4.1). By P14, al and a3 subunit mRNAs were present at different levels of expression in 
all thalamic nuclei listed in Table 4.1, except in the anteroventral thalamic nucleus where the 
a3 subunit mRNA was absent (Figures 4.2C and 4.6C). The a2 mRNA was present at 
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P14 in the anteroventral, paraventricular, anteromedial and medial genicular thalamic nuclei 
(Figure 4.4C, Table 4.1). Adult thalamic levels of aI, a2, and a3 GABAA receptor 
subunit mRNA expression were significantly reduced from the levels observed at P7 and 
, P14 (Table 4.1). In the adult, a2 mRNA expression was restricted to the anteromedial, 
paraventricular and anteromedial thalamic nuclei (Figure 4.4D, Table 4.1). a I and a3 
transcripts were weakly co-expressed in the adult anteroventral, paraventricular, 
anteromedial, reticular, laterodorsal, and lateral posterior thalamic nuclei (Figures 4.2D and 
4.6D). In addition, the al transcript was weakly expressed in the adult dorsal lateral 
genicular nucleus (Figure 4.2D, Table 4.1), whereas the a3 mRNA was present in the adult 
ventrolateral thalamic nucleus (Figure 4.4D. Table 4.1). 
4.2.1.4 Cerebellum 
Expression of a subunit mRNAs in the PO cerebellum included weak expression of aI, 
exJ and a6 GABAA receptor subunit mRNAs in the external granule cell layer (Figures 
4.1A, 4.2A, 4.5A, 4.6A, 4.7A). By P7, the al subunit mRNA of the GABAA receptor 
was abundantly expressed in Purkinje cells and the internal granule cell layer, and 
moderately expressed in basket cells of the molecular layer and in the external granule cell 
layer (Figures 4.lB, 4.2B and 4.20E, 4.20F). Weak levels of mRNA expression were 
apparent for the a2 subunit in the P7 Purkinje cell layer and for the a2 and a3 subunits in 
the internal and external granule cell layers (Figures 4.3B, 4.4B, 4.5 B, 4.6B). The a6 
subunit mRNA was uniquely and abundantly expressed in the internal granular cell layer of 
the P7 (Figures 4.20G, 4.20H) and P14 (Figures 4.20K, 4.20L) cerebellum and moderately 
expressed in the internal cerebellar granule cell layer of the adult (Figures 4.200, 4.20P). 
Emulsion-dipped slides of the Pl4 cerebellum demonstrated that silver grains for the al 
transcript were abundantly distributed over the Purkinje cells and the internal and external 
granule cells (Figures 4.20). In the adult cerebellum, the al subunit mRNA was moderately 
expressed in the Purkinje cells and internal and external granule cell layers (Figures 4.ID, 
4.1D, 4.20M, 4.20N). The al subunit mRNA was also weakly expressed in the molecular 
layer of the Pl4 (Figures 4.201, 4.20J) and adult cerebellum (Figures 4.20M, 4.20N). a2 
mRNA was weakly expressed in the Pl4 (Figures 4.3C, 4.4C) and adult (Figures 4.3D and 
4.4D) Purkinje cell layer of the cerebellum. In the Pl4 cerebellum (Figures 4.5C, 4.6C), 
the a3 transcript was weakly in the molecular and internal and external granule cell layers, 
whereas in the adult cerebellum a3 mRNA expression was absent (Figures 4.5D and 4.6D). 
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4.2.2 GABAA Receptor P Subunit mRNA Distributions 
4.2.2.1 Cortex 
At birth, PI and p3 GABAA receptor subunit mRNAs were differentially distributed 
among the cerebral cortical cell layers. For example PI (Figure 4.8A) and p3 (Figures 
4.9A, 4.l0A) subunit mRNAs were moderately expressed in cerebral cortical layers I and II 
and weakly expressed in layers V and VI. In contrast to this similar signal intensity of PI 
and p3 subunit mRNAs in cortial layers I, II, V and VI, the PI transcript was also weakly 
expressed in cerebral cortical layers III and IV (Figure 4.8A), whereas the p3 subunit 
mRNA was moderately expressed in cortical layers III and IV (Figures 4.9A and 4. lOA). In 
the P7 cerebral cortex, the PI transcript was expressed weakly in all layers (Figure 4.8B), 
while the p3 subunit was expressed moderately in layers I, II, III, IV, and V (Figures 4.9B 
and 4.lOB). The p3 transcript localisation and levels of expression observed in the P7 
cerebral cortex were also present in the PI4 and adult cerebral cortex (Figures 4.9 and 4.10). 
Emulsion-dipped slides revealed that the silver grain distribution for the p3 subunit mRNA 
was localised over pyramidal cell somata in P14 cerebral cortical layers II, III and IV (Figure 
4.21 A, 4.21 C) In contrast, the PI transcript was expressed moderately throughout the P 14 
(Figure 4.8C) cerebral cortex and weakly in all adult cortical layers (Figure 4.8D). 
4.2.2.2 Hippocampus 
In the PO pyramidal cell layer, both the PI (Figure 4.8A) and p3 (Figures 4.9A, 4.lOA) 
GABAA receptor subunit mRNAs were moderately expressed (Figures 4.8, 4.9 and 4.10). 
In addition to the pyramidal cell distribution, the signal for the p3 subunit transcript was also 
present at a moderate level in the PO dentate gyrus granule cell layer (Figures 4.9A and 
4.lDA). In the P7 (Figures 4.9B, 4.10B) and P14 (Figures 4.9C, 4.lOC) hippocampus, the 
p3 transcript was abundantly expressed throughout the pyramidal cell layer and in the 
dentate gyrus (Figures 4.9B,C and 4.lOB,C), whereas the PI subunit mRNA was 
expressed at moderate levels in the P7 (Figure 4.8B) and P14 (Figure 4.8C) pyramidal cell 
layer and increased from weak to moderate expression levels in the P7 (Figure 4.8B) and 
PI4 (Figure 4.8C) dentate gyrus granule cells, respectively. Silver grain distribution for the 
p3 subunit mRNA in the PI4 dentate gyrus was observed over granule cell bodies, and only 
weakly over a small subset of hilar intemeurons (Figures 4.21E, 4.21G) In the adult 
hippocampus, PI (Figure 4.8D) and P3 (Figures 4.9D, 4.lDD) transcripts were moderately 
expressed in the pyramidal cell layer. The PI transcript (Figure 4.8D) was weakly 
expressed in the adult dentate gyrus, while the p3 mRNA (Figures 4.9D, 4.10D) was 
expressed moderately in the adult dentate granule cells. 
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4.2.2.3 Thalamus 
Throughout postnatal development and in the adult brain, the ~P subunit rnRNA of the 
GABAA receptor was expressed weakly in the anteroventral, paraventricular, anteromedial, 
ventrolateral, dorsal lateral genicular, medial lateral genicular, ventral posterior, laterodorsal, 
and lateral posterior thalamic nuclei (Figures 4.9, 4.10). In the PO (Figure 4.8A), P7 
(Figure 4.8B) and adult (Figure 4.8D) thalamus, ~f rnRNA was expressed at weak levels in 
the anteroventral, parventricular, anteromedial, ventrolateral, ventral posterior, laterodorsal 
and lateral posterior thalamic nuclei. The ~ 1 subunit rnRNA was expressed at moderate 
levels in the laterodorsal and lateral posterior PI4 thalamic nuclei (Figure 4.8C, Table 4.2) 
and at weak levels in the anteroventral, paraventricular, anteromedial, ventrolateral and 
ventral posterior P14 (Figure 4.8C, Table 4.2) thalamic nuclei. 
4.2.2.4 Cerebellum 
At birth, of the two ~ subunit mRNAs studied, only the ~P subunit transcript (Figures 
4.9A, 4.lOA) was expressed in the molecular and internal granular cell layers of the 
newborn cerebellum. By P7, the ~N transcript (Figure 4.8B and Table 4.2) was expressed 
weakly in the stellate and basket cells of the molecular layer and in the internal and external 
granule cell layers. In contrast, the ~P subunit mRNA (Figures 4.9B, 4.lOB) was 
expressed moderately in the molecular layer and abundantly in the internal and external 
granule cell layers. There was a moderate level of ~ 1 mRNA expression (Figure 4.8C) in 
the molecular and internal and external granule cell layers of the P 14 cerebellum, whereas 
silver grain distribution for the ~P transcript (Figures 4.9C, 4.lOC), at P14 was distributed 
weakly over basket cell somata of the molecular layer and abundantly over internal and 
external granule cell somata of the cerebellum (Figures 4.211, 4.211). In the adult 
cerebellum both the ~ 1 (Figure 4.8D) and ~P (Figures 4.9D and 4.lOD) subunit mRNAs 
were expressed weakly in the molecular and internal and external granule cell layers. 
4.2.3 GABAA Receptor y and 0 Subunit mRNA Distributions 
4.2.3.1 Cortex 
At birth, the mRNAs for the yl (Figures 4.11 A, 4.12A) and y3 (Figure 4.15A) subunits 
of the GABAA receptor were expressed weakly thoughout all cerebral cortical layers. The 
"(2 subunit probe ("(2T), which identifies both the "(2L and "(2S alternatively-spliced variants, 
was intensely distributed in cerebral cortical layers I, II, III, and V and showed a moderate 
signal intensity in cortical layers IV and V (Figures 4.13A, 4.14A). Throughout postnatal 
development and in the adult brain, the y3 subunit mRNA of the GABAA receptor was 
expressed weakly throughout the neocortex (Figure 4.15). In the P7 (Figures 4.11B, 
4.12B) and P14 (Figures 4.11C, 4.12C) cerbral cortex, the yl transcript was moderately 
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expressed in all cortical layers, whereas in the adult (Figures 4.11D, 4.12D) the level of yl 
mRNA was reduced to weak. levels of expression in all cortical layers. The signal for the 
y2T mRNA was abundantly expressed in cortical layers III and V and was expressed at 
moderate levels in layers I, II, IV, and VI of the P7 (Figures 4.l3B, 4.l4B) and adult 
(Figures 4.l3D, 4.l4D) cerebral cortex. In contrast to the differential levels of y2T subunit 
mRNA expression in the P7 and adult cerebral cortex, at P14, the y2T transcript was 
abundantly expressed in all cortical layers (Figures 4.l3C, 4.l4C). Expression of the 
transcript for the ()l subunit of the GABAA receptor was not detected in the PO brain 
(Figures 4.16A, 4.17A), however in the P7 (Figures 4.16B, 4.17B) and P14 (Figures 
4.16C, 4.l7C) neocortex, mRNA for the () 1 subunit was moderately expressed in layers I, 
II, III, and IV and was weakly expressed in layers V and VI. In the adult a weak signal for 
the () 1 GABAA receptor subunit mRNA was found in all layers of the cerebral cortex 
(Figures 4.16D, 4.17D). 
4.2.3.2 Hippocampus 
The y2T subunit mRNA was the only y subunit mRNA of the three studied to be 
expressed at birth in the hippocampus. Expression of the y2T transcript was abundant in PO 
CAl pyramidal cells and moderately expressed in the CA3, in the hilus and in the granule 
ceIls of the dentate gyrus (Figures 4.13A, 4.14A). In the P7 (Figures 4.13B, 4.14B) and 
P 14 (Figures 4.13C , 4.l4C) hippocampus, the y2T subunit mRNA was expressed 
abundantly throughout the pyramidal cell layer as well as in the hilus and dentate gyrus. 
Silver grain distribution for the yZT subunit mRNA was present over P14 dentate granule 
cell bodies and hilar neurons (Figure 4.22E). The "{3 subunit transcript was expressed 
weakly in the CAl, CA3 and dentate gryus of the P7 (Figure 4.15B), P14 (Figure 4.l5C) 
and adult (Figure 4.15D) hippocampus. The yl subunit transcript was expressed weakly in 
the pyramidal cell layer, in hilar cells and in dentate granule cells of the P7 (Figures 4.llB, 
4.12B) and adult (Figures 4.11D, 4.12D) hippocampus. In the P14 hippocampus, the yl 
transcript was expressed moderately in the CAl through CA3 p~ramidal cells, in hilar 
intemeurons and in dentate granule cells (Figures 4.11 C, 4.l2C). Expression of the ()l 
subunit mRNA of the GABAA receptor was restricted to the dentate granule cells of the P7 
(Figures 4.l6B, 4.l7B), P14 (Figures 4.16C, 4.17C) and adult (Figures 4.l6D, 4.17D). 
4.2.3.3 Thalamus 
Expression of the "{3 (Figure l5A, Table 4.3) and ()1 (Figure 4.17 A) subunit mRNAs of 
the GABAA receptor was absent in the PO thalamus. In the PO thalamus, the yl (Figure 
4.12A) subunit mRNA was expressed at moderate levels in the anteroventricular, 
paraventricular, anteromedial, and ventrolateral thalamic nuclei and was expressed 
abundantly in the medial geniculate, lateral dorsal and lateroposterior thalamic nuclei. At PO, 
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the signal for the y2T (Figure 4.14A, Table 4.3) subunit mRNA was present at moderate 
levels in the paraventricular, ventrolateral, medial geniculate, reticular, laterodorsal and 
lateral posterior thalamic nuclei and at weak levels in the anteroventral, anteromedial, dorsal 
lateral geniculate, and ventral posterior thalamic nuclei. In the P7 thalamus, moderate levels 
of the yl mRNA were present in the paraventricular, anteromedial, dorsal lateral geniculate, 
laterodorsal and lateral posterior nuclei, while an abundant level of the yl transcript was 
present in the medial geniculate thalamic nucleus (Figure 4.12B, Table 4.3). The y2T 
subunit mRNA, at P7 was expressed abundantly in the anteroventral and medial geniculate 
thalamic nuclei, moderately in the paraventricular, anteromedial, dorsal lateral geniculate and 
reticular thalamic nuclei and finally at weak levels in the ventrolateral, ventral posterior, 
laterodorsal and later posterior thalamic nuclei (Figure 4.14B, Table 4.3). The 13 subunit 
mRNA was absent in the thalamus throughout postnatal development, as well as in the adult 
brain (Figure 4.15). At P7. the 81 subunit mRNA was expressed weakly in the 
paraventricular. ventrolateral. dorsal lateral geniculate. medial geniculate, ventral posterior 
and laterodorsal thalamic nuclei, and was moderately expressed in the anteroventral and 
anteromedial thalamic nuclei (Figure 4.17B, Table 4.3). In the P14 thalamus, the "{2T 
subunit mRNA was expressed abundantly in the antroventral, paraventricular, dorsal lateral 
geniculate and medial geniculate nuclei, and at moderate levels in the anteromedial, 
ventrolateral, reticular, ventral posterior, laterodorsal, and lateral posterior (Figure 4.14C, 
Table 4.3). The yl subunit mRNA was expressed at moderate levels in the anteroventral, 
ventral lateral, dorsal lateral geniculate, medial geniculate, ventral posterior, laterodorsal and 
lateral posterior Pl4 thalmic nuclei, and at abundant levels in the P14 parventricular nucleus 
(Figure 4.12C. Table 4.3). At P14, the 81 subunit mRNA was expressed weakly in the 
anteroventral, anteromedial, ventrolateral, dorsal lateral geniculate, and medial geniculate 
thalamic nuclei and at moderate levels in the the ventral posterior and laterodorsal thalamic 
nuclei (Figure 4.l7C, Table 4.3). In the adult thalamus yl (Figure 4.12D, Table 4.3) and 
y2T (Figure 4.14D) GABAA receptor subunit mRNAs were expressed weakly in the 
anteromedial, ventrolateral, ventral posterior, lateral dorsal and lateral posterior thalamic 
nuclei and moderately in the paraventricular, dorsal lateral geniculate and medial geniculate 
thalamic nuclei. The 01 GABAA receptor subunit mRNA was expressed weakly in the 
anteroventricular, dorsal lateral geniculate and medial geniculate thalamic nuclei. and was 
moderately expressed in the anteromedial, ventrolateral, and ventral posterior adult thalamic 
nuclei (Figure 4.17D. Table 4.3). 
4.2.3.4 Cerebellum 
In the newborn cerebellum, "{2T (Figures 4.13A, 4.14A) and 13 (Figure 4.15A) subunit 
mRNAs were expressed at moderate levels in the internal granule cell layer, while the 
mRNA for the yl (Figures 4.11A, 4.12A) subunit of the GABAA receptor was expressed 
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weakly and the 81 (Figures 4.16A, 4.17 A) subunit mRNA was absent from all areas of the 
PO cerebellar cortex. The -y2T subunit mRNA was also expressed moderately in the Purkinje 
cell and molecular layers of the PO cerebellar cortex (Figure 4.l3A, 4.14A). In the P7 
cerebellum, the -y2T subunit mRNA was abundantly expressed in the Purkinje cell layer and 
the internal and external granule cell layers (Figures 4.13B, 4.14B). The 13 (Figure 4.l5B) 
and 81 (Figures 4.16B, 4.17B) subunit mRNAs were weakly expressed in the P7 basket 
cells of the cerebellar molecular layer and were moderately expressed in the P7 internal and 
external granule cell layers. The yl subunit mRNA was expressed weakly in the P7 
molecular layer and internal and external granule cell layers. The P7 pattern of -y2T mRNA 
expression was also present in the Pl4 cerebellar cortex. Silver grain distribution for the 
-y2T transcript was abundantly distributed over P 14 cerebellar Purkinje cell somas and 
granule cell bodies (Figure 4.22B). At P14, the yl subunit mRNA was expressed 
moderately in all layers of the cerebellar cortex (Figures 4.11 C, 4.12C), whereas the 13 
subunit mRNA was expressed weakly in the molecular layer and abundantly in the internal 
and external granular cell layers (Figure 4.15C). The 81 subunit mRNA is also present in 
the cerebellum at Pl4 in the molecular and internal and external granule cells layers (Figures 
4.16C, 4.17C). In the adult cerebellum the -y2T subunit transcript was abundantly expressed 
in the Purkinje cell layer, weakly in the molecular layer and moderately in the internal and 
external granule cell layers (Figures 4.13D, 4.14D). The y1 (Figures 4.11 D, 4.12D), 13 
(Figure 4.15) and 81 (Figures 4.16D, 4.17D) subunit mRNAs of the GABAA receptor were 
expressed weakly in the adult molecular layer and moderately in the adult internal and 
external granule cell layers. 
4.2.4 Co-Expression of GABAA Receptor Subunit mRNAs during Postnatal 
Development 
Serial sections were used to study the co-distribution of GABAA receptor mRNAs in 
the cerebellum and hippocampus of the developing murine CNS. In parallel P14 sections, 
both the -y2T and al subunit transcripts were co-localised to Purkinje cells and granule cells 
of the cerebellum, as illustrated by the arrowheads in Figure 4.22B and 4.22C. In 
hippocampal parallel Pl4 sections, cells within the internal granular cell layer of the dentate 
gyrus that uniquely expressed the -y2T subunit mRNA were devoid of al subunit mRNA 
expression as illustrated by the small arrowheads in Figures 4.22E and 4.22F. However, 
co-expression of the a 1 and -y2T subunit mRNAs was present over hilar neurons, as 
indicated by the large arrowhead in Figures 4.22E and 4.22F. In both the PI 4 hippocampus 
and cerebellum, serial sections demonstrated that the mRNAs for the ~P and a1 subunits of 
the GABAA receptor were co-localised in the dentate granular cell somata and cerebellar 
granular cell bodies, respectively. The ~P (Figures 4.21A, 4.21C) and al (Figures 4.21B, 
4.21D) subunit transcript were also co-expressed in pyramidal cell somata in layers II, III, 
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and N of the P 14 cerebral cortex. Similar to the a 1 and yZT localisation, there were also 
differences in the presence or absence of ~P and al subunit mRNAs in specific cell types. 
For example, the p3 subunit mRNA was not expressed in Pl4 cerebellar Purkinje cells, 
whereas the al subunit transcript was abundantly expressed in the P14 Purkinje cell type. 
4.3 Discussion 
This chapter describes the regional and cellular localisation of 10 GABAA receptor 
subunit mRNAs during murine postnatal CNS development. The results presented in this 
chapter demonstrate that during postnatal development and in the adult brain, each GABAA 
receptor subunit mRNA has a unique, but overlapping pattern of mRNA distribution. The 
number of GABAA receptor subunit transcripts and the abundance of GABAA receptor 
subunit mRNA expression increases with the completion of cell migration and differentiation 
and the coincidence of synapse development. In the adult murine CNS, the level of GABAA 
receptor subunit transcript expression had decreased from postnatal levels, yet the number of 
subunit mRNAs expressed was similar to the number reported for the later stages of 
postnatal development. 
At birth, Table 4.4 indicates that of the four a isoform mRNAs studied, the a2 and a3 
subunits are the predominant a isoforms, while p3 is the predominant P isoform and the '11 
and yZ are the predominant '1 isoforms of the GABAA receptor in the PO CNS. The possible 
type and number of GABAA receptor complexes in the newborn is dependent on the regional 
distribution of the various GABAA receptor subunit mRNAs. For example in the PO 
cerebral cortex although the a2 and al subunit mRNAs are expressed in layers I (aI, (2) 
or II (a2), only the a3 subunit of the a isoforms studied is expressed in cerebral cortical 
layers III through VI. Hence the most abundant receptor complex in PO cerebral cortical 
layers III through VI would be a3/p3/yZT. In contrast, in the PO hippocampus the most 
abundant GABAA receptor complex would be a2/p3/y2T. Other studies on the ontogenic 
expression of GABAA receptor subunit mRNAs in rat indicate that at PO, the a5, a4, and 
P2 subtype mRNAs are also present at moderate levels (Poulter et al., 1993; Wisden et al., 
1992, Laurie, Wisden and Seeburg, 1992b) in the developing cerebral cortex. 
As this study has demonstrated, the pronounced cortical expression of the a, ~I and 'Y 
subunit genes by birth predicts the early formation of functional GABAA receptors. 
Paradoxically, although cortical HZ binding is already substantial at birth (60% of adult) 
(Candy and Martin, 1979; Lippa et al., 1981; Chisholm, Kellogg and Lippa, 1983) and is 
coupled to GABAA receptors (Palacios, Niehoff and Kuhar, 1979; Eichinger and Sieghart, 
1986; Kellog and Pfleger, 1989), the number of rat cortical GABA and muscimol binding 
sites is approximately 25% of adult levels. The impedance of substantial GABAA receptor 
binding in the newborn may be due to either early subunit composition or post-translational 
subunit modifications. In the adult rat brain, such mismatches in the densities of GABAA 
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and BZ binding sites also occur in regions such as the cerebellum, thalamus and 
hippocampus (Unnerstall et at., 1981; Olsen, McCabe and Wamsley, 1990). 
At PO, in the medial and triangular septal regions, very few GABAA receptor subunit 
mRNAs are expressed and hence the possible receptor complexes at this stage in 
development would consist of only a2 and 1'1 or 12 subunits. From transient expression 
studies in L929 fibroblasts, a 1 ~ 1, but not a 1 12 or ~ 112, sUbtypes assemble to produce 
benzodiazepine insensitive GABAA receptor channels (Angelotti, Uhler and Macdonald, 
1993). Hence at this stage in postnatal development either the GABAA receptor complexes 
assembled are non-functional or another ~ subunit, such as ~2 may be the primary ~ 
transcript in this region of the developing CNS. In fact, in a study of ontogenic expression 
of GABAA receptor subunit mRNAs in the rat, the ~2 subunit mRNA was also detected in 
the PO medial septum (Wisden et at., 1992). 
In the PO thalamic nuclei, results from in situ hybridisation analysis would predict 
GABAA receptor complexes with subunit compositions of a2L~ 1/1'1, a2L~PLNDfI cx2L~ lI12T, 
a2L~PLN2TI aPL~lLNDfI aPL~lLN2TI a3/p3/1'1 and a3/p3/12T. Although cx4 and as subunit 
mRNAs are also expressed in the rat PO thalamus (Laurie, Wisden and Seeburg, 1992b; 
MacLennan et al., 1991), the levels of transcript expression for both a variants are weak and 
therefore a4 and as containing receptor complexes would be a minor component of the 
GABAA receptor response of the PO thalamus. The ~2 transcript was not detected in the 
thalamus at this stage of CNS development (Laurie, Wisden and Seeburg, 1992b). 
Transcripts for aI, a3, a6, PI, ~PI 1'1, 12, and i3 subunits of the GABAA receptor are 
present in the thick PO external granule cell layer and in granule cells migrating through the 
molecular layer to the internal granule cell layer. a6 mRNA expression at this stage in 
development is very weak. In fact, results of this study indicate that the a6 transcript is 
abundantly expressed only after the completion of granule cell migration from the external to 
the internal granule cell layer, which occurs between P2 and P21 (Altman, 1972; Meinecke 
and Rakic, 1990). After migration, granule cells within the internal granule cell layer extend 
dendrites which will become postsynaptic to the axons of the Golgi II cells and it is at this 
time that the receptor proteins can be detected by immunocytochemistry and electron 
microscopy (Meinecke and Rakic, 1990). In contrast, both GAD and GABA 
immunoreactivities can be detected in the very early stages (P2-P7) of postnatal cerebellar 
development. 
Although this study and others have concluded that a6 expression is limited to cerebellar 
granule cells, Varecka et at., (1994) have also observed murine a6 GABAA receptor subunit 
expression in the cochlear granule cells. Both cerebellar granule cells and cochlear granule 
cells are thought to arise from a single precursor pool. Immunocytochemical analysis further 
supports the localisation of the a6 polypeptide in granule cells of the dorsal cochlear 
nucleus, as well as in axons of the olfactory nerve including the glomerular endings, layer II 
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of the dorsal horn of the spinal cord and in the retinal synaptic layers, particularly the inner 
plexiform layer (Gutierrez, Khan and De BIas, 1996). 
Although cerebellar granule cells receive GABAergic input from only a single cell type, 
the Golgi cell, two types of GABAA receptor-mediated inhibition (phasic and tonic) have 
been described. In adult rats, granule cells express six GABAA receptor subunits abundantly 
(aI, a6, ~2I ~PI '"(2, and 8). This relative abundance of rat GABAA receptor subunits 
differs from data presented in this chapter, where of the subunits studied in the adult mouse, 
ai, a6, ~PI yl, Y2 and 0 were expressed abundantly in cerebellar granule cells. Co-
assembly of these subunits results in at least four to six distinct GABAA receptor SUbtypes. 
With the use of electron microscopy Nusser, Sieghart and Somogyi (1998) have 
demonstrated that the subcellular localisations of ai, a6, ~2LP and Y2 subunits are 
concentrated in GABAergic Golgi synapses (Nusser et aI., 1996) and at lower 
concentrations in the extrasynaptic membrane. In contrast, immunoparticles for the 0 
subunit could not be found in synaptic junctions, although they were abundantly present in 
the extrasynaptic dendritic and somatic membranes. Gold particles for the a6, Y2 and ~2LPI 
but not the al and 0 subunits were also concentrated in some glutamatergic mossy fiber 
synapses, where their co-localisation with AMPA-type glutamate receptors was 
demonstrated. The authors conclude that the exclusive extrasynaptic presence of the 0 
subunit-containing receptors, together with their kinetic properties, suggests that tonic 
inhibition could be mediated mainly by extrasynaptic aS~2LPM receptors, whereas phasic 
inhibition is attributable to the activation of synaptic a 1 ~2LPv2I aS~2LPv2 and a 1 aS~2LPy2 
receptors (Nusser, Sieghart and Somoygi, 1998). Jones et aI., (1997) have recently 
demonstrated that in an a6-deficient mouse, the levels of the 8 polypeptide were drastically 
reduced, suggesting that an a60-containing receptor complex is required for proper 
membrane targeting. 
Recently, Jechlinger et aI., (1998) have utilised a new method to quantitate the subtypes 
of a6-containing GABAA receptors present in the adult rat cerebellum. Results obtained 
from these studies indicated that a6 receptors in the cerebellum are composed predominantly 
of aS~xy2 (32%), alaS~xy2 (37%), aS~xo (14%) or alaS~xo (15%) subunits. 
Experiments to determine the relative abundance of the ~ subunits indicated that 10%, 51 % 
and 21 % of a6 receptors contained homogeneous ~ I, ~2 or ~P subunits, respectively, 
whereas two different ~ subunits were present in 18% of all a6 receptors. This method can 
be used to resolve the total number, subunit composition and abundancy of GABAA receptor 
subtypes in other brain regions. 
In the cerebellum, Wisden et al. (1992) described the detection of GABAA receptor 
subunit mRNAs in rat Purkinje cells at birth, while McKernan et al., (1991 a) described the 
postnatal increase in cerebellar aI-like immunoreactivity on Western blots. Results from 
Wisden et ai., 1992 indicate that increases in postnatal expression of GABAA transcripts in 
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both rat Purkinje and postmigratory granule cells (0.1, ~2I ~PI y2, 0) would be paralleled by 
increases in GABAA and type I BZ binding after P8 (Coyle and Enna, 1976; Candy and 
Martin, 1979; Palacios and Kuhar, 1981; Chisholm, Kellogg and Lippa, 1983; Zdilar, 
Rotter and Frostholm, 1991). An acceleration of BZ binding mainly in the molecular layer 
between P14 and P28 is probably due to the coincident development of the Purkinje cell 
dendritic tree (Jacobson, 1978) and extensive production of receptors containing 
all~ NI~PLy2T /0). In cultured rat hippocampal neurons, the suppression of 0.6 expression 
can be over-ridden temporarily (Killisch et al., 1991). Whereas moderate BZ binding is 
present in rat neonatal cerebellum, [3H]-muscimol and [3H]-GABA binding only begins 1 to 
2 weeks after birth (Coyle and Enna, 1976; Palacios and Kuhar, 1981). Diazepam-resistant 
[3H] Ro 15-4513 binding, that is a feature of the aS~xy2 GABAA receptors appears in the 
rat cerebellar granule cell layer after P6 (Uusi-Oukari et al., 1991). Exchange of 0.1 for 0.2 
or 0.3 and yl for y2 in recombinant a~y receptors drastically al ters their responses to GABA 
and BZ agonists and inverse agonists (Ymer et ai., 1990; Puia et ai., 1991). Until P8-P 12, 
GABA apparently mediates neuronal depolarisation through GABAA receptors rather than 
hyperpolarisation as found in the adult brain. This difference is thought to be due to 
opposite electrochemical chloride gradients. 
One exception of this switch from the depolarising to the hyperpolarising effect of 
GAB A-activated chloride currents in the adult occurs in the hypothalamic suprachiasmatic 
nucleus (SCN) where circadian behaviour is manifest by an endogenous clock. In the SCN, 
immunoreactivity for a2, a3, a5, and y2 GABAA receptor subunit polypeptides have been 
identified, while immunoreactivity for 0.1, a2, a3, a5, ~2LP and y2 GABAA receptor 
subunit polypeptides has been demonstrated in areas that receive SCN input including the 
intergeniculate leaflet, subparaventricular zone, paraventricular hypothalamic nucleus, the 
retrochiasmatic area and the paraventricular nucleus of the thalamus (Gao, Fritschy and 
Moore, 1995). Within the circadian timing system there is also a differential distribution of 
GABAA receptor polypeptides at the cellular level. Immunoreactivities for the a2 and P2/3 
subunit polypeptides were predominantly found in neuropil, while immunoreactive products 
for 0.3, 0.5 and y2 subunits were predominantly localised over perikarya. Immunoreactive 
localisation of the 0.1 subunit polypeptide occurred over both neuropil and perikarya 
thalamus (Gao, Fritschy and Moore, 1995). Wagner et aI., (1997) used an in vitro brain-
slice technique to study the effect of bath-applied GABA on adult SCN neurons at various 
times of the day and discovered that GABA acted as an inhibitory neurotransmitter at night, 
decreasing the firing frequency, but during the day GABA acted as an excitatory 
neurotransmitter, increasing the firing frequency. This dual effect was mediated through 
GABAA receptors and may be attributed to an oscillation in intracellular chloride 
concentration. 
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Figure 4.1 
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Figure 4.1 Regional distribution of the GABAA receptor aI-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old ~CF and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the exl-subunit mRNA of the GABAA 
receptor. CAI-3, field CAI-3 of Ammon's hom; Cb, cerebellum; CG, central grey; Cle, 
central nucleus, inferior colliculus; Ctx, cortex; DG, dentate gyrus; DLG, dorsal lateral 
geniculate nucleus; Ent, entorhinal cortex; Hi, hippocampus; Ic, inferior colliculus, IL, 
infralimbic cortex; LD, laterodorsal thalamic nucleus; LHb, lateral habenular nucleus; LP, 
lateral posterior thalamic nucleus; PaS, parasubiculum; PrS, presubiculum; Sb, subiculum. 
Scale bar represents 0.3 mm. Exposure time was 25 days on Kodak XAR-5 film. 
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Figure 4.2 Regional distribution of the GABAA receptor al-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain 
sections hybridized with an oligonucleotide specific for the aI-subunit mRNA of the 
GABAA receptor. AM, anteromedial thalamic nucleus; BSt, bed nucleus stria terminalis; 
CAI-3, field CAl-3 of Ammon's horn; Cb, cerebellum; CPu, caudate putamen; Ctx, 
cortex; DG, dentate gyrus; DLG, dorsal lateral geniculate nucleus; Ent, entorhinal cortex; 
GP, globus pallidus; IML, interstitial nucleus mlf; MG, medial geniculate nucleus; mlf, 
medial longitudinal fasciculus; PaS, parasubiculum; PrS, presubiculum; Rt, reticular 
thalamic nucleus; Sb, subiculum; SubG, subgeniculate nucleus; VP, ventral posterior 
thalamic nucleus. Scale bar represents 0.3 mm. Exposure time was 25 days on Kodak 
XAR-5 film. 
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Figure 4.3 Regional distribution of the GABAA receptor a2-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the a2-subunit mRNA of the GABAA 
receptor. Av, anteroventral thalamic nucleus; CAl-3, field CAl-3 of Ammon's hom; CI, 
centrolateral thalamic nucleus; CPu, caudate putamen; DG, dentate gyrus; DLG, dorsal 
lateral geniculate nucleus; Ent, entorhinal cortex; LD, laterodorsal thalamic nucleus; LHb, 
lateral habenular nucleus; LP, lateral posterior thalamic nucleus; LS, lateral septal nucleus; 
MHb, medial habenular nucleus; MG, medial geniculate nucleus; OPT, olivary pretectal 
nucleus; PT, paratenial thalamic nucleus; PV, paraventricular thalamic nucleus; Sb, 
subiculum; TS, triangular septal nucleus. Scale bar represents 0.3 mm. Exposure time 
was 25 days on Kodak XAR-5 film. 
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Figure 4.4 Regional distribution of the GABAA receptor a2-subunit transcript in the 
brains of C57BU6J mice during postnatal development. 
I-day old (A), 7-day-old (D), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the a2-subunit mRNA of the GABAA 
receptor. Ac, accumbens nucleus; AD, anterodorsal thalamic nucleus; A V, anteroventral 
thalamic nucleus; A Vvl, anteroventral thalamic nucleus, ventrolat; BSti, bed nucleus stria 
terminalis, intermed div; CA, central amygdaloid nucleus; Cb, cerebellum; CLi, caudal 
linear nucleus raphe; Ctx, cortex; DG, dentate gyrus; Ent, entorhinal cortex; G, gelatinosus 
thalamic nucleus; IMD, intermediodorsal thalamic nucleus; La, lateral amygdaloid 
nucleus; LS, lateral septal nucleus; MD, mediodorsal thalamic nucleus; MG, medial 
geniculate nucleus; PaS, parasubiculum; PH, posterior hypothalamic area; PrS, 
presubiculum; Re, reuniens thalamic nucleus; Rh, rhomboid thalamic nucleus; RI, rostral 
interstitial nucleus mlf; Sb, subiculum; tt, tenia tecta; tu, olfactory tubercle; VDB, nucleus 
vertical limb diagonal band; ZI, Zona incerta. Scale bar represents 0.3 mm. Exposure 
time was 25 days on Kodak. XAR-5 film. 
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Figure 4.5 Regional distribution of the GABAA receptor a3-subunit transcript in the 
brains of C57BU6J mice during postnatal development. 
I-day old (A), 7-day-old (n), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the o.3-subunit mRNA of the GABAA 
receptor. CAI-3, field CAI-3 of Ammon's horn; Cb, cerebellum; CG, central grey; CI, 
centrolateral thalamic nucleus; Ctx, cortex; Ic, inferior colliculus; LD, laterodorsal 
thalamic nucleus; LP, lateral posterior thalamic nucleus; Sb, subiculum; VL, ventrolateral 
thalamic nucleus. Scale bar represents O.3mm. Exposure time was 25 days on Kodak 
XAR-5 film. 
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Figure 4.6 Regional distribution of the GABAA receptor a3-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the a3-subunit mRNA of the GABAA 
receptor. AV, anteroventral thalamic nucleus; CAl -3, fi eld CAI -3 of Ammon's horn; Cb, 
cerebellum; IMD, intermediodorsal thalamic nucleus; LS , lateral septal nucleus; MHb, 
medial habenular nucleus; PF, parafascicular thalamic nucleus; PT, paratenial thalamic 
nucleus; PVA,'paraventricular thalamic nucleus, anterior; Rt, reticular thalamic nucleus; 
Sb, subiculum;. Scale bar represents 0.3 mm. Exposure time was 25 days on Kodak 
XAR-5 film . 
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Figure 4.7 Regional distribution of the GABAA receptor a6-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the a6-subunit mRNA of the GABAA 
receptor. Cb, cerebellum; Gel, granule cell layer. Scale bar represents 0.3 mm. Exposure 
time was 25 days on Kodak XAR-5 film. 
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Figure 4.8 Regional distribution of the GABAA receptor {3I-subunit transcript in the 
brains of C57BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (e) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the PI-subunit mRNA of the GABAA 
receptor. CAI-3, field CAI-3 of Ammon's hom; Cb, cerebellum; CPu, caudate putamen; 
Ctx, cortex; DG, dentate gyrus; GP, globus pallidus; Ie, inferior colliculus, IL, infralimbic 
cortex; LS, lateral septum; Sc, superior colliculus. Scale bar represents 0.3 mm. Exposure 
time was 25 days on Kodak XAR-5 film. 
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Figure 4.9 Regional distribution of the GABAA receptor {33-subunit transcript in the 
brains of CS7BU6J mice during postnatal development. 
I-day old (A), 7-day-old (B), 14 day-old (C) and adult CD) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the ~PJsubunit mRNA of the OABAA 
receptor. CAl-3, field CAI-3 of Ammon's hom; Cb, cerebellum; CO, Central gray; Cpu, 
caudate putamen; Ctx, cortex; DO, dentate gyrus; Ent, entorhinal cortex; Ic, inferior 
colliculus; IL, infralimbic cortex; LD, laterodorsal thalamic nucleus; LHb, lateral 
habenular nucleus; LP, lateral posterior nucleus; LS, lateral septum; MHb, medial 
habenular nucleus, PV A, paraventricular nucleus. Scale bar represents 0.3 mm. Exposure 
time was 25 days on Kodak XAR-5 film. 
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Figure 4.10 Regional distribution of the GABAA receptor {33-subunit transcript in the 
brains of C57BU6J mice during postnatal development. 
i-day old (A), 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the ~PJsubunit mRNA of the GABAA 
receptor. Acb, accumbens; APT, anterior pretectal nucleus; AV, anteroventral nucleus; 
CAl-3, field CAl-3 of Ammon's horn; Cb, cerebellum; CPu, caudate putamen; Ctx, 
cortex; DG, dentate gyrus; GP, globus pallidus; MHb, medial habenular nucleus; PaS, 
parasubiculum; PrS, presubiculum; PT, paratenial thalamic nucleus; PYA, paraventricular 
thalamic nucleus; TS, triangular septal nucleus; tt, tenia tecta. Scale bar represents 0.3 
mm. Exposure time was 25 days on Kodak XAR-5 film. 

Chapter 4 DeveLopmentaL Expression II 
Figure 4.11 
l()i 
Figure 4.11 Regional distribution of the GABAA receptor rJ-subunit transcript in the 
brains ofCS7BU6J mice during postnatal development. 
I-day old (A). 7-day-old (B), 14 day-old (C) and adult (D) mouse horizontal brain sections 
hybridized with an oligonucleotide specific for the 'Y1-subunit mRNA of the GABAA 
receptor. Cb. cerebellum; CG. central gray; CIC, central nucleus inferior coIIiculus; Ctx, . 
cortex; OpG, deep gray layer of superior colliculus; OpWh, deep white layer of superior 
colliculus; 03V, dorsal 3rd ventricle; Fi, fimbria hippocampus; Hi, hippocampus; Ie, 
inferior colliculus; lnG, intermediate gray layer superior coIIiculus; LO, laterodorsal 
thalamic nucleus; LP, lateral posterior thalamic nucleus; MHb, medial habenulae nucleus; 
PaS, parasubiculum; Pcom, nucleus posterior commissure; PrS, presubiculum; SuG, 
superficial gray layer of superior colliculus; tt, tenia tecta Scale bar represents 0.3 mm. 
Exposure time was 25 days on Kodak XAR-5 film. 
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Figure 4.12 Regional distribution oftlte GABA,( receptor r1-subunit transcript in the 
brains ojC57BU6J mice during postnatal development:. A: I-day old (A), 7-day old 
(B), 14-day old (C) and adult (D) mouse horizontal brian sections hybridized with an 
oligonucleotide specific for the 1-1 subunit mRNA of the GABAA receptor. CAl-3, field 
CAI-3 of Ammon's hom; Cb cerebellum; Ce, central amygdaloid nucleus; DG, dentate 
gyrus; GP, globus pallidus; IL, infralimbic cortex; IMD, intermediodorsal thalamic 
nucleus; MG, medial geniculate nucleus; MS, medial septal nucleus; PaS, parasubiculum; 
PrC precommissural nucleus; PrS, presubiculum; PT, paratenial thalamic nucleus; PYA, 
paraventricular thalamic nucleus; TS, triangular septal nucleus; VL, venterolateral 
thalamic nucleus. Scale bar represents O.3mm. Exposure time was 25 days on Kodak 
XAR-5 film. 
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Figure 4.13 Regional distribution of the GABA" receptor y.2T -subunit transcript in 
the brains ojC57BU6J mice during postnatal development. A: I-day old (A), 7-day old 
(B), 14-day old (C) and adult (D) mouse horizontal brain sections hybridized with an 
oligonucleotide specific for the y2T-subunit mRNA of the GABA
A 
receptor. AD, 
anterodorsal thalamic nucleus; AV, antereoventral thalamic nucleus; CAl-3, fields CA 1-3 
of Ammon's horn; Cb, cerebellum; CO, central gray; Cpu, caudate putamen; Ctx, cortex; 
DO, dentate gyrus; Ent, entorhinal cortex; Lhb, lateral habenular nucleus; LS, lateral 
septum; opt, optic tract; tt, tenia tecta. Scale bar represents O.3mm. Exposure time was 25 
days on Kodak XAR-5 film. 
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Figure 4.14 Regional distribution of the GABA,4 receptor ~T -subunit transcript in 
the brains ofCS7BU6J mice during postnatal development. A: I-day old (A), 7-day old 
(B), 14-day old (C) and adult (D) mouse horizontal brain sections hybridized with an 
oligonucleotide specific for the y2T-subunit mRNA of the GABA
A 
receptor. AV, 
antereoventral thalamic nucleus; CAI-3, fields CA 1-3 of Ammon's horn; Cb, cerebellum; 
CG, central gray; CI, claustrum; Cpu, caudate putamen; Ctx, cortex; DG, dentate gyrus; 
IMD, intermediodorsal thalamic nucleus; LS, lateral septum; MG, medial geniculate 
nucleus; PV, paraventricular thalamic nucleus; Rt reticular thalamic nucleus; TS, 
triangular septal nucleus; VL, ventrolateral thalamic nucleus. Scale bar represents O.3mm. 
Exposure time was 25 days on Kodak XAR-5 film. 

Chapter 4 Developmental Exp ression l/ 
Figure 4.15 
107 
Figure 4.15 Regional distribution of the GABA A receptor '}B -subunit transcript in the 
brains of C57BU6J mice during postnatal development. A: I-day old (A), 7 -day old (B), 
I4-day old (C) and adult (D) mouse horizontal brain sections hybridized with an 
oligonucleotide specific for the y3-subunit mRNA of the GABAA receptor. Cb, 
cerebellum; CAI-3, fields CAI-3 of Ammon's hom; Ctx, cortex; DG, dentate gyrus; LS, 
lateral septum. Scale bar represents O.3mm. Exposure time was 25 days on Kodak XAR-5 
film. 
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Figure 4.16 Regional distribution of the GABAA receptor 81 -subunit transcript in the 
brains ofC57BU6J mice during postnatal development. A: I-day old (A), 7-day old (B), 
I4-day old (C) and adult (D) mouse horizontal brain sections hybridized with an 
oligonucleotide specific for the ol-subunit mRNA of the GABAA receptor. Av, 
anteroventral thalamic nucleus; Cb, cerebellum; Cpu, caudate putamen; Ctx, cortex; DG, 
dentate gyrus; DLG, dorsal lateral geniculate nucleus; GP, globus pallidus; LD, 
laterodorsal thalamic nucleus. Scale bar represents O.3mm. Exposure time was 25 days on 
Kodak XAR-5 film. 
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Figure 4.17 Regional distribution of the GABAA receptor 01 -subunit transcript in the 
brains of CS7BU6J mice during postnatal development. A: I-day old (A), 7-day old (B), 
14-day old (C) and adult (D) mouse horizontal brain sections hybridized with an 
oligonucleotide specific for the ol-subunit mRNA of the GABAA receptor. Am, , 
anteromedial thalamic nucleus; Cb, cerebellum; Cpu, caudate putamen; Ctx, cortex; Gcl, 
granule cell layer; VPL, ventral posterior lateral thalamic nucleus; VPM, ventral posterior 
medial thalamic nucleus. Scale bar represents O.3mm. Exposure time was 25 days on 
Kodak XAR-S film. 
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Figure 4.18 Control sections for the GABAA. receptor aI, a2, a3, a6, {3I, {33-subunit 
probes. Horizontal sections were hybridized with a probe labeled to a specific activity of 
. 109 dpmlJlg in the presence of a 30-fold excess of unlabeled oligonucleotide. All controls 
shown are virtually devoid of signal demonstrating the specificity of the probe and 
hybridization conditions. (A), al probe, (ll) a2 probe, (C) a3 probe, (D) a6 probe, (E) 
PI probe, (F) p3 probe. Exposure time was 25 days on Kodak XAR-5 film. 
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Figure 4.19 Control sections for the GABA,( receptor r1, 12T, j8, o1-subunit probes. 
Horizontal sections were hybridized with a probe labeled to a specific activity of 109 
dprnlJlg in the presence of a 30-fold excess of unlabeled oligonucleotide. All controls 
shown are virtually devoid of signal demonstrating the specificity of the probe and 
hybridization conditions. (A), 81 probe, (B) j'2T probe, (C) "(3 probe, (D) 81 probe. 
Exposure time was 25 days on Kodak XAR-5 film. 
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Figure 4.20 Cellular localization of the aJ and a6 subunit mRNAs of the GABAA 
receptor during postnatal development and in the adult brain. al probe (A, B, E, F, I, J, 
M, N) and 0.6 probe (C, D, G, H, K, L, 0, P). Bright-field (A, E, I, M) and dark-field (B, 
F,}, N) views of the 0.1 GABAA receptor subunit mRNA in the C57BL/6J cerebellum at 
PO (A, B), P7 (E, F), P14 (I, J) and adult (M, N) cerebellum. Bright-field (C, G, K, 0) and 
dark-field (D, H, L, P) views of the a6 GABAA receptor subunit mRNA in the C57BU6J 
cerebellum at PO (C, D), P7 (G, H), P14 (K, L) and adult (0, P) cerebellum. Scale bar 
represents 6 J.lm. 
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Figure 4.21 Cellular localization of the a1 and {33 subunit mRNAs of the GABAA 
receptor during postnatal development and in the adult brain. a1 probe (B, 0, F, H, I, 
K) and ~P probe (A, C, B, G, J). Bright-field (B) and dark-field (D) views of the al 
GABAA receptor subunit mRNA in the C57BL/6J cerebral cortex at P14. Bright-field (F) 
'", 
and dark-field (H) views of the al GABAA receptor subunit mRNA in the C57BL/6J 
hippocampus at P14. Bright-field (M) and dark-field (K) views of the a1 GABAA receptor 
subunit mRNA in the C57BL/6J cerebellum at P14. Bright-field (A) and dark-field (C) 
views of the ~P GABAA receptor subunit mRNA in the C57BL/6J cerebral cortex at P14. 
Bright-field (E) and dark-field (G) views of the ~P GABAA receptor subunit mRNA in the 
C57BU6J hippocampus at P14. Dark-field (J) view of the ~P GABAA receptor subunit 
mRNA in the C57BU6J cerebellar cortex at P14. The large arrowheads indicate the co-
localisation of al and ~P subunit mRNAs in cerebral cortical pyramidal cells (B and D) 
and dentate gyrus granule cells (E, F, G, H). Small arrowheads indicate the absence of a1 
and ~P co-localisation in a population of dentate granule cells in the inner layer of the 
dentate gyrus, in hippocampal hilar cells (E, F, G ,H) and in cerebellar Purkinje cells (I, J, 
K). Scale bar represents 6 J..lm. 
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Figure 4.22 Cellular localization of the aJ and "aT-subunit mRNAs of the GABAA 
receptor during postnatal development and in the adult brain. a I probe (A, C, F) and "{2 
probe (B, 0, E). Dark-field (C, F) views of the al GABAA receptor subunit mRNA in 
theP14 cerebellum (C) and P14 hippocampus (F). Bright-field (D) and dark-field (B, E) 
'0 
views of the p3 GABAA receptor subunit mRNA in the C57BU6J P14 cerebellum. The 
large arrowhead (A, B, C) indicates co-localisation of the 12T and al subunit mRNA in 
granule cell somas and the small arrowhead (B, C) indicates co-localization of the "{2T and 
a I subunit in the Purkinje cell soma. The large arrowhead (E, F) indicates the co-
localization of both the al and 12T mRNAs in hilar interneurons, while the small 
arrowhead indicates that only the 12T mRNA is present in cells in the inner layer 0 the 
dentate gyrus. Scale bar (E) represents 26 11m. 
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Table 4.1 Regional distribution of the GABAA receptor al-, a2-, a3-and a6-subunit 
transcripts in the brains of C57BU6J mice during postnatal development. 
Hybridization signals, obtained with oligonucleotides specific for the aI-subunit mRNA, 
the a2-subunit mRNA, the a3-subunit mRNA, or the a6-subunit mRNA were arbitrarily 
'scored as either high, +++; moderate, ++; low, +; weak, (+); or not detectable, -. Nd 
indicates not determined. The results are derived from Figures 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 
4.7 and from data not shown. I-day, 7-day and 14-day correspond to the days after birth 
and adult refers to a 50 to 60-day old mouse. 
Region / 1 DAY 7 DAY 14 DAY ADUlT 
Nucleus 
al a2 a3 a6 al a2 a 3 a6 al a 2 a 3 a6 al a 2 a3 a 6 
Cortex 
Layer I-II + + + - +++ ++ ++ - +++ +++ +++ - ++ + ++ -
Layer ill - + ++ - + + + - ++ + ++ - + + + -
Layer IV - - ++ - +++ + ++ - +++ + ++ - ++ + ++ -
Layer V - - ++ - ++ + ++ - +++ + +++ - ++ + ++ -
Layer VI - - ++ - ++ + + + - ++ + ++ - + + ++ -
Entrohineal - + ++ - +++ + + - ++ + + +++ - ++ + ++ -
Ctx 
Hippo -
camp us 
CAl + +++ + - +++ +++ ++ - +++ +++ + - ++ ++ + -
CA3 - +++ + - + +++ ++ - ++ +++ - - + ++ - -
DG - + - - ++ ++ - - +++ +++ - - ++ ++ - -
Basa l 
N uc le i 
CPu + + - - + + - - + + - - - + - -
Acb - - - - - + - - - + - - - + - -
GP - - - - - + - - +++ + - - - + - -
Amygdala 
La - - - - - ++ - - - ++ - - - - - -
Sep tum 
LS - + + - - + - - + ++ + - - + - -
M S - + - - - + - - + ++ + - - + - -
TS - + - - - + - - + ++ + - - - - -
Medial - - + - ++ - ++ - - - +++ - - - ++ -
Habenula 
Thalamus 
AV - ++ + - - + + - + ++ - - + + + -
PV - ++ + - - ++ + - + ++ +++ - + + + -
AM - + + - ++ - + - r ++ ++ - + + + -
VL - + + - - + + - + - + - - - + -
DLG - + + - ++ + + - ++ + ++ - + - - -
MG - ++ + - ++ - + - ++ - ++ - - - - -
Rt - - +++ - - - ++ - + - +++ - + - ++ -
VPL - + + - - - - - + - + - - - - -
LD - + ++ - ++ - + - ++ - + - + - + -
LP - ++ ++ - ++ - + - ++ - ++ - + - + -
Infe rior 
colJi culi 
Ce ntral nu . - - + - +++ - + - +++ - + - ++ - ++ -
Superior 
co lli culi 
Central grey - - + - ++ - + - ++ - + - + - ++ -
DpWh - - + - ++ - + - ++ - + - + - ++ -
S ubi -
culum 
Para R. Sub + ++ + - +++ ++ ++ - ++ + ++ ++ - ++ + ++ -
Para A. Sub + ++ + - +++ ++ + + - +++ ++ ++ - ++ + ++ -
Cere-
be llum 
Purkinje - - - - +++ + - - +++ + - - ++ + - -
Ste ll ate/ - - - - ++ - - - + - + - + - - -
basket cells 
LG. cells + - + + +++ + + +++ +++ - + +++ ++ - - +++ 
E.G. cells - - - - +++ + + +++ +++ - + +++ ++ - - +++ 
... 
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Table 4.2 Regional distribution of the GABAA receptor {31- and {33-subunit 
transcripts in the brains of C57BU6J mice during postnatal development. 
Hybridization signals, obtained with oligonucleotides specific for the ~lJsubunit mRNA, 
and the ~PJsubunit mRNA were arbitrarily scored as either high, +++; moderate, ++; low, 
'+; weak, (+); or not detectable, -. N d indicates not determined. The results are derived 
from Figures 4.8, 4.9, 4.10 and from data not shown. I-day, 7-day and I4-day correspond 
to the days after birth and adult refers to a 50 to 60-day old mouse. 
Region/ 1 DAY 7 DAY 14 DAY ADUlT 
Nucleus 
Pl p3 Pl p3 Pl p3 Pl p3 
Cortex 
Layer I-II ++ ++ + ++ ++ ++ + ++ 
Layer III + ++ + ++ ++ ++ + ++ 
Layer IV + ++ + ++ ++ ++ + ++ 
Layer V + + + ++ ++ ++ + ++ 
Layer VI + + + + ++ + + + 
Entrohineal Ctx + + ++ ++ ++ + ++ 
Hippocampus 
CAl ++ ++ ++ +++ ++ +++ ++ ++ 
CA3 ++ ++ ++ +++ ++ +++ ++ ++ 
Dentate Gyrus - ++ + +++ ++ +++ + ++ 
Basal Nuclei 
Caudate-putamen + ++ + + + + + + 
Nu. accumbens + - + - + + + + 
Globus pallidus + - + - + + + + 
Amygdala 
Lateral amygdaloid - - - - - - - -
Septum 
Bed nucleus s. t. - - - - - - - -
Lateral septum + + + + + + + + 
Medial septum - - - - - - - + 
Triangular septum - - - - - - - -
Medial Habenula - + - + - + - + 
Thalamus 
Anteroventral thaI. + + + + + + + + 
Paraventricular nu . + + + + + + + + 
Reuniens thaI. nu . + + + + + + + + 
Anteromedial thaI. + + + + + + + + 
Ventrolateral thaI. + + + + + + + + 
Dorsal lateral genicul . - + - + - + - + 
Medial lateral genicui. - + - + - + - + 
Reti cular nucleus - - - - - - - -
Ven tr. posterior nu . + + + + + + + + 
Laterodorsal thaI. + + + + ++ + + + 
Lateral posterior thaI. + + + + ++ + + + 
Infer ior co lliculi 
Central nucleus. - + + + ++ + + + 
Su perio r co lliculi 
Central grey - + + + ++ + + + 
Deep white layer - + + + ++ + + + 
Subiculum 
Para R. Sub + ++ + +++ + ++ + + 
Para A. Sub + ++ + +++ + ++ + + 
Ce rebellum 
Purkinje layer - - - - - - - -
Stellatelbasket ce ll s - + + ++ ++ + + + 
Interior granule. ce lls - - + +++ ++ +++ + + 
Exterior granule cell s - - + +++ ++ +++ + + 
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Table 4.3 Regional distribution of the GABAA receptor r1-, y2-, yJ-and 81-subunit 
transcripts in the brains of C57BU6J mice during postnatal development. 
Hybridization signals, obtained with oligonucleotides specific for the "(I-subunit mRNA, 
the y2-subunit mRNA, the y3-subunit mRNA, or the 8I-subunit mRNA were arbitrarily 
scored as either high, +++; moderate, ++; low, +; weak, (+); or not detectable, -. Nd 
indicates not determined. The results are derived from Figures 4.11,4.12,4.13,4.14,4.15, 
4.16,4.17 and from data not shown. I-day, 7-day and 14-day correspond to the days after 
birth and adult refers to 50 to 60-day old mice. 
Re gion/ 1 DAY 7 DAY 14 DAY ADUlT 
Nu cleu s 
y1 y2T y3 81 y1 y2T y3 81 y1 y2T y3 01 y1 y2T y3 01 
Cortex 
Layer I-II + +++ + - ++ ++ + ++ ++ +++ + + + ++ + + 
Layer ill + ++ + + - ++ +++ + ++ ++ +++ + + + +++ + + 
Layer IV + ++ + - ++ ++ + ++ ++ +++ + + + ++ + + 
Layer V + +++ + - ++ +++ + + ++ +++ + + + +++ + + 
Layer VI + ++ + - ++ ++ + + ++ +++ + + + ++ + + 
Entrohineal + ++ . + - ++ ++ + + ++ +++ + + + ++ + + 
Ctx 
H ip po-
campus 
CA l - +++ - - + +++ + - ++ +++ + - + ++ + -
CA3 - ++ - - + +++ + - ++ +++ + - + ++ + -
DG - ++ - - + +++ + + ++ +++ + + + +++ + + 
Basal 
Nu cle i 
CPu + + + - + + + + ++ + + + + + + + 
Acb + + - - + + + - ++ + + - + + + -
GP + + + - + +++ + + +++ + + + ++ + + + 
Amygda la 
La - + - - - + - - - ++ - - - +++ - -
Septum 
Lateral ++ + - - +++ + + - +++ + + - +++ + + -
Medial ++ + - - ++ + + - ++ + + - ++ + + -
Triangular ++ - - - +++ + - - +++ ++ + - +++ + + -
Media l +++ ++ + - +++ ++ - - +++ +++ - - ++ ++ - -
Habenula 
T h a lam us 
AV ++ + - - + +++ - ++ ++ +++ - + + ++ - + 
PYA ++ ++ - - ++ ++ - + +++ +++ - - ++ ++ - -
AM ++ + - - ++ ++ - ++ + ++ - + + + - ++ 
VL ++ ++ - - + + - + ++ ++ - + + + - ++ 
DLG - + - - ++ ++ - + ++ +++ - + ++ ++ - + 
MG +++ ++ - - +++ +++ - + ++ +++ - + ++ ++ - + 
Rt - ++ - - - ++ - - - ++ - - - + - -
VPL + + - - + + - + ++ ++ - ++ + + - ++ 
LD +++ ++ - - ++ + - + ++ ++ - ++ + + - -
LP +++ ++ - - ++ + - - ++ ++ - - + + - -
Co ll ic ul i 
I.F. C ++ +++ - - ++ ++ - - ++ +++ - + ++ ++ - -
Central grey ++ ++ - - ++ ++ - - ++ +++ - - ++ ++ - -
DpWh ++ ++ - - ++ ++ - - ++ +++ - - ++ ++ - -
Subi -
culu m 
Para R. Sub ++ +++ + - +++ ++ + - +++ +++ + - +++ +++ + -
Para A. Sub ++ +++ + - +++ ++ + - +++ +++ + - +++ +++ + -
Cer e-
be llum 
Purki nje - ++ - - - +++ - - +++ - - - +++ - -
Stell ate/ - ++ + - + ++ + + ++ ++ + + + + + + 
basket cells 
I.G. cells - - - - + +++ ++ ++ ++ +++ +++ ++ ++ ++ ++ ++ 
E.G. cell s + ++ ++ - + +++ ++ ++ ++ +++ +++ ++ ++ ++ ++ ++ 
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Table 4.4 Relative expression levels of the GABAA receptor a1-, a2-, a3-, /31-, 
/33-, rl-. .,a-, y3- and o1-subunit transcripts in serial horizontal sections of 1 day-old 
CS7BU6J mouse brains. 
Hybridization signals, obtained with oligonucleotides specific for these murine GABAA 
receptor subunit transcripts were arbitrarily scored as either high, +++; moderate, ++; low, 
+; weak, (+); or not detectable, -. Nd indicates not determined. The results are derived 
from Figures .4.1 - 4.17 and from data not shown. Note that these results take into account 
differences in the relative autoradiographic and photographic exposure times 
(approximately 5-fold) of the al-, a2-, a3-, a6-. ~NJI ~PJ. and y2-subunit transcripts 
compared with the ,),1-, ')'3- and 31-subunit transcripts. 
Regi on / 1 DAY 
Nu c l e u s 
a l a2 a 3 a6 ~l ~P yl y2T y3 01 
Co rtex 
Layer I-IT + + + - ++ +++ + +++ - -
Layer m - + ++ - + +++ + +++ + -
Layer IV - - ++ - + +++ + ++ + -
Layer V - - ++ - + ++ + +++ + -
Layer VI - - ++ - + ++ + ++ + -
Hip poca mpu s 
CA l + +++ + - ++ +++ - +++ - -
CA3 - +++ + - + + +++ - ++ - -
Dentate gyrus - ++ - - + ++ - ++ - -
Basal Nucle i 
Caudate-putamen + + - - + +++ + + + -
Nu . accum bens - + - - + ++ + + - -
Globus pall idus - + - - + - + + + -
Se ptum 
Lateral septum - ++ + - + + ++ + - -
Medial septum - ++ - - - - + + - -
Triangular septum - ++ - - - - ++ - - -
Medial Habenula - ++ ++ - + ++ ++ + -
T ha lamu s 
Anterovcntral thaI. - +++ ++ - + + ++ + - -
ParaventricuJar nu. - ++ + - + ++ ++ ++ - -
AnteromediaJ thaI. - + + - + + ++ + - -
Ventrolateral thaI. - + + - + ++ + ++ - -
Dorsal lateral genicul - + + - + + ++ + - -
Medial genicul - +++ ++ - + + +++ ++ - .-
Reticular nucleus - - ++ + - - - - ++ - -
Ventr. pos tcrior nu . - + + - + + ++ + - -
Laterodorsal thaI. - + ++ - + + +++ ++ - -
Lateral posterior thaI. - ++ ++ - + + +++ ++ - -
Co lli culi 
I.c.Central nucleus. - - ++ - - + ++ +++ - -
Central grey - - ++ - - + +++ ++ - -
Deep white layer - - ++ - - + ++ +++ - -
Subi culum 
Para R. Sub + +++ ++ - + +++ +++ +++ + -
Para A. Sub + + ++ ++ - + +++ +++ +++ + -
Ce rebellum 
Purkinje layer - + - - - - - + - -
Stellate/basket cells - - - - + + + - + + -
Interior granule cell s - - - - - - - - - -
Ex terior granule cells + + - + + + ++ + ++ + -
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Table 4.5 Relative expression levels of the GABAA receptor a1-, a2-, a3-, {31-, 
{33-, r1-, y2-, ')13- and oI-subunit transcripts in serial horizontal sections of 7 day-old 
C57BU6J mouse brains. 
Hybridization signals, obtained with oligonucleotides specific for these murine GABAA 
receptor subunit transcripts were arbitrarily scored as either high, +++; moderate, ++; low, 
+; weak, (+); or not detectable, -. Nd indicates not determined. The results are derived 
from Figures 4.1 - 4.17 and from data not shown. Note that these results take into account 
differences in the. relative autoradiographic and photographic exposure times 
(approximately 5-fold) of the a1-, a2-, a3-, a6-, PI-, P3-. and y2-subunit transcripts 
compared with the y1-, 13- and ol-subunit transcripts. 
Region / 7 DAY 
Nucle u s 
al a2 a3 a6 131 ~P y l y2T y3 01 
Cortex 
Layer I-II +++ ++ ++ - + +++ ++ ++ + + 
Layer ill ++ + + - + + ++ ++ +++ + + 
Layer IV +++ + ++ - + +++ ++ ++ + + 
Layer V ++ + ++ - + +++ ++ +++ + + 
Layer VI ++ + ++ - + +++ ++ ++ + + 
Entrohineal Ctx + ++ - + +++ ++ ++ + + 
Hippocam pus 
CA l ++ +++ ++ - ++ +++ ++ +++ + -
CA3 + +++ ++ - ++ +++ ++ +++ + -
Dentate gyrus ++ + + - - ++ +++ + +++ + + 
Basal Nucle i 
Caudate-putamen + + - - + + + + + + 
Nu. accumbens - + - - + + + + + + 
Globus pall idus - + - - + - +++ + + + 
Se ptum 
Lateral septum - + - - + - +++ + + -
Medial septum - + - - + - +++ + + -
Triangular septum - + - - + + +++ + + -
Medial Habenula ++ - ++ - + + + ++ + - -
Thalam us 
Anteroventral thaI. - + + - + - + +++ - ++ 
Paraventricu lar nu. - ++ ++ - + ++ +++ ++ - + 
Anteromedial tha I. ++ - + - + - + + - ++ 
Ventrolateral thaI. - + + - + + + + - + 
Dorsal lateral genicu l ++ + + - + + ++ ++ - ++ 
Medial lateral genicul ++ - + - + + ++ +++ - + 
Reticular nucleus - - +++ - + - - + - -
Ventr. posterior nu . - - - - + + + + - ++ 
Laterodorsal thal. ++ - + - + + + + - + 
Lateral posterior thaI. ++ - + - + + ++ + - -
Infe rior co lliculi +++ - + - + + + + ++ - -
Superior co lliculi 
Central grey ++ - + - + + ++ ++ - -
Deep white layer ++ - + - + + ++ ++ - -
Subic ulum 
Para R. Sub +++ ++ ++ - + +++ +++ ++ + -
Para A. Sub +++ ++ ++ - + +++ +++ ++ + -
Cerebellu m 
Purkinje +++ + - - - - - +++ - -
Stellatelbasket cell s ++ - - - + ++ + ++ + + 
Interior granule cells +++ + + +++ + +++ ++ +++ ++ ++ 
Exterior gran ule cells +++ + + +++ + +++ ++ ++ + ++ ++ 
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Table 4.6 Relative expression levels of the GABAA receptor al-, a2-, a3-, /31-, 
/33-, r1-, )Q-, y3- and 01-subunit transcripts in serial horizontal sections of 14 day-old 
C57BU6J mouse brains. 
Hybridization signals, obtained with oligonucleotides specific for these murine GABAA 
receptor subunit transcripts were arbitrarily scored as either high, +++; moderate, ++; low, 
+; weak, (+); or not detectable, -. Nd indicates not determined. The results are derived 
from Figures 4.1 - 4.17 and from data not shown. Note that these results take into account 
differences in the relative autoradiographic and photographic exposure times 
(approximately 5-fold) of the al-, a2-, a3-, a6-, ~ 1-, ~PJI and "(2-subunit transcripts 
compared with the 1'1-,13- and aI-subunit transcripts. 
Region/ 14 DAY 
Nucleus 
al a2 a3 a6 ~l ~P yl y2 T y3 81 
Cortex 
Layer I-II +++ +++ +++ - ++ ++ ++ +++ + ++ 
Layer III ++ + ++ - ++ ++ ++ +++ + ++ 
Layer IV +++ + ++ - ++ ++ ++ +++ + ++ 
Layer V +++ + +++ - ++ ++ ++ +++ + + 
Layer VI ++ + ++ - + ++ ++ +++ + + 
Entrohineal Ctx ++ + + +++ - ++ ++ ++ +++ + + 
Hippocampus 
CA l +++ +++ ++ - ++ +++ ++ +++ ++ -
CA3 + +++ - - ++ +++ ++ +++ ++ -
Dentate gyrus ++ +++ - - ++ +++ ++ +++ ++ + 
Basal Nuclei 
Caudate-putamen + + - - + + ++ + + + 
Nu. accumbens - + - - + + ++ + + -
Globus patl idus +++ + - - + + +++ + + + 
Septum 
Lateral septum + ++ + - ++ + +++ + + -
Medial septum + ++ + - ++ - ++ + + -
Triangular septum + ++ + - ++ - +++ ++ + -
Medial Habenula ++ ++ +++ - ++ + +++ ++ + -
Thalamus 
Anteroventral thaI. + ++ - - ++ + ++ +++ - ++ 
Paraventricular nu . + ++ +++ - + ++ +++ +++ - -
Anteromedial thaI. + ++ - - + + +++ ++ - + 
Ventrolateral thaI. + + - - + + ++ ++ - + 
Dorsal lateral genicul +++ + ++ - + + ++ +++ - + 
Medial lateral genicul +++ - ++ - + + ++ + - + 
Reticular nucleus - - +++ - - - - - - -
Ventr. posterior nu . ++ + + - + + ++ + - ++ 
Laterodorsal thaI. ++ - + - ++ + ++ + - ++ 
Lateral posterior thaI. ++ - + - ++ + ++ + - ++ 
Inferior co llicu li +++ - + - ++ ++ ++ +++ - + 
Superior colliculi 
Central grey ++ - + - ++ ++ ++ +++ + -
Deep white layer +++ - + - ++ ++ ++ +++ + -
Subicu lum 
Para R. Sub +++ +++ + - + ++ +++ +++ + -
Para A. Sub +++ +++ + - + ++ +++ +++ + -
Cerebellum 
Purkinje +++ + - - - - ++ +++ - -
Stetlatelbasket ce lls ++ + + - ++ + ++ ++ + + 
Interior granule cells +++ + + +++ ++ +++ ++ +++ +++ ++ 
Exterior granule ce lls +++ + + +++ ++ +++ ++ +++ +++ ++ 
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Table 4.7 Relative expression levels of the GABAA receptor al-, a2-, a3-, /31-, 
/33-, rl-, ')'2-, y3- and oJ-subunit transcripts in serial horizontal sections of adult 
C57BU6J mouse brains. 
Hybridization signals, obtained with oligonucleotides specific for these murine GABAA 
" receptor subunit transcripts were arbitrarily scored as either high, +++; moderate, ++; low, 
+; weak, (+); or not detectable, -. Nd indicates not determined. The results are derived 
from Figures 4.1 - 4.17 and from data not shown. Note that these results take into account 
differences in the relative autoradiographic and photographic exposure times 
(approximately 5-fold) of the a.l-, a.2-, a.3-, a.6-, ~ 1-, ~PJI and yZ-subunit transcripts 
compared with the 11-, -y3- and 51-subunit transcripts. Adult mice were 50 to 60 days old. 
Adult 
Nuc l e u s 
a1 a2 a 3 a6 (31 (33 y1 yT 2 y3 01 
Cortex 
LayerI-il ++ ++ ++ - + ++ + + + + 
Layer ill ++ + + - + ++ ++ ++ + + 
Layer IV ++ + ++ - + ++ ++ + + + 
Layer V ++ + ++ - + ++ ++ ++ + + 
Layer VI ++ + ++ - + ++ ++ ++ + + 
Hi ppocamp us 
CA l ++ ++ + - + +++ + ++ - -
CAJ + ++ - - + +++ + ++ - -
Dentate gyrus ++ ++ - - + +++ + +++ - -
Basal Nucl ei 
Caudate-putamen - + - - + + + - + + 
Nu. acc umbens - + - - + + + - - -
Globus pall idus - + - - + + ++ - - -
Se ptum 
Lateral septum - + - - + + +++ + + -
Medial septum - + - - + + +++ + + -
Triangular septum - - - - + + +++ + + -
Medial Habenula - ++ ++ - - + ++ - - -
Thalam us 
Anteroventral thaI. + + + - + - + + - -
Para ventricular nu . + + + - + ++ ++ + - -
Anteromedial thaI. + + + - + - ++ + - ++ 
Ventrolateral thaI. - - + - + - + + - + 
Dorsal lateral ge ni cul. + - - - + - + ++ - -
Medial geniculate ++ - - - + - ++ ++ - ++ 
Retic ular nucleus + - ++ - + - - ++ - -
Laterodorsal thaI. + - - - + - ++ + - -
Lateral pos teri or thaI. + - - - + - + + - -
Co lli cu li 
I.C . Central nucleus. ++ - ++ - + + ++ + - -
Central grey + - ++ - + + + + + + - -
Deep white layer + - ++ - + + ++ + - -
S ubi culu m 
Para R. Sub ++ ++ ++ - + + + + - -
Para A. S ub ++ ++ ++ - + + + + - -
Cerebellum 
Purkinje cell layer +++ + - - - - - ++ - -
Ste ll atelbasket cell s + - - - + + + + - + 
Interior granular cell s ++ - - +++ + + ++ + ++ ++ 
Exterior granular cells ++ - - +++ + + ++ + ++ ++ 
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5.1 Introduction 
Heterogeneity within a receptor class, as demonstrated for the GABAA receptor in 
Chapter 4 is due predominantly to the developmental and differential localization of large 
numbers of receptor subunit mRNAs. Translation of these mRNAs and the assembly of 
the ir products into hetero-oli gomeric receptors creates numerou s subtype variations. 
Further synaptic diversification may also occur, however through molecular alterations to 
either nucleic acid or protein and include: I) RNA editing; 2) alternative-splicing of a 
mRNA ; 3) allelic variation as seen with D4 dopamine receptor variants in the human 
population (Vantol et ai., 1992); and post- tran s lational modification s, (protein 
phosphorylation). 
Protein phosphorylation is a common mechanism for regulating the function of a wide 
variety of proteins, including ligand-gated ion channels. A variety of data now indicate 
that protein phosphorylation within the CNS regulates the efficacy of synaptic 
tran smiss ion, both by modulating the release of neurotransmitter from the presy naptic 
nerve terminal and by modulating the sensitivity of receptors in the postsy naptic 
membrane (Greengard, 1978; Kandel and Schwartz, 1982; Huganir and Greengard , 1990; 
Nicoll et al., 1988). The desensitization of neurotransmitter receptors could playa role in 
the modulation of synaptic transmission during high-frequency firing of the presynaptic 
neuron or under conditions in which there are significant resting levels of neurotransmitter 
in the synaptic cleft. 
All GABAA receptor P subunits have a consensus site for PKA phosphoryl at ion, 
corresponding to serine 409 in PI (Swope et aI., 1992; Ymer et aI., 1989), and thi s res idue 
can be phorphorylated by PKA and PKC (Moss, Doherty and Huganir, 1992). PKA or 
PKC activation in HEK-293 cells transiently expressing GABAA receptors decreases the 
sensitivity to GABA (Moss et aI., 1992; Krishek et aI., 1994). The GABAA receptor y2 
subunit has two serine phosphorylation sites, one of which is miss ing in the 12 splice 
variant (Moss, Doherty and Huganir, 1992; Whiting, McKernan and Iversen, 1991). 
Mutation of the 409 (P 1), 327 ("(2) and 343 ("(2) serine sites abolishes the e ffect of PCK. 
The molecular alteration of the AMPA GluR-B(Q) and GluR-B(R) SUbtypes of the 
glutamate receptor was the first reported example of variation in a mRNA arising from 
RNA editing (Sommer et ai., 1991). The editing process is highly selective for GluR-B 
subunits only, and is developmentally regulated (Burnashev et al., 1992). The conversion 
of a glutamine to arginine amino acid in the putative M2 domain of the GluR-B subunit 
results in hetero-oligomeric AMPA receptors containing GluR-B subunits and low 
divalent ion (Ca2+) permeabilites (Hume, Dingledine and Heinemann, 1991; Burnashev 
et al., 1992). 
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Alternative-RNA splic ing, as a mechani sm for creating diversity within the CNS has 
been reported for several receptor systems. The D2 dopamine receptor (Dal Toso et aI., 
1989; Giros et ai., 1989; Monsma et ai. , 1989; Chio et ai., 1990) and the a subunit of the 
acetylcholine receptor (Beeson et ai., 1990) are alternatively-spliced transcripts with 29 
and 25 amino ac id inserti ons, respective ly. The function of these insertions remains 
unkown. 
As described in section 1.4.6, alternative-splicing of primary transcripts of the GABAA 
receptor "{2 subunit in human, bovine, chick, rat and mouse (Whiting, McKernan and 
Iverson, 1990; Kofuji et al., 1991; G lencorse, Bateson and Darli son, 1992; Bateson et al., 
199 1) results in two mRNAs that differ by the presence or absence of a 24 base pair (8 
amino ac ids) insertion in the cytoplasmic loop between the third and fourth putative 
transmembrane-spanning domains. The insertion contains a site for prote in kinase C 
(PKC) phosphory lat ion and may be involved in the potenti ating effect of EtOH on the 
GABA response of the GABAA receptor (Wafford, et al., 1990). The 24 base insertion 
may also playa role in the inhibitory modulation by the benzodiazepine inverse agoni st, 
Ro 15-45 13 on ethanol potenti ation (Wafford, McKernan and Iversen, 1990). 
To date, the "{2 GABAA receptor subunit is the only example within the ligand-gated 
ion superfamily of an alternatively-spli ced transcript with a poss ible role in synapti c 
plasti c ity . The dete rmin ation of the temporal expression of the y2 subunit mRNA 
vari ants will provide an insight into the patterns of heterogene ity expressed during the 
developent of the CNS. Thi s chapter describes the embryonic and postnatal expression of 
the alternative ly-spliced 12 GABAA receptor subunit mRNAs in the C57BLl6J mouse 
brain . 
5.2 Results 
5.2.1 Regional and Cellular in situ hybridisation 
Oligonucleotide probes spec ific for either the y2S subunit mRNA or the y2L subunit 
mRNA, and an ol igonuc leotide (y2T) that recogni zes both of these transcripts, were used 
for in situ hybridi sation studies. The expression patterns of the "{2L and y2S transcripts 
during late murine embryogenesis (embyronic days 14.5 to 19.5) are shown in Figure 5. \. 
The regional di stribution patte rns of the "{2-subunit-variant transcripts in I-day-o ld, 7-
day-old, 14-day-old and adult mouse brains are shown in Figures 5.2 to 5.5. The signal s 
on parallel control sections with each of the three oligonucleotide probes were competed 
with a thirty-fold molar excess of the appropriate unlabel1ed oligonucleotide (Figure 5.6), 
thus confirming the specificity of the hybridisations. The y2S subunit and the y2L subunit 
mRNAs are di stributed throughout the mouse neuraxis. They are developmentally 
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regul ated with the 12S subunit mRNA being the predominant 12 splice vari ant express ion 
in the one-day o ld murine brain . The abundance of the 12S transcript dec reases at 
postnatal day 7 but peaks again at postnatal day 14 (Figures 5.2 D, 5.3 D, 5.4 A and 5.5 
A). The y2L subunit mRNA is the predominant y2 transc ript in the adult e NS (Figures 
5.3 D and E , 5.4 D and E). The mRNA di stribution patterns resulting from i ll situ 
hybridi sation experiments using 7-day-old , 14-day-o ld and adult brains revea l th at the 
y2 S- and 12L-subunit mRNAs are co-expressed in the cortex, hippocampus, and 
cerebellum . The in situ hybridi sati on results are summari zed in Tables 5. 1 and 5.2. 
5.2.2 Embryonic Expression 
The y2S subunit mRNA was the only splice vari ant of the two y2 alternati vely-spliced 
mRNAs studied , present in the eNS during late embryogenes is (Figure 5. 1, Table 5.1). 
In the 14.5 day embryo, the "(2L transcript is absent (Figure 5 .1 F) , while the y2S mRNA 
is strongly expressed in the medula oblongata, midbrain , dorsal root ganglia and weakl y 
expressed in the cerebellum primordium, cortical pl ate , and diencephalon (Fi gure 5. 1 E). 
By embryonic day 19.5, the y2S transcript is strongly ex pressed in the corti cal pl ate, 
olfac tory lobe, di encephalon and midbrain , and weakly expressed in the cerebe llum 
primordium, hippocampus, spinal cord and medull a oblongata (Figure 5. 1 A). The y2L 
transcript is not detectable in the 19.5 day embryo (Figure 5. 1 B). Express ion of the y2S 
transc ript is eNS spec ific during later stages of embryogenesis. 
5.2.3 Postnatal Expression - Cortex 
The y2S -subunit mRNA is expressed in neuronal ce lls in layers I through 6 of the I-day 
old mouse isocortex (Fi gure 5.7 A and B). In 7-day old, and 14-day old mouse brains, the 
y2S-subunit mRNA predominates, although both subunit vari ants are ex pressed (Figures 
5.2 D , 5.3 D , 5.4 A, 5.5 A) and appear in some instances to co- loca li ze within 
subpopulations of granule and pyramidal cell s (data not shown). In the adult brain , the 
leve l of "(2S-subunit mRNA within the isocortex has been greatly reduced in compari son 
with the expression of y2L-subunit mRNA (Figures 5.4 D, 5 .5 D) . Both y2 subunit 
mRNAs are detected in layers II to VI, in the adult mouse brain (data not shown). 
5.2.4 Postnatal Expression - Basal Nuclei 
Again , as seen in the cortex only the y2S-subunit vari ant is expressed in the caudate-
putamen and nucleus accumbens of a I-day old mouse brain. Both subunit vari ants are 
expressed in the I-day old globus pallidus and within thi s structure the 12L-subunit 
mRNA is the dominant isoform (Figures 5.2 A and B , 5.3 A and B). By day 7, the y2L-
subunit mRNA is the only isoform expressed in the three basal nuclei (Figures 5.2 D and 
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E, 5.3 0 and E) and the expression of this transcript peaks by postnatal day 14 (Figures 
5.4 A and 5.5 A), whereby the level of mRNA for the y2L subunit decreases to adult 
values (Figures 5.4 Band 5.5 B) . Expression of the y2S-subunit mRNA is present in the 
caudate putamen, nucleus accumbens and globus pallidus at postnatal day 14, but is 
absent in the basal nuclei of the adu lt mouse brain (Figures 5.4 D and 5.5 D). 
5.2.5 Postnatal Expression - Septum 
In the I-day old brain, y2S-subunit mRNA is expressed in the lateral and medial septal 
nuclei as well as in the nucleus of the diagnonal band (Figures 5.2 A, 5.3 A) . y2L-subunit 
mRNA express ion within these region is first detected in the 7-day postnatal brain (Figure 
5.3 E). In the adult brain, only the the y2L-subunit mRNA signal is detec table in the 
lateral and medial septal nuclei and in the nucleus of the diagonal band (Figure 5.5 E). In 
the ventral septum of I-day old mouse brain , a strong hybridization signal for the y2S 
subunit variant is detected in the bed nucleus of the stria terminalis (Figure 5.3 A) 
5.2.6 Postnatal Expression - Colliculi 
In the I-day postnatal mouse brain, y2S is the on ly y2 transcript ex pressed in the 
midbrain inferior and superior colliculi (Figure 5.2 A and B). By postnatal day 7, the Y2L 
transcript is the predominant Y2 mRNA expressed in both the inferior and superior 
collicu li (Figure 5.2 D and E). y2S mRNA expression in the collicu li was weak in the 7-
day old brain while the hybridization signal intensity increased slightly at postnatal day 
14 (Figures 5.2 0 and 5.3 D). In the adu lt mouse brain the Y2L transcript is the only Y2 
mRNA expressed in the inferior and superior colliculi (Figures 5.4 D and E). Y2L mRNA 
is strongly expressed in the central nucleus and deep layers of the adult superior 
colliculus (Figures 5.4 E). 
5.2.7 Postnatal Expression - Hippocampus 
y2S transcript expression, in the I-day postnatal mouse brain is detected in the CA 1-3 
and faintly in the dentate gyrus regions of the hippocampus (Figures 5.2 A and 5.3A). At 
day 7 of postnatal development, the y2L-subunit mRNA signal is detected in the CA 1-3 
regions of the inferior horn and very faintly in the dentate gyrus, while y2S mRNA 
expression is strong in the dentate gyrus and pyramidal cell regions (Figures 5.2 D and E, 
5.3 D and E). In the adu lt mouse brain the hybridisation signal for the y2S transcript is 
decreased from the 14-day postnatal values, however, the pattern of Y2S mRNA expression 
remained the same as that seen in the 7-day old mouse brain. The signal for the y2L and 
12S mRNAs is strongest at postnatal day 14, although only a weak level of y2L mRNA 
expression was detected in the dentate gyrus (Figures. 5.4 A and B, 5.5 A and B) In the 
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adult brain 12L is the dominant fo rm of the 12 transcripts expressed and a strong signal for 
the 12L mRNA is now found in both the CA 1-3 and dentate gyrus regions (Figures 5.4 E 
and 5.5 E). The expression of the 12 variants was further studied at the cellul ar leve l using 
liquid emul sion autorad iography. Dark field analysis of signal di stribution within the 
molecular cell layer of the I-day old mouse dentate gyrus detected a strong hybridization 
pattern for the 12S transcript. 12S mRNA is weakly expressed in the dentate granule cell 
layer of the postnatal day I brain (Figure 5.7 C and D). The 12L mRNA was not present in 
the dentate gy rus at this stage of CNS development (data not shown). A punctate 
di stribution of signal for the 12L mRNA, in the hilus suggests that the expression of the 
12L transcript is locali zed to interneurons, in the hilus of 7-day, 14-day and adu lt mouse 
brain (Figure 5.8 F and H and data not shown) . 12L mRNA is detected as a weak signal in 
the granule and molecular cell layers of the 7-day and 14-day dentate gyrus (Figures 5.2 E. 
5.3 E, 5.4 B and 5.5 B). In the adult brain the hybridisation signal for the 12L transcript is 
strong in the granule cell layer of the dentate gyrus and appears to overl ap the expression 
of the 12S transcript in subsets of dentate cells (Figure 5.8 B, D , F and H). Overlapping 
patterns of expression for the 12S and 12L transcripts are present in the pyramidal cell s of 
the adult hippocampus (Figure 5.8 A, C, E, and G). In postnatal day I brain only the 12S 
subunit is expressed in the pyramidal cell s of CA 1-3 (Figure 5.7 C and D) . 
5.2.8 Postnatal Expression - Thalamus 
The 12S mRNA is widely di stributed among the thalamic nuclei of the I day postnatal 
brain (Figures 5 .2 A and 5.3 A). The rhomboid, anteroventral, mediodorsal, medial 
geniculate and paraventricular thalamic nuclei of the postnatal I-day brain express the only 
one splice vari ant , the 12S transc ript , of the y subunit of the GABAA receptor. 
Overlapping patterns of expression for the two alternatively spliced mRNAs are found in 
the ventral posterol ateral and ventral posteromedial thalamic nucle i and in the deep 
mesencephalic nucleus of the I-day old brain (Figures 5.2 A, Band 5.3 A, B). Within 
these nucle i the 12S is the predominant splice variant. 
At postnatal day 7 a hybridi sation signal for the 12L mRNA is found in the ventrolateral 
and rostral interstiti al thalamic nuclei and in the red nucleus of the midbrain (Figure 5.2 E 
and 5.3 E). Both the 12L and 12S transcripts are expressed in the anteroventral and 
paraventricular thalamic nuclei. The 12L transcript is the predominant splice variant in the 
anteroventral 7-day thalamic nucleus whereas the 12s mRNA is the most abundant 12 
transcript in the paraventricular 7-day thalamic nucleus. 
By day 14, the hybridisation signal for the 12S mRNA has increased relative to the 
levels expressed in the 7-day old brain. The 12S transcript is the only y splice variant 
found in the paraventricular, anteroventral and medial thalamic nuclei. The y2L mRNA 
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expression is unique to the ventral lateral geniculate and rostral interstitial thalamic nuclei 
and the midbrain red nucleus. In the 14-day brain, overlapping patterns of expression for 
the two splice variants in the 14-day postnatal brain are detected in the posterior thalamic 
nucleus, where the y2S trancript is the predominant mRNA expressed. 
5.2.9 Postnatal Expression - Cerebellum 
Hybridi sation signals indicate that the y2S mRNA is the major splice variant expressed 
in the external cerebellar granu le cell layer at PI, while y2L mRNA levels at thi s stage of 
development are very low (Figure 5.7 E and F and data not shown). The y2S splice variant 
is never found in Purkinje cells at any developmental stage, nor in the adult brain. In the 
cerebell ar granu le cell and molecular layers, the y2S transcript decreases from P1 to P7, 
whereby the level of y2S mRNA expression remains constant through P 14 before 
expression decreases yet further in the granule cell and molecular laye rs of the adult 
cerebe llum. In the adu lt cerebellum the transcript for 12S is barely detectable (Figures 5.4 
D, 5.5 D, and 5.9 B). The y2L transcript is present in the cerebell ar Purkinje cell layer, 
where its expression increases during postnatal development. The hybridi sation signal for 
the y2L transcript is strongest in Purkinje ce ll s compared to other cell types in the adu lt 
cerebe llum (Figure 5.9 A). 
5.3 Discussion 
The results from in situ hybridi sation studies using oligonucleotide probes spec ific for 
the two alternative ly-spli ced forms of the y2 GABAA receptor subunit are summarized in 
Tables 5.1 and 5.2 and demonstrate that the express ion of the splice variants is 
developmentally regulated. The "{2S mRNA is widely distributed along the mouse 
neurax is and is the predominant transcript during late embryogenesis and in the I-day 
postnatal mouse brain . In contrast, in the adu lt brain, y2L is the major y2 mRNA splice 
variant, with widespread distribution in the cortex, hippocampus, basal nuclei, cerebellum, 
thalamus and midbrain. 
The predominance of the 12S mRNA splice variant during early postnatal development 
is in agreement with results from RNase protection analysis of C57B II6 mouse whole brain 
total RNA isolated at various postnatal stages ranging from the day of birth to six weeks of 
age (Wang and Burt, 1991). This observation is also supported by quantitative PCR 
analysis of y2 sp lice variant expression in cerebellar and cortical postnatal PO to P21 total 
RNA preparations (Bovolin et al., 1992). 
The studies by Wang and Burt, (1991) and Bovolin et al., ( 1992) also support 
observations described in thi s chapter that the "{2L mRNA splice variant is the predominant 
form of y2 mRNA in the adu lt CNS. This contrasts with the chick (Glencorse, Bateson 
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and Darli son, 199 1) and the rat (Miralles et ai. , 1994), where such a c lear distinction 
between the two 12 mRNA isoform s has not been observed. This difference may re fl ect 
spec ies variations , although the design of the o ligonucleotides and hybridi sation conditions 
used in the rat in situ analys is (Miralles et al., 1994) is such that the 12S probe is ve ry 
likely to have hybridi sed to the 12L mRNA obscuring any drop in 12S mRNA level. 
Ex press ion of the GABAA receptor 12 subunit gene is subject to c lear transc ripti onal 
regulation (considering 12S and 12L mRNAs together) between various developmental 
timepoints and between the ce ll types of different brain regions. Although the 12 gene is 
expressed virtuall y everywhere in the brain at some leve l throughout deve lopment, a 
variety of regulation patterns can be di scerned. Cell s of hippocampal CA I and CA2 
reg ions, and of cerebral cortex layers II-V, show consistently high 12 gene express ion from 
P I through to the adult, whi le cell s of the central nuc le i o f the superior and infe rior 
colli culi also show consistent postnatal 12 gene ex pression although at a somewhat lower 
leve l than is seen in the hippocampus and cortex. Initi al hi gh postnatal ex press ion at PI , 
followed by a progress ive dec rease to low adult leve ls is a pattern of GABAA receptor 12 
subunit gene express ion found in cell s of the caudate-putamen and nucleus accumbens of 
the basal gangli a, the latera l and medi al septum and most thalamic nuc lei. The reverse 
express ion pattern , with low levels of 12 gene transcription at P I increas ing to hi gh levels 
therafter, is found in ce ll s of the dentate gyrus, the entorhinal cortex and in Purkinje cell s 
of th e cerebe llum. More moderate increases in 12 ex press ion durin g postnata l 
development are found in ce ll s of the medial habenula. Some reg ions such as the co lliculi 
and the granule ce ll layer of the cerebellum also show observably higher 12 expression at 
P 14 than at any other deve lopmental time point. A ll these observations point to a prec ise 
developmental programme of regulation of GABAA receptor"{2 subunit gene expression, 
with each cell type showing a characteri stic temporal patte rn of express ion level. 
Alte rn ative splicing of the 12 mRNA precursor transcript is also clearly subject to 
temporal regulation during development. The alternative splic ing mechani sm is switched 
on only after birth. The earliest appearance of the y2L splice variant mRNA is in ce ll s of 
the globus pallidus at PI, but by P7 significant levels of "{2L mRNA are seen in virtually 
all brain regions (Table 5.2). There does not seem to be a general correlation between the 
onset of alternative splicing and stages of ce llular brain development such as proliferation , 
migration or innervation , since the various regions of the mouse brain are at quite different 
stages in the ir deve lopment at birth , yet most cells turn on alternative splicing of the 12 
mRNA precursor in a s imil ar time frame . Myelination appears to be th e one 
developmental CNS process that does correlate with the onset of y2 alternative splicing, 
however it is just as likely that alternative splicing of the 12 precursor is ac tivated by 
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signaling events triggered by the environmental and physiological alterations assoc iated 
with birth . 
In most ce ll types of the deve loping mouse brain , alternative splicing leadin g to 
in sertion of the exon encoding an ex tra PKC phosphorylation site is superimposed upon 
pre-ex isting 12 gene express ion with the y2S mRNA as the only splice variant. As 
alternative splicing is activated, the y2L mRNA splice variant appears progress ively and 
eventu all y predominates . The increase in y2L levels re lative to y2S as postnatal 
development progresses ari ses from a combination of the gradual ac tivation of alternati ve 
splicing in increas ing numbers of ce ll s with time, and the increas ing level of alternative 
splicing within each cell. This in situ hybridization analysis used adjacent sec tions for y2L 
and 12S assessment, but it is not possible to prove that a particular ce ll gives both y2S and 
y2L signals. It is therefore not yet clear whether the activation of alternative sp licing leads 
to a rapid all or nothing switch from y2S to y2L mRNA in each ce ll. In areas such as the 
subiculum , cortex and hippocampus, where hi gh levels of y2L mRNA and lower but 
significant levels of y2S mRNA are found together in the adult brain , in regions with well -
defin ed cell types, it is poss ible that alternative splicing only acts on a portion of the 
mRNA precursor population of each ce ll. This is an important point to establi sh, since 
such a situation would make the alternative splicing process itse lf a site for regulation of 
the relative phosphorylation state of GABAA receptors in adult hippocampal and cortical 
cells. 
Purkinje cells of the cerebellum show a unique developmental express ion pattern , in 
which the onset of 12 gene transcription and alternative splicing are correlated, so that only 
y2L mRNA is ever formed . It is possible that the alternative splicing mechanism is 
constitutive, or is at least sw itched on earli er in development, in Purkinje cells, but this 
would be an exception to the general rule. An intriguing alternative possibility is that the 
sw itch th at activates alternative splicing also, directly or indirectly , activates y2 gene 
transcription in Purkinje cells. 
Recently a null mutation in the y2 gene demonstrated that loss of the y2 subunit results 
in postnatal lethality , retarded growth, and sensorimotor dysfunction (Gunther et aI. , 
1995). These findings further the studies demonstrating that GABAA receptors are 
necessary for normal CNS development. Our results demonstrate a temporal and cellular 
regulation of 12 splice variants during late embryogenesis and postnatal CNS 
development. Although a number of in vitro studies have demonstrated the regulation of 
GABAA receptors by protein phosphorylation (Kirkness et al., 1989; Browning et al., 
1990; Moss el al ., 1992; Lin el al., 1994; Krishek et al., 1994), it is yet to be elucidated 
what role phosphorylation of the receptor y2 subunit plays in vivo. 
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Figure 5.1 Regional distribution of the GABAA receptor y2S- and y2L-
subunit transcripts in 14.5,' 17.5 and 19.5 day old C57Bl16 embryos. A: 
embryonic 19.5 day saggital section hybridised with an oligonucleotide specific for the "(2 
short ("(2S)-subunit mRNA of the GABAA receptor; B: embryonic 19.5 day saggital section 
.,probed with an oligonucleotide specific for the "(2 long ("(2L)-subunit mRNA of the GABAA 
receptor; C: embryonic 17.5 day sagital section hybridised with an oligonucleotide specific 
for the "f2S-subunit mRNA of the GABAA receptor; D: sagital section of a 17.5 day embryo 
stained with thionin; E: embryonic 14.5 day saggital section hybridised with an 
oligonucleotide specific for the "f2 short ("(2S)-subunit mRNA of the GABAA receptor and 
F: embryonic 14.5 day sagital section probed with an oligonucleotide specific for the "f2long 
C"f2L)-subunit mRNA of the GABAA receptor. cb, cerebellar primordium; co, cortical plate; 
d, diencephalon; drg, dorsal root ganglia; he, heart; hi, embryonic hippocampus; I, liver; m, 
medulla oblongata; mb, midbrain; 01, olfactory lobe; sc, embryonic spinal cord; t, thymus. 
Scale bar represents 1.5 mm. Exposure time was 15 days on Kodak XAR-5 film. 
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Figure 5.2 Regional distribution of the GABAA receptor 12S-, 12L- and 
12T-subunit transcripts in the brains of C57BLI6J mice during postnatal 
development. A: I-day old mouse horizontal brain section hybridised with an 
oligonucleotide specific for the 12 short {12S)-subunit mRNA of the GABAA receptor; B: 1-
day old mouse brain section probed with an oligonucleotide specific for the 12 long ("f2L)-
, subunit mRNA of the GABAA receptor; C: 1 day-old mouse brain section hybridised with 
an oligonucleotide designed to recognize both the "f2L- and "f2S-altematively-spliced forms 
of the 12 GABAA receptor subunit mRNA; D: 7 day-old mouse brain section hybridised 
with an oligonucleotide specific for the "f2S-subunit mRNA of the GABAA receptor; E: 7 
day-old mouse horizontal brain section probed with an oligonucleotide specific for the 12L-
subunit mRNA of the GABAA receptor and F: 7 day-old mouse brain section hybridised 
with an oligonucleotide designed to recognize both the y2L- and y2S-altematively-spliced 
forms of the 12 GABAA receptor subunit mRNA. Av, anteroventral thalamic nucleus; Cb, 
cerebellum; CG, central grey; Ctx, cortex; DG, dentate gyrus; DpG, deep grey layer; DpWh, 
deep white layer; Ent, entorhinal cortex; Hi, hippocampus; Ic, inferior colliculus; LHb, 
lateral habenular nucleus; LS, lateral septum; MHb, medial habenal nucleus; PaS, 
parasubiculum ; PrS, presubiculum; Sb, subiculum; Sc, superior colliculus. Scale bar 
represents 2.2 mm. Exposure time was 15 days on Kodak XAR-5 film. 

Chapter 5 Alternative-splicing 
Figure 5.3 
132 
" 
Figure 5.3 Regional distribution of the GABAA receptor y2S-, y2L- and 
y2T-subunit transcripts in the brains of CS7BLI6J mice during postnatal 
development. A: I-day old mouse horizontal brain section hybridised with an 
oligonucleotide specific for the ')'2S-subunit mRNA of the GABAA receptor; B: I-day old 
mouse brain section probed with an oligonucleotide specific for the ')'2L-subunit mRNA of 
the GABAA receptor; C: 1 day-old mouse brain section hybridised with an oligonucleotide 
designed to recognize both the ')'2L- and ')'2S-altematively-spliced forms of the ')'2 GABAA 
receptor subunit mRNA; D: 7 day-old mouse horizontal brain section hybridised with an 
oligonucleotide specific for the ')'2S-subunit mRNA of the GABAA receptor; E: 7 day-old 
mouse brain section probed with an oligonucleotide specific for the ')'2L-subunit mRNA of 
the GABAA receptor and F: 7 day-old mouse brain section hybridis~d with an 
oligonucleotide designed to recognize both the ')'2L- and ')'2S-altematively-spliced forms of 
the ')'2 GABAA receptor subunit mRNA. AM, anteromedial thalamic nucleus ; A V, 
anteroventral thalamic nucleus; BSt; bed nucleus stria terminalis; CAI-3, fields CAl-3 of 
Ammon's hom; CI, centrolateral thalamic nucleus; Ctx, cortex; DG, dentate gyrus; DpM, 
deep mesencephalic nucleus; GP, globus pallidus; lA, interanteromedial thalamic nucleus; 
PV A, parventricular thalamic nucleus, anterior; R, red nucleus; Re, reuniens thalamic 
nucleus; Rt, reticular thalamic nucleus; scp, superior cerebellar peduncle; VPL, ventral 
posterolateral thalamic nucleus; VPM, ventral posteromedial thalamic nucleus. Scale bar 
represents 2.2 mm. Exposure time was 15 days on Kodak XAR-5 film. 
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Figure 5.4 Regional distribution of the GABAA receptor y2S-, y2L- and 
llT-subunit transcripts in the brains of C57BLI6J mice during postnatal 
development. A: 14-day old mouse horizontal brain section hybridised with an 
oligonucleotide specific for the 'Y2S-subunit mRNA of the OABAA receptor; B: 14-dayold 
mouse brain section probed with an oligonucleotide specific for the 'Y2L-subunit mRNA of 
the OABAA receptor; C: 14 day-old mouse brain section hybridised with an oligonucleotide 
designed to recognize both the 'Y2L- and 'Y2S-altematively-spliced forms of the 12 OABAA 
receptor subunit mRNA; D: Adult mouse brain section hybridised with an oligonucleotide 
specific for the 'Y2S-subunit mRNA of the OABAA receptor; E: Adult mouse horizontal brain 
section probed with an oligonucleotide specific for the 'Y2L-subunit mRNA of the OABAA 
receptor and F: adult mouse brain section hybridised with an oligonucleotide designed to 
recognize both the 'Y2L- and "I2S-altematively-spliced forms of the "12 OABAA receptor 
. . 
subunit mRNA. CAl-3, fields CAI-3 of Ammon's hom; Cb, cerebellum; CPu, caudate 
putamen; Ctx, cortex; DO, dentate gyrus; Ie, inferior colliculus; LD, laterodorsal thalamic 
nucleus; LP, lateral posterior thalamic nucleus; PaS, parasubiculum; PrS, presubiculum; Sb, 
subiculum; SC t superior colliculus. Scale bar represents 2.0 mm. Exposure time was 15 
days on Kodak XAR-5 film. 
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Figure 5.5 Regional distribution of the GABAA receptor y2S-, y2L- and 
y2T-subunit transcripts in the brains of CS7BLI6J mice during postnatal 
development. A: 14-day old mouse horizontal brain section hybridised with an 
oligonucleotide specific for the y2S-subunit mRNA of the GABAA receptor; B: 14-dayold 
mouse brain section probed with an oligonucleotide specific for the y2L-subunit mRNA of 
the GABAA receptor; C: 14 day-old mouse brain section hybridised with an oligonucleotide 
designed to recognize both the y2L- and y2S-altematively-spliced forms of the y2 GABAA 
receptor subunit mRNA; D: Adult mouse horizontal brain section hybridised with an 
oligonucleotide specific for the y2S-subunit mRNA of the GABAA receptor; E: Adult mouse 
brain section probed with an oligonucleotide specific for the y2L-subunit mRNA of the 
GABAA receptor and F: adult mouse brain section hybridised with an oligonucleotide 
designed to recognize both the y2L- and y2S-altematively-spliced forms of the y2 GABAA 
receptor subunit mRNA. AV, anteroventral thalamic nucleus; CAI-3, fields CAI-3 of 
Ammon's hom; Cb, cerebellum; CPU, caudate putamen; Ctx, cortex; DG, dentate gyrus; La, 
lateral amygdaloid nucleus; mI, medial lemniscus; PaS, parasubiculum; PrS, presubiculum; 
PV A, paraventricuIar thalamic nucleus, anterior; R, red nucleus; RI, rostral interstitial 
nucleus mIf, medial longitudinal fasciculus; Rt, reticular thalamic nucleus; Sb, subiculum; 
scp, superior cerebellar peduncle; TS, triangular septal nucleus; VL, ventrolateral thalamic 
nucleus. Scale bar represents 1.7 mm. Exposure time was 15 days on Kodak XAR-5 film. 
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Figure 5.6 Control hybridisations. Parallel control sections were hybridised in 
the presence of a 3D-fold molar excess of the appropriate unlabelled oligonucleotide in all 
experiments. These resulted in the generation of blank autoradiographs. Control sections 
were hybridised with the oy2(S)-subunit specific CAl, the oy2CL)-subunit specific (B) and the 
oy2T -subunit specific (C) oligonucleotide probes. Exposure time was for 15 days on Kodak 
, XAR-5 film. 
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Figure 5.7 Cellular localisation of the GABAA receptor '}QS. subunit 
transcript in the cortex, hippocampus and cerebellum of one day old 
C57BLI6J mice. 
Bright-field (A) and dark-field (B) views of the y2S GABAA receptor subunit mRNA in the 
C57BU6J cortex at PO. Bright-field (C) and dark-field (0) views of the y2S GABAA 
receptor subunit mRNA in the C57BU6J hippocampus at PO. Bright-field (E) and dark-field 
(F) views of the y2S GABAA receptor subunit mRNA in the C57BU6J cerebellum at PO. 
Arrow heads illustrate the labeling of cerebellar granule cells by the y2S probe. Scale bar 
represents 21 11m. 
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Figure 5.8 Cellular localisation of the GABAA receptor 128. and 12L. 
subunit transcripts in the hippocampus of adult C57BLI6J mice. 
')'2S probe (A, B, C, D) and ')'2L probe (E,F,G,H). Bright-field (A, B) and dark-field (C,D) 
views of the "{2S GABAA receptor subunit mRNA in the adult C57BU6J. Bright-field (E, F) 
and dark-field (G, H) views of the ')'2L GABAA receptor subunit mRNA in the adult 
C57BL/6J hippocampus. Arrowheads illustrate labeling of hilar cells by the "{2L GABAA 
receptor subunit probe. (C) Scale bar represents 27 /lm, (D) Scale bar presents 15 /lm. 
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Figure 5.9 Cellular localisation of the GABAA receptor I'2S· ,I'2L· and 1'2 T· 
subunit transcripts in the cerebellar cortex of adult C57BLI6J mice. 
yS probe (B), ')'2L probe (A) and ')'2T probe (C, D). Bright-field (C) and dark-field (A,B,D) 
views of the y2 GABAA receptor subunit mRNA in the adult C57BL/6J cerebellum. 
Arrowheads indicate the labeling of Purkinje cells by the ')'2L and ')'2T probes. Scale bar 
represents 6 ~m. 
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Table 5.1 Regional distribution of the GABAA receptor y2S. and y2L. 
subunit transcripts in 14.5, 17.5 and 19.5 day old C57Bl16 embryos. 
Hybridisation signals, obtained with oligonucleotides specific for the y2S-subunit mRNA 
and the y2L-subunit mRNA were arbitarily scored as either high, +++; moderate, ++; low, 
+; weak, (+); or not detectable, -. The results are derived from Figure 5.1 and data not 
... shown. The day a vaginal plug is visible is recorded as day 0.5. 
E14.5 E17.5 E19.5 
Region y2S y2L y2S y2L y2S y2L 
Neopallial cortex + - +++ - +++ -
Olfactory lobe - - ++ - +++ -
Midbrain ++ - ++ - ++ -
Hypothalamus + - ++ - ++ -
Thalamus + - ++ - ++ -
Hippocampus - - + - + -
Spinal cord + - + - ++ -
Dorsal Root Ganglia ++ - ++ - + -
Medulla oblongata + - + - ++ -
Pons + - + - ++ -
Cerebellar primordium + - + - ++ -
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Table 5.2 Regional distribution of the GABAA receptor y2S-, "(2£. and 
"(2T-subunit transcripts in the brains of CS7BLI61 mice during postnatal 
development. Hybridisation signals, obtained with oligonucleotides specific for the y2S-
subunit mRNA, the ')'2L-subunit mRNA or the y2T-subunit mRNA, which recognizes both 
the y2S- and ')'2L-subunit transcripts, were arbitarily scored as either high, +++; moderate, 
++; low, +; weak, (+); or not detectable, -. The results are derived from Figures 5.2, 5.3, 
... 5.4, 5.5 and from data not shown. 1-day, 7-day and 14-day correspond to the days after 
birth and adult refers to a 50 to 60-day old mouse. 
Regionl IDAY 7DAY 14 DAY ADUlT 
Nucleus 
y2S y2L y2T y2S y2L y2T y2S y2L y2T y2S y2L y2T 
Cortex, 
Layer I-II + - + + + -1+ + + -1+ (+) -1+ -1+ 
Layerm-IV +++ - +++ + + -1+ + + -1+ + -1+ +++ 
Layer IV-VI 
-1+ 
-
-1+ + + -1+ + + -1+ + -1+ +++ 
Entrohineal Ctx + - + -1+ + +++ -1+ + +++ + -1+ +++ 
Hippocampus 
CAl +++ - +++ -1+ + +++ -1+ + +H- + -1+ +++ 
CA3 +++ - +++ -1+ + +++ -1+ + +++ + -1+ +++ 
DG + - + -1+ (+) -1+ -1+ + +++ + -1+ +++ 
Tenia Tecta 
-1+ 
-
-1+ + + -1+ + + -1+ + -1+ +++ 
Basal Nuclei 
Caudate-putamen .+++ 
-
+++ - + + (+) (+) + - + + 
Nu. accumbens +++ - +++ - + + (+) (+) + - + + 
Globus pallidus + -1+ +++ - + + (+) (+) + - + + 
Amygdala 
Lateral amygdaloid nu. 
- - - - - - - -
-
(+) (+) + 
Septum 
Bed nucleus s.t. 
-1+ 
-
-1+ (+) + + (+) + + (+) + + 
Lateral septum 
-1+ 
-
-1+ 
- + + (+) + + - + + 
Medial septum 
-1+ 
-
-1+ 
- + + (+) + + - + + 
Triangular septum + 
-
+ - + + (+) -1+ -1+ - + + 
Medial Habenula + + -1+ (+) -++ -++ (+) -++ -++ - -++ -++ 
Thalamus 
Anteroventral thaI. 
-1+ 
-
-1+ + + -1+ + + -1+ - + + 
Paraventricular nu. 
-1+ 
-
-1+ + + -1+ + (+) + - + + 
Reuniens thaI. nucleus +++ - +++ + (+) + -1+ + +++ - + + 
Anteromedial thaI. + - + (+) + + (+) + + - + + 
Ventrolateral thaI. 
-1+ 
-
-1+ (+) + + (+) + + (+) + + 
Dorsal lateral genicul 
-1+ 
-
-1+ 
- + + - + + - + + 
Medial lateral genicul 
-1+ 
-
-1+ 
-
(+) (+) 
-
(+) (+) 
-
-1+ -1+ 
Reticular nucleus 
-++ .. -++ .. - .. .. + + .. + + 
Red nucleus ++- - -1+ - + + - + + - + + 
Ventr. posterior nu. ++- - -++ .. + + (+) + + .. + 
Laterodorsal thaI. ++- - -1+ - + + .. -1+ -1+ .. -1+ -++ 
Lateral posterior thal. ++- - -1+ .. + + .. -1+ -1+ - -1+ -1+ 
Colliculi 
-
Central nucleus 
-1+ (+) -1+ (+) -1+ -1+ + -1+ +++ 
-
-1+ -1+ 
Central grey + (+) + (+) -++ -++ + -++ +++ - -++ -++ 
Deep white layer + (+) + (+) + + (+) + + - + + 
Subiculum 
-1+ .. -1+ -1+ + +++ -1+ + +++ + -1+ +++ 
Para R. Sub + - + + (+) + -1+ + +++ (+) -1+ -1+ 
ParaA. Sub + .. + + (+) + ++- + +++ (+) -1+ -1+ 
Cerebellum 
Purkinje 
- + + - -1+ -1+ .. -1+ -1+ - +++ +++ 
Stellatelbasket cells + + + + + + + -1+ +++ (+) -1+ -1+ 
Interior granule cells 
-1+ (+) -1+ + -1+ +++ + -1+ +++ (+) -1+ -1+ 
Exterior granule cells 
-1+ (+) -1+ + -1+ +++ + -1+ +++ (+) + + 
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6.1 Introduction 
Substitution mutagenesis and site-directed mutagenesis are important tools for the 
determination of the structural components of ligand-gated ion channels .. With this 
methodology, primary sequences essential for channel gating, conduction and selectivity, 
pharmacological specification, ligand interactions, sites of allosteric drug interactions and 
sites required for subunit assembly and subcellular localization have been identified. 
Within the ligand-gated ion channel superfamily, structure-function analysis has been most 
extensively carried out for the muscle and neuronal nicotinic acetylcholine receptors. 
The pore region (M2), of the muscle nicotinic acetylcholine receptor was the first 
structural feature of a receptor identified through chimaera assembly and site-directed 
mutagenesis (Imoto et ai., 1986; 1988, Galzi et ai., 1991a). Mutational analysis 
demonstrated that M2 and its vicinity contain important determinants of ion flux through 
the AChR channel and contribute binding sites for noncompetitive antagonists (lmoto et 
ai., 1986; Giraudat et aI., 1986; Hucho, Oberthur, Lottspeich, 1986). The importance of 
the muscle nicotinic AChR M2 sequence for ion flux was further illustrated using an 
alternative approach which demonstrated that a highly charged peptide corresponding to 
the M2 segment of the nAChR could form stable ion channels with two discrete 
conductance states (Ghosh and Stroud, 1991). The peptides which had the potential to 
form an amphipathic <x-helix with 4 negatively charged and 3 positively charged residues 
on one side of the <x-helix did not however, sufficiently mimic the electrophysiological 
properties of the native AChR. 
Site-directed mutagenesis allows discrete nucleotide changes in the coding sequence 
for a targeted protein. This mutagenesis method was used to further the characterization of 
the AChR M2 domain, through the introduction of point mutations that altered the net 
charge of the charged or glutamine residues around the proposed transmembrane 
segments. Analysis of these mutants demonstrated that three clusters of negatively 
charged and glutamine residues neighbouring segment M2 of the <x-, ~JI ,,(-, and &'subunits 
form anionic (cytoplasmic, intermediate and extracellular) rings that act as major 
determinants of ion flux (Imoto etal., 1988). Mutations altering the size and polarity of 
uncharged polar amino acid residues between the extracellular and cytoplasmic rings, 
determined that a ring-like cluster of uncharged polar residues adjacent to the intermediate 
ring also playa critical role in determining the rate of ion flux (lmoto et ai., 1991) and the 
residence time and equilibrium binding affinity of QX-222, a quaternary ammonium 
anesthetic derivative that acts as an open channel blocker (Leonard et ai., 1988). 
As discussed in the introduction (Section 1.4.5), the anion-selective glycine and 
GABAA receptors display significant amino acid identities with the cation-selective 
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nAChRs. In particular, in the M2 transmembrane domain, several of the structural 
moieties such as the cytoplasmic ring and polar rings of threonines or serines are critical 
for the determination of ion flux, and therefore these amino acids are highly conserved 
across anionic and cationic ligand-gated ion channel sequences. 
One difference between the anionic and cationic channels occurs at the N-terminal 
region of M2, where an additional amino acid in the short segment linking MI and M2 is 
included in anionic channel sequences. Insertion of an uncharged residue at the N-
terminus of the nicotinic a7 M2 converts the cationic-selective channel into an anion-
selective channel gated by acetylcholine (Galzi et aI., 1992). 
In this chapter we describe the use of single amino acid changes in GABAA a 1 and PI 
receptor subunits to define the structure-function relationships of two highly conserved 
amino acids for agonist (muscimol) and antagonist (Ro 15-1788) binding. The two 
conserved amino acids are located in the putative cysteine loop and M 1 transmembrane 
domain of ligand-gated ion channel receptors. Transient expression of mutant GABAA 
receptor subunits in HEK293 cells was used to analyze the effect of the single amino acid 
substitutions on PH] muscimol and [3H] Ro15-1788 binding of al,ply2L GABAA 
receptor complexes 
6.2 Results 
6.2.1 Mutation Strategy 
Ligand-gated ion channels belong to a superfamily of membrane proteins that mediate 
fast neuronal signaling. As outlined in Chapter 1, the glycine receptor a 1 subunit 
(Grenningloh et ai., 1987), and the nicotinic AChR al subunit (Noda et ai., 1983), exhibit 
approximately 34% and 20% identity, respectively, to the GABAA receptor subunits. 
Hydropathy analysis of acetylcholine, GABA, glycine and serotonin 5HT3 ligand-gated 
ion channel sequences predicts four transmembrane spanning regions, with a large 
extracellular N-terminus containing consensus sites for N-linked glycosylation, an 
extracellular C-terminus and an intracellular loop between putative transmembranes 3 and 
4. Within the extracellular loop of acetylcholine, GABA, glycine and serotonin 5HT3 
ligand-gated ion channels, are two cysteine residues (bovine GABAA receptor al subunit 
numbering, C139 and C153) positioned 13 amino acids apart. This putative cysteine loop 
contains two amino acids at position P147 (proline) and D149 (aspartic acid) that are 
invariant across species and subunits of ligand-gated ion channels (Figure 6.1). Another 
site of 100 percent amino acid conservation is within the predicted M 1 transmembrane 
domain, where as shown in Figure 6.2, the proline at position 243 in the bovine a 1 
GABAA receptor subunit is present in all species and subunits of ligand-gated ion channel 
receptors. 
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6.2.2 Mutant Preparation 
To investigate the role of these highly conserved amino acids, 31 to 33 base 
oligonucleotides were designed to mutate the conserved sites from aspartic acid (Asp) to 
asparagine (Asn) or glutamine (Glu) in the putative cysteine loop and from proline (Pro) to 
alanine (Ala) in the predicted M 1 transmembrane spanning domain. Bovine a.l and ~2 
GABAA receptor subunit cDNAs were subcloned into the bacteriophage vector, M13mp19 
for production of single-stranded templates used in oligonucleotide-directed mutagenesis 
as outlined by Kunkel, Roberts, and Zakour, 1987. This mutagenesis method (Figure 6.3) 
increases the efficiency of mutagenesis, by utilizing a wild-type template in which uracils 
have been incorporated and therefore can be selected against in wild-type E. coli which 
synthesize uracil-N-glycosylase, an enzyme that removes uracil residues incorporated into 
DNA. Removal of the uracils results in the blockade of DNA synthesis and an increase in 
susceptibility of the template to cleavage by specific nucleases. Since the strand of DNA 
containing the mutation is synthesized in vitro, it therefore lacks uracil incorporation and 
remains intact in the wild-type E. coli. 
Bovine <xl GABAAR 
Bovine <X2 GABAAR 
Bovine <x3 GABAAR 
Bovine ~l GABAAR 
Bovine y2 GABAAR 
Bovine a. AchR 
Bovine ~ AchR 
Bovine 0 AchR 
Bovine y AchR 
Bovine e AchR 
Rat <xl GlycineR 
139 144 149 153 
RAECPMHLEDFPMDAHACPLK 
QAECPMHLEDFPMDAHSCPLK 
SAECRMHLEDFPMDVHACPLK 
TAACMMDLRRYPLDEQNCTLE 
DAECQLQLHNFPMDEHSCPLE 
KSYCEIIVTHFPFDEQNCSMK 
RSSCSIQVTYFPFDWQNCTMV 
RSSCPISVTYFPFDWQNCSLK 
RSSCPVSVTFFPFDWQNCSLI 
RSTCAVEVTYFPFDWQNCSLT 
TLACPMDLKNFPMDVQTCIMQ 
Figure 6.1 Amino Acid Sequence Alignment of the Cys-Loop Domains of Several 
Ligand-gated Ion Channel Receptor Subunits. The proline (P) at position 147 in the 
bovine GABAA a1 subunit cysteine (C) loop, as well as the aspartic acid at position 149 of 
the bovine GABAA a1 subunit represent amino acids which are conserved across species 
and subunits of ligand-gated ion channel receptors. 
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Bovine al GABAAR 
Bovine a2 GABAAR 
Bovine a3 GABAAR 
Bovine ~l GABAAR 
Bovine 12 GABAAR 
Bovine a AchR 
Bovine ~ AchR 
Bovine 5 AchR 
Bovine y AchR 
Bovine e AchR 
Rat al GlycineR 
Mutagenesis 
235 243 249 256 
YFVIQTYLPCIMTVILSQVSFWL 
YFVIQTYLPCIMTVILSQVSFWL 
YFVIQTYLPCIMTVILSQVSFWL 
YFILQTYMPSTLITILSWVSFWI 
YFTIQTYIPCTLIVVLSWVSFWI 
YFIVNVIIPCLLFSFLTGLVFYL 
FYLVNVIAPCILITLLAIFVFYL 
FYVINILVPCVLISFMINLVFYL 
FYVINIIAPCVLISSVAILIYFL 
FYVINIIVPCVLISGLVLLAYFL 
YYLIQMYIPSLLIVILSWISFWI 
Figure 6.2 Amino Acid Sequence Alignment of the Ml Transmembrane Domains of 
Several Ligand-gated Ion Channel Receptor Subunits. At position 243 in the bovine aJ 
GABAA receptor subunit Ml transmembrane domain, the proline (P) residue is conserved 
across all subunits of ligand-gated ion channel receptors. 
For generation of single amino acid changes in GABAA receptor subunit cDNAs, 
single-stranded al and ~ 1 templates were prepared from the CJ236 E. coli bacterial strain, 
which carries both dut- and ung- mutations. Mutation in the dut- gene leads to deficency 
in dUTPase, an enzyme which normally converts dUTP to dUMP and hence in the CJ236 
bacterial strain results in increase intracellular pools of dUTP. This increase in 
intracellular dUTP concentrations leads to incorporation of dUTP into DNA at sites 
normally occupied by thymine. A mutation in the ung- gene leads to the inability of the 
CJ236 E. coli strain to remove incorporated uracils from DNA and hence a small fraction 
of thymidine residues in the bacteriophage DNA are replaced by uracil (Sambrook, Fritsch 
and Maniatis, 1989). 
After annealing of the phosphorylated mutagenic oligonucleotide to the uracil-
containing template, the complementary strand was synthesized in vitro as outlined in 
Materials and Methods 2.3.3. The mutagenesis reaction was transfected into JM109 cells 
and plaques were selected and grown overnight at 37°C in 2TY for single-stranded 
template preparation prior to dideoxy sequence analysis (Methods 2.3.2 and 2.3.4). Sixty 
to eighty percent of the templates screened carried the mutation. Figure 6.4 demonstrates 
the dideoxy sequence analysis of the Asp to Asn mutation in the cysteine loop of the 
bovine GABAA receptor al subunit and the dideoxy sequence analysis of the Asp to Glu 
and Asp to Asn in the cysteine loop of the GABAA receptor ~ 1 subunit. A second base 
change in the Asp to Asn mutant maintains the arginine at position 145 in the bovine 
GABAA ~ 1 subunit. Figure 6.5 illustrates the dideoxy sequence analysis of the Pro to Ala 
mutations in the putative M 1 transmembrane domain of the bovine GABAA receptor 
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a 1 and ~ 1 . subunits. One mutant template for each mutation generated was than 
sequenced in its entirety to confirm that no other changes had been made during the 
mutagenesis and subcloning reactions. 
Generate single-stranded template DNA by growing 
recombinant bacteriophage M 13 in a dut- ung- F' strain 
of IE. coli. 
DNA polymerase 
Four dNTPs 
DNA ligase 
- ..... 
~~JJcWg 
/
Transt.:d-type 
E.coll 
Uracil-substituted strand of 
. DNA is degraded 
Plaques generated by strand of 
DNA synthesized in vitro 
Figure 6.3: Oligonucleotide-mediated, site-directed mutagenesis using the method of 
Kunkel, Roberts and Zakour, (1987). Selection against uracil substituted wild-type 
template in wild-type E. coli. This figure was modified from Sambrook, Fritsch and 
Maniatis, 1989. 
Mutant a 1 and ~ 1 bovine GABAA receptor subunit cDNAs were then subcloned into 
the eukaryotic expression vector pcDNAS for transient expression in HEK293 cells. In a 
separate set of experiments mutant GABAA receptor a 1 or ~ 1 subunit cDNAs or cRNAs 
transcribed from the Bluescript constructs with T7 RNA polymerase were co-injected with 
either wild-type al or ~ 1 and y2L subunit cDNAs or cRNAs into Xenopus oocytes and 
two electrode voltage clamp was used to record from the oocytes two days post injection. 
The oocyte experiments were done by Dr. Shahid Zaman and are described in his thesis 
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Figure 6.4 
146 
, 
Figure 6.4 Sequence analysis o/the nucleotide changes resulting in amino acid 
changes in the predicted cysteine loop o/the bovine al and {31 GABAA receptor 
subunits. 
Amino acid changes and receptor subunit are shown above the sequence. Site-directed 
changes in the wild-type sequence are indicated by arrows. 
Alpha 
WT 
GATC 
• :' •. ;; 
-.. .. 
-
..... - -, 
. ' .. 
" -
---
..... -. , 
~ . 
....... 
-
- ;:--
a'a:-... -
. -: 
.... 
-. 
- -... _-
.~Jff!~ 
-. a; •• , 
.... ; 
. .-
• . .-
I 
-
----
~ ":. ~ 
GATe 
i~~ 
--a, I: • 
·~i 
I- -
·1-. .. • • 
- . ,- . 
• 
WT 
C TAG 
-
, 
I 
.. ' 
... - I 
- ....... 
• J 
..- I 
... -
.-.. . ... 
• 
.. qt 
• 
... 
-
GATC 
I I 
.-
-
-III 
!!~ 
-
-- ' 
-_ . .... 
-= ~. 
-..... 
-. : .. i 
.. . -
.. : 
. -
Chapter 6 Mutagenesis 
Figure 6.5 
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Figure 6.5 Sequence analysis of the nucleotide changes resulting in amino acid 
changes in the putative MI transmembrane spanning domain of the bovine al and {3I 
GABA A receptor subunits. 
Amino acid changes and receptor subunit are shown above the sequence. Site-directed 
ehanges in the wild-type sequence are indicated by arrows. 
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dissertation (Zaman, 1993). Dr. Zaman also recorded from HEK293 cells expressing aI, 
PI, y2L wild-type and mutant GABAA receptor subunits using whole cell patch recording. 
Results from these experiments will be included in this chapter's discussion only in 
relation to the ligand binding results described in this chapter. 
6.2.3 Optimization of Transient HEK293 Transfection 
Initial experiments with calcium phospate transiently transfected HEK293 cells gave very 
poor binding results, when wild-type a I, PI and "(2L GABAA receptor subunits were co-
transfected. Alternative approaches for transient transfection of HEK293 cells, such as 
DEAE-dextran and electroporation were attempted, with little of no specific binding 
(results not shown) observed in isolated membranes from HEK293 cells transiently 
transfected with wild-type aI, PI, yZL GABAA receptor subunits. Since calcium 
phosphate appeared to be the best mediator of DNA transfer into HEK293 cells, several 
parameters (C02 concentration and pH of the BBS buffer (25 mM N-N Bis(2-hydroxy-
ethyl)-2-amino-ethanesulfonic acid, 140 mM NaCl, 0.75 mM Na2HP04) critical for high 
effiency stable transformation of HEK293 cells, were investigated in the transient 
transfection system using [3H] Ro 15-1788 binding as a measure of the number of GABAA 
receptors expressed under the different transfection conditions. 
To test the effect of CO2 concentration on transfection efficiency, HEK293 cells grown 
in Eagles MEM with 10 percent fetal calf serum (heat denatured), glutamine, and 
penicillin/streptomycin were plated at 4xl06 cells per 10 centimeter plate in 10 millilitres 
of medium and incubated overnight at 37 °C in a 5 percent C02 incubator. Fifteen ~ (5 
J.Lg of each ex 1, PI and y2L GABAA receptor subunit pcDNA8 construct) of DNA were 
mixed with 0.5 millilitres of 250 mM CaCI2, prior to the addition of 0.5 millilitres of 
2xBBS buffer, pH 7.1. After mixing, the DNA solution was allowed to stand at room 
te~perature for 15 minutes. One milliliter of the DNA solution was then dispersed over 
the surface of a 10 centimetre plate of HEK 293 cells prepared the previous day. Cells 
with the DNA solution were then incubated for 48 hours at 37 °C in either a 3% C02 
incubator or a 5% C02 incubator. Only membranes, from cells and DNA incubated at 3% 
C02 demonstrated specific [3H] Ro 15-1788 binding ( results not shown). 
Therefore to optimize the transfection efficiency at 3% C02, the experiment described 
above was repeated with 2xBBS buffers ranging in pH from 6.80 to 7.15. Cells were 
harvested 48 hours after transfection and membranes were prepared for binding assays to 
determine the presence of GAB A A receptors. Specific and non-specific [3H] Ro 15-1788 
binding was determined for each pH condition tested and the transfection efficiency was 
expressed as the percentage of specific [3H] Ro 15-1788 binding over the total counts used 
in the assay. As illustrated in Figure 6.6, the increase in transfection efficiency occurred 
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over a very narrow range of pH values (pH 7.00 to 6.90). Based on these results, all future 
transfection experiments were performed using BBS buffer at pH 6.95 and a 3 percent 
C02 incubator. 
co 
co 
,.... 
.... 
I 
In 
.... 
o 
a: 
-o 
Gl 
Cl 
(II 
-C 
Gl 
U 
... 
Gl 
Q. 
7.15 7.1 7.05 7 6.95 6.9 6.85 6.8 
pH ofBBS 
Figure 6.6: Optimization of calcium phosphate transfection of HEK293 cells. Wild-type 
bovine GABAA receptor aI, /31 and 12L subunits subcloned into the mammalian 
expression vector pCDNA8 were transiently transJected into HEK 293 cells using 250 mM 
calcium chloride and a series of BBS (25 mMN-NBis(2-hydroxy-ethyl)-2-amino-
ethanesulfonic acid, 140 mM NaCl, 0.75 mM Na2HP04) buffers (pH 6.80 to 7.15). Cells 
were harvested 48 hours post transfection, membranes were prepared and [3H]-Ro15-
1788 binding assays were used to deterimine the extent of GABAA receptor subunit 
expression. The percentage of specific [3H]-Ro15-1788 binding was determined by 
dividing the specific counts [total counts (dpm) - nonspecific counts (dpm)] by the total 
counts (dpm). 
6.2.4 Mutant Analysis 
To study the a.l and PI D149N, D149Q, and P243A mutations, ten 90 centimetre 
plates were prepared for each wild-type and mutant combination of an a.l, PI, and "(2L 
GABAA receptor subunit. Forty-eight hours post transfection cells were harvested at 40C, 
by scraping into 5 rnillitres of TBS (Tris buffered saline), pH 7.4. The cell suspension was 
149 
Chapter 6 Mutagenesis 
centrifuged at 5,000 rpm for 5 minutes at 40 C and the pellet was resuspended in 20 
millilitres of ice cold 50 mM Tris pH 7.3 prior to homogenization at 4°C. The 
homogenate was centrifuged at 20K rpm for 30 minutes at 4°C in a Sorval SS34 rotor. 
The pellet was resuspended in 20 millilitres of ice cold 50 mM Tris, pH 7.4, homogenized 
and centrifuged at 20K rpm for 30 minutes at 4°C in a Sorval SS34 rotor. The membrane 
pellet was resuspended in 5 millilitres of TBS, pH 7.4. Binding assays with [3H] 
muscimol or [3H] Ro 15-1788 were set up in triplicate and incubated on ice for 90 minutes. 
In assays using [3H] RoI5-1788, 10 ~ flunitrazepam was used to determine non-specific 
binding in triplicate, at each concentration of Ro 15-1788, while in assays using [3H] 
muscimol, 10 mM KCI was added to the binding reactions and 1 JlM GABA was used to 
determine non-specific binding, in triplicate, at each concentration of muscimol. Assays 
were harvested onto presoaked GFIB filters using 5 mM Tris, 1 mM EDTA, pH 7.4 at 4°C. 
Protein concentrations for each membrane homogenate were determined by Lowry assays. 
o 200 
[3H) Ro1S·1788 bound 
Figure 6.7 Scatchard plot of [3HJ Ro15-1788 binding to C57B1I6 adult mouse cortical 
membranes. Specific binding was determined by subtracting the binding in the presence 
of 10 J1M Jlunitrazepam. The results shown are from a single binding assay and were 
determined by regression analysis of the data. Each dilution of ligand is done in triplicate 
for the determination of both specific and non-specific binding. As observed from three 
separate experiments, Kd values were 1.67 + 0.10 nM and Rmax values were 200 ± 20 
pmollmg and were determined by regression analysis using the ERDA-UGAND program. 
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The results· of binding assays were expressed either as a saturation analysis or Scatchard 
plot. A saturation analysis was used when binding results indicated that there was no 
discemable specific binding from the membranes tested and in general is used to illustrate 
a saturation curve for a ligand that binds to a homogeneous receptor population. In a 
saturation curve, the total binding includes a component of nonspecific binding, which is 
nonsaturable, and a component of specific binding, which saturates at Bmax. The Bmax is 
the maximum amount of drug (usually expressed in picomoles or fentamoles per mg 
protein) which can bind specifically to the receptors in a membrane preparation. If one 
drug molecule binds to each receptor, the Bmax also indicates the concentration of 
receptors in the membrane preparation. The dissociation constant for a radiolabelled drug 
(Kd) or ligand is the concentration of ligand or drug, at equilibrium, that occupies 50% of 
the receptors and can be calculated from a Scatchard plot. 
The Scatchard plot is a graph of the amount of radioligand bound divided by the 
amount of radioligand free in the solution (Y axis) versus the amount of radioligand bound 
(x axis). The intercept on the X axis is equal to the Bmax and the slope ( -lIKd) of the 
Scatchard plot, is determined by regression analysis using an EBDA !Ligand program. 
0.8 
0.6 
0.2 
4 6 8. 
[3HJ Muscimol bound 
Figure 6.8 Scatchard plot of [3H] muscimol binding to C57Bl16 adult mouse cortical 
membranes. Specific binding was determined by subtracting the binding in the presence 
of 1 J.1M GABA. The results shown are from a single binding assay. Each dilution of 
ligand is done in triplicate for the determination of both specific and non-specific binding. 
As observed from three separate experiments, Kd values were 3.2 + 0.3 nM and Bmux 
values were 6.4 + 1.7 pmollmg and were determined by regression analysis of the data. 
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Figure 6.9 Scatchard plot of [3Hl Ro15-1788 binding to membranes isolated from 
HEK293 cells transfected with wildtype aI, {31 and "{2L. Specific binding was 
determined by subtracting the binding in the presence of 10 J.1M flunitrazepam. The results 
shown are from a single binding assay and were determined by regression analysis of the 
data. Each dilution of ligand is done in triplicate for the determination of both specific and 
non-specific binding. The Kd, 1.59 nM and the Bmax , 1.38 pmollmg were determined 
using the EBDA-LIGAND program. 
40 
:; 30 
Co 
....... 
"0 
= = c: 
.:= 
oe 
~ 20 
-
.;. 
-c: 
== 
-
-a 10 
2 3 4 
[3H] Ro1S-1788 (nM) 
Figure 6.10 Binding isotherm of [3Hl Ro15-1788 binding to membranes isolated/rom 
HEK293 cells trans/ected with wildtype al, {3I and 12L Specific binding was determined 
by subtracting the binding in the presence of 10 J1M jlunitrazepam. Untransfected cells 
showed no specific binding. 
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[3HJ Muscimol bound 
Figure 6.11 Scatchard plot of [3Hl muscimol binding to membranes isolated from 
HEK293 cells transfected with wildtype aI, /31 and ~i Specific binding was determined 
by subtracting the binding in the presence of 10 pM jlunitrazepam. The results shown are 
from a single binding assay and were determined by regression analysis of the data. Each 
dilution of ligand is done in triplicate for the determination of both specific and non-
specific binding. The Kd. 5.67 nM and the Rmax. 1.69 pmollmg were determined by the 
ERDA-UGAND program. 
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Figure 6.12 Scatchard plot of [3Hl Ro15-1788 binding to HEK 293 membranes 
transiently transfected with wt aI, /31 (149Asp-Glu), wt 12L GABAA receptor subunits. 
Specific binding was determined by subtracting the binding in the presence of 10 J..LM 
jlunitrazepam. The results shown are from a single binding assay and were determined by 
regression analysis of the data using the ERDA-LIGAND program. Each dilution of 
ligand is done in triplicate for the determination of both specific and non-specific binding, 
Kd 1.02 nM and Rmax 0.25 pmol/mg. 
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[3H] Ro15-1788 bound 
Figure 6.13 Seatehard plot of [3 HJ Ro15-1788 binding to HEK 293 membranes 
transiently transfeeted with wt aI, {31 (149Asp-Asn) , wt 12L GABAA receptor subunits. 
Specific binding was determined by subtracting the binding in the presence of 10 )JM 
Jlunitrazepam. The results shown are from a single binding assay and were determined by 
regression analysis of the data using the EBDA-LIGAND program. Each dilution of 
ligand is done in triplicate for the determination of both specific and non-specific binding. 
Kd 0.82 nM and B max O. 15 pmol/mg. 
Subunit combination [3H]Ro15-1788 binding: KI. [3H]Muscimol binding: KI, 
expressed Bmax Bmax 
wta 1, wt~ 1, wry2L 1.35 ± 0.7 nM, 1.46 ± 0.1 5.89 ± 0.3nM, 1.69 ± O. 3 
pmol/mg pmol/mg 
aID-N, wt~lI wry2L ND ND 
aI, ~faJbI wty2L 1.1 + 0.1 nM, 0.31 + 0.1 ND 
pmol/mg 
aI, ~ ID-N, wty2L 0.82 + .08 nM, 0.20 + 0.07 ND 
pmol/mg 
Table 6.1: Summary of Kd and Bmax values for receptors formed from wild-type 
subunits only or with wild-type subunits and GABAA a or f3 subunits with point 
mutations in the cysteine loop. Kd values are expressed in nM, and Bmax values in 
pmol/mg. ND: No specific binding detected. Values were averaged from three separate 
transfection experiments in HEK293 cells. 
No expression was detected using either [3H]Ro 15-1788 or [3H]muscimol with the 
receptor combination containing the alD-N mutation. Successful transfection was 
determined by the presence of mRNA for all three subunits, in HEK293 cells transiently 
transfected with the wild-type ~ 1, y2L and mutant a I subunits (data not shown). Although 
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[3H]Ro 15-1788 binding was detected in receptor combinations with a mutant ~ 1 subunit. 
no [3H]muscimol binding was detected. mRNA for all three GABAA subunits transfected 
were detected in the HEK293 cells, 48 hours after transfection (data not shown). 
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Figure 6.14 Scatchard plot 0/ [3Hl Ro15-1788 binding to HEK 293 membranes. 
transiently trans/eeted with mutant a M1 pro-ala, wt /31 and wt ~i GABAA receptor 
subunits. Specific binding was determined by subtracting the binding in the presence of 
10 pM !lunitrazepam. The results shown are from a single binding assay and were 
determined by regression analysis using the ERDA program. Each dilution of ligand is 
done in triplicate for the determination of both specific and non-specific binding. Kd 0.73 
nM and Bmax 0.19 pmol/mg. 
The Kd for [3H] Ro15-1788 binding was decreased for the receptor combination 
containing the mutant PI 149D-E subunit when compared with the K<i for [3H] Ro15-1788 
binding. This decrease in the Kd was not statistically different as determined by a 
Student's t-test, (p=O.065). The decrease in the Bmax for the receptor combination 
containing the mutant P 1149D-E subunit when compared with the Bmax for the wild-type 
receptor combination was statistically significant (p<O.OOOl). The difference in the KdS 
of the receptor combination containing the P 1149D-N mutation compared with the receptor 
combination containing wildtype subunits only, was statistically different as determined by 
a Student's t-test (p=0.008). As seen with the ~ ID-E mutant subunit, the Bmu for the 
receptor combination containing mutant PI D-N mutation was significantly different when 
compared with the Bmax of the wild-type receptor combination (p< 0.0001). 
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Figure 6.15 Binding isotherm of [3 HI Ro15-1788 binding to membranes isolated from 
HEK293 cells transfected with wild-type aI, {31pro-ala and wild-type ~i. Specific 
binding was determined by subtracting the binding in the presence of 10 JiM 
jlunitrazepam. Untransfected cells show no specific binding. 
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Figure 6.16 Scatchard plot of [3H] Ro15-1788 binding to HEK 293 membranes. 
transiently transfected with wt a, mutant {31 Ml pro-ala, and wt "PL GABAA receptor 
subunits. Specific binding was determined by subtracting the binding in the presence of 
10 pM jlunitrazepam. The results shown are from a single binding assay and were 
determined by least-squares analysis of the data. Each dilution of ligand is done in 
triplicate for the determination of both specific and non-specific binding. As observed from 
three different experiments, Kd 1.47 nM and Bmax 1.39 pmollmg and were determined by 
the EBDA-UGAND program. 
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Figure 6.17 Scatchard plot of PH] muscimol binding to HEK 293 membranes 
transiently transfected with wt a, mutant /31 Ml pro-ala, and wt llL GABAA receptor 
subunits. Specific binding was determined by subtracting the binding in the presence of 
10 J1M Jlunitrazepam. The results shown are from a single binding assay. Each dilution 
of ligand is done in triplicate for the determination of both specific and non-specific 
binding. Kd 0.98 nM and Bmax 1.53 pmol/mg and were determined using the EBDA-
LIGAND program. 
Subunit combination [3H]Ro 15-1788 binding: I<d, [3H]Muscimol binding: ~I 
expressed Bmax Bmax 
wta 1, wt~ 1, wty2L 1.35 ± 0.1 nM, 1.5 ± 0.2 5.89 ± 0.3nM, 1.7 + 0.1 
pmollmg pmollmg 
wt~lI wty2L 0.51 ± 0.03 nM, 0.16 ± 0.03 ND 
pmollmg 
alp-A, wt~lI wty2L 0.87 ± 0.09 nM, 0.19 ± 0.04 ND 
pmollmg 
ai, ~ IP-A, wty2L 1.47 ± 0.1 nM, 1.5 ± 0.3 0.89 ±...0.09nM, 1.6 ± 0.4 
pmol/mg pmol/mg 
Table 6.2: Summary of Kd and Bmax values for receptors containing wildtype subunits, 
only or with wildtype subunits and GABAA a or f3 subunits with point mutations in the 
putative Ml transmembrane domain. 
KD values are expressed in nM. and Bmax values in pmol/mg. ND: No specific binding 
detected. Values were averagedfrom three seperate transfection experiments. 
The difference in the ~s of [3H]Ro 15-1788 binding for the wild-type ~ 1, "(2L receptor 
combination only, compared with the wild-type aI, ~ 1, y2L receptor combination was 
statistically significant as determined by a Student's t-test (p<O.OOOl). Comparison of the 
Kd of [3H]Ro 15-1788 binding for receptor combinations including mutant a 1243pro-ala 
subunits with the Kd of [3 H]Ro 15-1788 binding for the wild-type aI, ~ 1, "(2L receptor 
combination indicated that there was a statistical difference between the two ~s 
(p=0.0016). A Student's t-test comparing the ~s of [3H]RoI5-1788 binding for receptor 
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a one minute incubation in Amersham detection buffers 1 and 2. Following the one 
minute incubation, the detection buffer was removed and the membrane exposed to 
Hyperfilm-ECL for 10 minutes. 
Western blot analysis, of membrane preparations from transiently transfected HEK293 
cells using a polyclonal anti-al GABAA receptor antibody demonstrates that although an 
a1 subunit protein is present in the membranes of cells transfected with; 1) wild-type aI, 
~NI y2L subunits, 2) wild-type al, y2L and mutant ~fN49aJk subunits, and 3) mouse 
cortical membranes, no immunoreactive product was present for the a 1 subunit protein in 
the membranes of cells transfected with wild-type ~ 1, y2L and mutant a 1 243pro-ala 
subunits (Figures 6.18 and 6.19A). Western blot analysis of membrane preparations from 
transiently transfected HEK293 cells using a polyclonal antiJ~ 1 GABAA receptor antibody 
demonstrated that the ~ 1 protein was abundantly represented in membranes of cells 
transfected with; 1) wild-type aI, ~ 1 y2L subunits and 2) wild-type aI, y2L and mutant 
~ 1243P-A subunits, and weakly expressed in membranes of cells transfected with; 3) wild-
type ~NI y2L and mutant aI243P-A, subunits (Figure 6.19B). Western blot analysis of 
membrane preparations from transiently transfected HEK293 cells using a polyclonal anti-
y2 GABAA receptor antibody (recognizes both the Land S splice variants) demonstrated 
that the y2 protein was abundantly represented in membranes of cells transfected with; 1) 
wild-type aI, ~ 1 y2L subunits and 2) wild-type ai, y2L and mutant ~ 1243P-A subunits, 
and weakly expressed in membranes of cells transfected with; 3) wild-type ~ 1, y2L and 
mutant a1243P-A, subunits (Figure 6.19C). 
1 2 3 4 
tJD~"D ... _~frD" ~ .... 
. J.~DJD 
plkaa~JJ­
Ie .. -
5 6 7 8 
' . 
-. 
-
Figure 6.18 Western blot analysis of membrane preparations from transiently 
transfected HEK293 cells using a polyclonal anti·a1 GABAA receptor antibody. 
HEK293 cells were transfected with 1) wild-type /31, 12L and mutant a1J49D-N 
{transfection #1}, 2) wild-type /31, 12L and mutant a1/49D-N {transfection #2}, 3) wild-
type /31, 12L and mutant al243P-A {transfection #1}, 4) wild-type aI, /31, 12L {transjection 
#l}, 5) wild-type /31, 12L and mutant a1 J49D-N (transfection #3 j, 6) wild-type /31, 12L and 
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mutant ai243P-A (transfection #2), 7) wild-type ai, {31, y2L (transfection #2) GABAA 
receptor subunits. Controls for anti-al GABAA receptor antibody specificity included: 8) 
mouse cortical membranes and 9) untransfected HEK293 membranes. 
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Figure 6.19 Western blot analysis of membrane preparations from transiently 
transfected HEK293 cells using a polyclonal anti-a1 subunit, anti- {31 subunit or anti-r2 
subunit GABAA receptor antibody. 
Western blots of membrane proteins isolated from transfected HEK293 cells were probed 
with anti-al subunit (A), anti-{31 subunit (B) or anti-12 subunit (C) antibodies. In the 
lanes are samples from HEK293 cells transfected with the cDNA combinations: (1) wild-
type aI, {31 and 12L subunits; (2) wild-type {31, 12L and mutant a1243P-A subunits; (3) 
wild-type ai, y2L and mutant {3i243P-A subunits: ur, untransfected HEK293 cell 
membranes. Molecular marker sizes (kDa) are marked (and two of the marker proteins 
are shown in C). The a1 subunit is the band at 50 kDa in A. In B, the heavy band at 52 
kDa corresponds to the {31 subunit and in C, the heavy band at 49 kDa corresponds to the 
12 subunit. 
6.3 Discussion 
In this chapter, site-directed mutageneis was used to mutate two amino acids that are 
highly conserved among members of the ligand-gated ion channel superfamily. The 
aspartic acid which is at position 149 in the bovine 0.1 amino acid sequence was mutated 
to asparagine and the aspartic acid in the comparable position in the bovine f31 subunit was 
mutated to either asparagine or glutamic acid. In the putative Ml transmembrane domain, 
the proline was mutated to alanine in both the 0.1 and f31 subunits. The effects of 
mutations within the 0.1 and f31 GABAA receptor subunits were studied through 
[3H]Ro 15-1788 and [3H]muscimol binding analysis of membrane preparations isolated 
from transiently transfected HEK293 cells. 
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6.3.1 Amino acid exchange at residue 149 (wild.type D) within the putative cysteine 
loop 
Is there an agonist protobinding site for ligand-gated ion channels? Within the ligand-
gated ion superfamily, a highly conserved sequence of 15 amino acids (cys loop) in the N-
terminal extracellular region, has been modeled as a rigid amphiphilic p-hairpin and 
postulated to act as a major determinant of a conserved structural binding cleft for an 
agonist. Aspartic acid is one of only two invariant acidic residues present in the 
extracellular region of ligand-gated ion channel subunits and available for interaction with 
the positively charged amine group of agonists such as GABA. In the Cockcroft model 
(Cockcroft et aI., 1990) of the binding complex of ligand-gated ion channel receptors, the 
invariant aspartate residue at position 11 of the cys-Ioop is postulated as the anionic site 
that interacts with the positively charged amine group of agonists and a local dipole within 
the 1t electron system of agonists is modeled in a favorable 'orientation in the electrostatic 
field of the invariant aspartate. In this model, a marked two residue periodicity in the 
average hydrophobicity predicted a p-strand to occur over positions 1 through 7 and over 
positions 10 through 14. A type VIa p-turn is predicted to start at position 7 and is 
consistant with invariance of the proline residue at position 9 of the cys-Ioop (Cockcroft et 
aI., 1990). In this model, the invariant aspartate residue appears on the hydrophilic face. 
This model predicts that when residues within the cys loop are substituted for alanine, 
there is little change in the main chain conformation. 
In this chapter, we described mutagenesis of the aspartic acid in the cysteine loop of 
the bovine a1 and PI GABAA receptor subunits which resulted in either a 
nonconservative change leading to loss of a negative charge (asparagine) or a conservative 
change in which a negatively charged residue was maintained at position 11 (glutamic 
acid). Transient expression of these mutated subunits with wild-type subunits in an a I, PI 
y2L configuration, in HEK293 cells, resulted in: 1) loss of GABAA receptor Ro 15-1788 
binding (aID-N, wtPl, wty2L), 2) no change in Ro15-1788 binding (wtal, PID-E, wty2L), 
and 3) a statistically significant increase in GABAA receptor Ro15-1788 binding affinity 
(wtal, ~NaJkI wty2L). No muscimol binding was detected for any of the mutant receptor 
combinations expressed in HEK293 cells. Since muscimo1 has both a lower specific 
activity and a lower binding affinity than Ro 15-1788, reduction of the Bmax for receptor 
combinations including either a mutated al or PI subunit in the aspartic acid of the 
cysteine loop obviously had a dramatic effect on the ability to detect the membrane· 
localized GABAA receptor complexes through muscimol binding. In the experiment 
including a mutant a1D-N and wt~N and wt"(2L subunits, neither Ro15-1788 or muscimol 
binding was detected. Western blot analysis of membrane preparations used in the 
receptor binding analysis, demonstrated that immunoreactive products were present for 
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both the al and ~ 1 subunits, and mRNA analysis confirmed the presence of all three 
subunit (aI, ~ I, and y2L) mRNAs in the transiently transfected cells. The presence of 
GABAA receptor protein in the membrane preparations, but a lack of Ro 15-1788 and 
muscimol binding suggest that the aspartic acid residue in the cysteine loop can playa role 
in both agonist and antagonist binding. Conservation of the negative charge at the aspartic 
acid site in the cysteine loop of the ~ 1 subunit resulted in receptors that were identical to 
the wild-type receptors in Ro 15-1788 binding affinity. In further comparison of wild-type 
and mutant receptors containing the ~ 10-E subunit, there was a significant decrease in the 
Bmax, and lack of muscimol binding for the mutant receptor membrane preparations. As 
discussed earlier, a decrease in the Bmax suggests that the assembly or efficient trafficking 
of the GABAA receptor complex was impaired. An increase in affinity for Ro15-1788 in 
the mutant receptor containing the ~ 1 D-N subunit further suggests that the aspartic acid site 
in the cysteine loop plays a role in antagonist binding. 
In comparison to our results, Amin, Dickerson and Weiss, (1994) also found that 
mutation of a1 and"f2 GABAA receptor subunits to glutamic acid (conservative change) at 
the aspartic acid position in the cysteine loop resulted in either no impairment of GABA-
mediated activation or a slight decrease in the BCso, when aI, ~2 and y2 subunit cRNAs 
were co-expressed in Xenopus oocytes. Similar to our results with the ~ 10-N mutation, 
Amin, Dickerson and Weiss, (1994) found that substitution of the aspartic acid position in 
the cysteine loop with asparagine in the ~2 subunit resulted in no GAB A-activated 
currents. In Xenopus oocyte experiments, substitution of aspartic acid for glutamic acid 
(conservation of charge) in the ~2 subunit resulted in GAB A-activated currents, where 
there was no effect on the ECso, a dramatic decrease in the amplitude of the current and a 
decrease in the Hill coefficient, suggesting a decrease in the cooperativity of channel 
activation (Amin, Dickerson and Weiss, 1994). Mutations involving changes to amino 
acids at positions 5 (leucine) and position 9 (proline) in the cysteine loop of the ~2 
GABAA receptor subunit, when co-expressed in Xenopus oocytes with wild-type aI, y2 
subunits generally resulted in only a slight impairment in activation of the GABA channel, 
suggesting that this impairment may occur indirectly through structural alterations of the 
protein (Amin, Dickerson and Weiss, 1994). 
Mutation of the cysteines in the cysteine loop to serine resulted in little or no 
expression of the GABAA 'Y subunit in the receptor complexes, as determined by blockade 
of the GABA induced current by 10 J.lM Zn2+, as well as a lack of potentiation by 1 J.1M 
diazepam (Amin, Dickerson and Weiss, 1994). Lack of functional expression of subunits 
with a mutation of cysteine to serine in the cysteine loop suggests that the cysteine loop 
may be required for proper folding or assembly of the subunits in the plasma membrane. 
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Conservative substitutions of amino acids forming the binding sites of ACh-, glycine-, 
and GABA-operated ion channels typically yield ECso increases of at least lO-fold, 
whereas less conservative substitutions typically abolish agonist-dependent gating (Galzi 
et ai., 1991a; O'Leary and White, 1992; Tomaselli et aI., 1991; Vandenberg, Handford, 
and Schofield, 1992; Amin and Weiss, 1993). Interestingly, mutation of aspartic acid in 
the cysteine loop of the homomeric glycine receptor did not impair sensitivity to action by 
glycine (Vandenberg et aI., 1993) and monoclonal antibodies directed against the cysteine 
loop of the nACh channel indicated that the cysteine loop was not part of the agonist 
binding site (Lennon et aI., 1985; Criado et al., 1986). Cysteine to serine mutations at the 
conserved cysteines in the extracellular domain of the glycine receptor abolished 
expression of functional glycine receptors in Xenopus oocytes (Akagi, Hirai and 
Hishinuma, 1991). Disruption of the disulfide loop structure in the nACh channel a or ~ 
subunits led to intracellular retention of the assembled receptor complexes, suggesting that 
the cysteine loop may be required for efficient transport of the receptors to the plasma 
membrane (Sumikawa and Gehle, 1992). These data indicate that these 2 cysteines are 
critical for AChR and glycine receptor function but do not define the precise role they 
play. 
6.3.2 Amino acid exchange at residue 243 (wild. type P) in putative transmembrane 
domain 1 (Ml) 
Within Ml, an internal proline (Pr0243) and cysteine (Cys244) are strongly conserved 
for all subunits and species of GABAA, nicotinic acetylcholine and glycine receptors. The 
residues immediately preceding and following Pro-eys are almost always aliphatic but are 
not strictly conserved. The cysteine residue is invariant among vertebrate AChR and is 
replaced only by serine or threonine in some invertebrate AChR subunits (Hermans-
Borgmeyer et ai., 1986) and in the ~ subunits of GABAA and glycine receptors. Thus, the 
Ml cysteine appears to be a critical residue that can, however, tolerate conservative 
substitutions. In comparison the proline residue at position 243 is invariant across all 
species and subunits of GABAA, nicotinic acetylcholine and glycine receptor subunits. To 
determine the role of this invariant proline in agonist and antagonist binding, we mutated 
pr0243 in the 0.1 and ~ 1 GABAA receptor subunits to alanine. 
In HEK293 cells, transient expression of wild-type ~ 1, "(2L and mutant a 1243pro-iUa 
subunits resulted in receptors with a statistically significant increase in Ro15-1788 binding 
affinity, a significant decrease in the Bmax and no detectable muscimol binding when 
compared with l<ds and Bmaxs for muscimol and Ro 15-1788 binding of wild-type 0.1, ~ 1 
and y2L GABAA receptors. Examination of the membrane preparations from transiently 
transfected HEK293 cells expressing the mutant a1243pro-ala subunit, by Western blot 
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analysis with an al subtype-specific antibody, revealed the absence of the al243pro-ala 
subunit protein. Western blot analysis with a ~N subunit-specific antibody demonstrated 
however, the presence of the ~ 1 GABAA subunit protein in the same membrane 
preparation used to determine the presence or absence of the al243pro-ala subunit protein. 
A Student'S t-test also demonstrated that there was no significant difference between the 
Ro 15-1788 binding affinity for ~ 1 and y2L only receptor subunits expressed in HEK293 
cells and the Ro15-1788 binding affinity for a 1 243pro-ala, ~NI y2L subunits expressed in 
HEK293 cells. The inability to detect the a 1243pro-ala subunit in the HEK293 membranes 
and the lack of statistical significance between the KdS and Bmaxs for the ~lIy2i and 
aI243pro-ala, ~ 1, "{2L subunit combinations indicates that transient expression of a 1243pro-
ala. ~ 1, y2L subunit in HEK293 cells results in receptors with ~ 1, y2L subunits only. 
Further evidence of the absence of the ah43pro-ala mutant subunit from the HEK293 
membrane preparations was demonstrated in whole cell patch recordings from the 
transiently transfected HEK293 cells. As reported by Zamin (Cambridge thesis, 1993), the 
response elicited by 100 J.1M GABA from HEK 293 cells expressing the 
al pro24Pala.~ 1,y2L receptor combination, in separate experiments was blocked by 100 J.LM 
bicuculline and inhibited by 100J.LM Zn2+. In the HEK293 cells transiently expressing the 
mutant al subunit, there was also no potentiation by 50 J.LM diazepam and an increase in 
the rate of repolarization following 10 J.LM ~JCCM (methyl ~Jcarboline 3-carboxylate) 
application (Zamin, Cambridge thesis, 1993). As seen with the a 1 243pro-ala, ~lI y2L 
combination, when ~ ly2L subunits only were expressed in HEK293 cells, currents elicited 
by 100 J.LM GABA, in separate experiments were inhibited by 100 J.LM Zn2+, potentiated 
by 50 J.1M diazepam yet were unaffected by 10 11M ~JCCM eZamin, Cambridge thesis, 
1993). In all experiments reported above voltages were clamped at -60 mY. For zinc 
. sensitivity, there was no statistical difference between mutant and ~ 1 y2L combinations 
expressed in HEK 293 cells (p=O.3) (Zamin, Cambridge thesis, 1993). The ability of Zn2+ 
to block GABA responses was used as an indicator for the presence of the y2L subunit in 
the receptor complex and modulation of the GABA response to the ~Jcarboline. ~JCCM 
was used to differentiate the expression of a ~ 1 y2L combination from the expression of an 
ex 1 ~ 1 y2L combination, since it haS been reported that the GABA response ellicited by an 
expressed ~Ny2p subunit combination is antagonised by DMCM (Knoflach et al., 1991). 
These results suggest that the al subunit-specific antibody did not detect the presence of 
the a 1243pro-ala mutant subunit in the HEK293 membrane preparations, because either the 
al mutant subunit was present at concentrations below detection by the antibody or 
because the mutation in the al subunit had decreased the affinity of the protein for the 
antibody. Further analysis will be necessary to determine the stoichiometry of the mutant 
receptor complex. 
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In HEK293 cells, transient expression of wild-type aI, y2L and mutant ~ 1243pro-ala 
subunits resulted in receptors with a statistically significant increase in muscimol binding 
affinity, no significant change in the B max and no detectable alteration in Ro 15-1788 
binding kinetics, when compared with ~s and Bmaxs for muscimol and Ro 15-1788 
binding of wild-type ai, ~ 1 and y2L GABAA receptors. Examination of the membrane 
preparations from transiently transfected HEK293 cells expressing the mutant ~ 1243pro-ala 
subunit, by Western blot analysis with a ~ 1 subtype-specific antibody, confirmed the 
presence of the ~ 1 pro-ala subunit protein. In HEK 293 cells transiently expressing the aI, 
~ 1243pro-ala, y2L GABAA receptor subunits, whole cell patch recording demonstrated that 
currents elicited by application of 100 ~ GABA were blocked by 100 J.lM bicuculline 
and potentiated by 50 J.lM diazepam (Zaman, Cambridge thesis, 1993). Expression of the 
ai, ~ 1243pro-ala, y2L combination of subunits in HEK293 cells resulted in a decrease in the 
ECso for GABA which was statistically greater than wildtype (Zamin, Cambridge thesis, 
1993), an observation which is in agreement with the binding results reported in this 
chapter. In L929 fibroblasts, the GABAA receptor a 1 ~ 1243pro-alay2L SUbtype had 
increased GABA affinity (Greenfield et al., unpublished results), as was reported in this 
chapter for [3H]muscimol binding of the a1 ~ 1243pro-alay2L SUbtype in HEK293 cells. 
Barbiturates have long been known to enhance postsynaptic GABAA currents (Schulz 
and Macdonald, 1981; Ransom and Barker, 1976; Macdonald and Barker, 1978) both by 
modulation of GAB A-induced currents and by direct activation in the absence of GABA, 
and these effects are thought to be responsible for the anesthetic, sedative and 
anticonvulsant actions of the barbiturates (Schulz and Macdonald, 1981; Macdonald and 
Barker, 1978). In acutely transfected L929 cells the al~N24PproJala"E2i SUbtype 
demonstrated selectively reduced sensitivity to barbiturates, suggesting a role for the ~ 
subunit in barbiturate-induced enhancement of GABAA receptor currents. The ~ 1243pro-
ala mutation may affect the barbiturate binding site directly, but it is more likely that is 
changes the allosteric coupling between agonist binding and channel gating. 
As evidence against the possibility that there are shared or overlapping sites of action 
for GABA and barbiturates, there are several mutations which provide a precedence for 
separate sites of binding for GABA and its modulators. For example, in two regions 
between the cysteine loop and the Ml transmembrane domain, threonine (TI60, T202) and 
tyrosine (YI57, Y205) residues, through site-directed mutagenesis have been identified as 
critical sites for the activation of currents by GABA but not by pentobarbital. 
In conclusion, we have shown that mutations of the highly conserved amino acids in 
the putative cysteine loop and transmembrane domain 1 of ligand-gated ion channel can 
have significant effects on either agonist or antagonist binding and on subunit trafficking 
or assembly. In particular: 1) amino acid exchange of aspartic acid to asparagine in the 
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putative cysteine loop of al GABAA receptor subunit results in loss of agonist binding, 
probably due to an impairment in the assembly or processing of the mutant subunit; 2) 
amino acid exchange of aspartic acid to asparagine in the putative cysteine loop of the ~ 1 
GABAA receptor subunit results in a significant increase in antagonist (Ro 15-1788) 
binding; 3) amino acid exchange of aspartic acid to glutamic acid (conservative change) in 
the putative cysteine loop of the ~ 1 GABAA receptor subunit results in a reduction in the 
Bmax for flunitrazepam suggesting that the assembly or efficient trafficking of the 
GABAA receptor complex is impaired. Mutation in the highly conserved proline residue 
of the PI GABAA receptor subunit putative Ml transmembrane domain results in a 
significant decrease in the binding affinity of muscimol, while the same mutation in the a1 
subunit of the GABAA receptor results in no detectable binding by muscimol or 
flunitrazepam and an absense of al immunoreactivity in membrane preparations from 
transiently transfected HEK293 cells. The inability of the apy ternary complex to 
assemble when the Ml mutation is in the a subunit but not the p subunit suggests that the 
proline in M 1 is important for oligomeric assembly in the a subunit but not the p subunit. 
An alternative interpretation of this difference includes a consideration of the composition 
of the ternary structure. If the pentameric GABAA receptor assembly is composed of 
EalF2E~ 1) 1 (y2L)2, then a mutation in an a subunit could have a greater distortion on the 
structure of the receptor complex. 
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7.1 Introduction 
Molecular diversity within the GABAA receptor ion channel gene family arises through 
subunit multiplicity, temporal and spatial regulation of gene expression and alternative 
splicing of subunit mRNAs. At the protein level, the sensitivity of the GABAA receptor 
complex to agonists and modulators of the GABA response, occurs through the 
heteromultimerization of GABAA subunits which thereby generates vast combinatorial 
possibilities in terms of GABAA receptor composition. Further diversification of GABAA 
receptor responses occur through subunit trafficking and post translational modifications, 
such as phosphorylation. In this thesis, I have described the developmental onset of 
GABAA receptor gene expression, the distribution and temporal expression of GABAA 
receptor subunit genes and splice variants within the developing and adult murine central 
nervous system, and the role of highly conserved amino acids within the cysteine loop and 
Ml transmembrane domains in structural characteristics associated with binding of agonist 
and antagonists at these sites. These results must be considered in the context of similiar 
studies involving voltage-gated ion channels and other members of the ligand-gated ion 
channel receptor superfamily. 
7.2 Diversity at the gene level 
A considerable amount of ion channel molecular diversity stems from the existence of 
multiple gene members within a family. Typical ion channel families have six or more genes 
coding an a subunit protein, as well as several auxiliary subunits (y, 8, £) that act to 
modulate ion channel function. The p subunits can be integral parts of the ion channel (ACh 
and GAB A) or act as modulators of channel activity (KvPl) (Isom, De Jongh and Catterall 
1994). Although NMDA receptors lack a ~ subunit, they share a sirniliar complexity to ACh 
and GABA receptors, in that the NMDA receptor complex is composed of the essential 
subunit NMDARl, which when combined with various NMDAR2 subunits (A-D) yields 
functional diversity (Monyer et al., 1992). So far, only one type of subunit has been detected 
for AMPNKA receptors based on a 70 to 85 percent amino acid identity among identified 
sequences, however as is the case. with GABAA receptor subunits, formation of tetrameric 
or pentameric structures with varying subunit composition clearly leads to an enormous 
potential diversity of AMPNKA ion channel variants. 
Receptor complexity becomes even greater if the ordering of subunits is important and 
therefore a receptor consisting of just two subunits a and p, with a stoichiometry of a2p3, 
could exist for example as aappp, or apapp. If the specific temporal and spatial 
expression patterns of gene products are carefully controlled, for example, by tissue specific 
promoters, then precise functional variations are possible. Expression of nAChR at the 
.neuromuscular junction is one example of this process. During embryonic development, 
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nAChR chamiels consist of a, ~I 'Y, and 0 subunits. This channel complex Ea.~lDvF has the 
properties of; 1) a more rapid turnover, 2) longer channel open time and 3) smaller 
conductance, than the adult nACh receptor a~ob subunit combination. The adult channels 
also tend to be clustered at subsynaptic sites while the embryonic form is found over the 
entire muscle surface. Thus the presence of the 'Y versus E subunit drastically alters the 
properties of the channel. An exception to the restricted temporal expression of the 'Y subunit 
occurs in response to denervation. 
Another member of the ligand-gated ion channel receptor superfamily, the glycine 
receptor also demonstrates developmentally-restricted subunit expression. In this case, the 
glycine receptor al subunit is found almost exclusively in the adult central nervous system, 
while 0.2 expression is confined to the embryo and the first three weeks of life (Becker, 
Hoch and Betz 1988; Kuhse, Schmieden and Betz 1990). The predominantly embryonic 
form of the glycine receptor Ea.2~F has a single channel conductance that is similiar to the 
adult form Ea.l~FI but differs from the adult form in that a.2~ receptors have a much longer 
mean open time (Takahashi et al., 1992). Consistent with these glycine receptor properties, 
is the observation that dorsal hom neurons have more rapid IPSPs in adult cells (Takahashi 
et al., 1992). 
Other ligand-gated ion channels, however, do not have specific embryonic subunits, yet 
do demonstrate developmental changes in expression. One example of this developmental 
regulation occurs in cerebellar granule cells, where changes in NMDA receptor subunit 
composition may play a role in cell migration during early postnatal development (Komuro 
and Rakic 1993). Single-channel analysis of developing granule cells indicates the 
expression of a high conductance channel with a long open time, in migrating neurons is 
replaced by a lower conductance channel with a brief open time in the adult (Farrant et a/., 
1994). These properties correspond well with the properties of heterologously expressed 
NMDA receptors of NRI and NR2AIB (high conductance), and NRI and NR2C (low 
conductance) respectively (Monyer et al., 1992; Stern et al., 1992). mRNA for the NR2C 
subunit appears postnatally and is predominantly localized to cerebellum (Monyer et ai., 
1992). Other areas of the adult CNS retain the high conductance NR2AIB type of channel. 
Assuming a pentameric structure, with no constraints on assembly, there are 151,887 
possible subunit combinations of the GABA receptor (Burt and Kamatchi, 1991). excluding 
splice variants. More realistically, if one assumes a stoichiometry of a2~NDv2 there are 137 
variants. Although this is still an impressive number, its relevance is limited unless at least 
some of these variants exhibit different biological activities. Distribution patterns described in 
Chapter 4 of this thesis support the hypothesis that diversity is achieved in part, through 
differential subunit composition. Differences in the temporal regulation of GABAA receptor 
genes leads to distinct functional properties. This is particularly evident during 
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embryogenesis and early postnatal development where activation of hippocampal GABAA 
receptors leads to marked membrane depolarization (Ben-Ari et al., 1989), rather than 
hyperpolarization. 
7.3 Developmental regulation of GABAA receptor subunit expression 
7.3.1 Embryonic differences in the expression of GABAA receptor subunit 
mRNAs between rat and mouse. 
In Chapter 3, RT-PCR analysis of embryonic, postnatal and adult total RNA isolated 
from the entire embryo or from whole brain indicated that in the mouse, GABAA receptor 
a4, a5, ~2I yl, and y3 subunit expression begins during the later stages of embryogenesis, 
while GABAA receptor a I, a2, a3, a6, ~ 1 and y2 subunit mRNAs are expressed 
throughout murine development and in the adult murine CNS. This pattern of murine 
GABAA receptor subunit expression differs from in situ hybridization studies characterizing 
GABAA receptor subunit mRNA distribution during rat embryogenesis (Laurie et ai., 1992). 
Laurie et al., (1992) found abundant a3 expression in the 14 day rat embryo, but very little 
expression of a4 GABAA receptor subunit mRNA and an absence of a6 GABAA receptor 
mRNA at rat embryonic day 14. These results differ from the RT-PCR results presented in 
Chapter 3, where, for example, the a6 GABAA receptor mRNA was detectable at E14 in the 
mouse. These differences in detection of GABAA receptor subunit mRNAs may be a 
reflection of the greater assay sensitivity of RT -PCR over in situ hybridization analysis. 
In the study by Laurie et ai., (1992) the ~ 1 subunit transcript was present in the E14 rat 
embryo, but the ~2 and ~P GABAA receptor mRNAs were rare or absent at embryonic day 
14 in rat development. These rat developmental results for GABAA receptor ~ subunit 
mRNA expression are similiar to the results for the mouse E14 day embryo, reported in 
Chapter 3 of this thesis. At embryonic day 14 in the rat, both yl and y2 GABAA receptor 
subunit transcripts were detectable (Laurie et al., 1992), while the y3 transcript was 
expressed at very low levels. In contrast, murine transcripts for yl and y3 were not detected 
by RT -PCR analysis, while the. y2T transcript was present in all developmental stages 
studied. 
Although embryonic day 14.5 in the rat corresponds to embryonic day 13 in the mouse, 
the differences observed between rat and murine GABAA receptor subunit expression cannot 
be explained by this offset in rat and murine prenatal development. As mentioned above, 
RT-PCR analysis is a more sensitive detection assay for identifying the presence of a 
transcript and may account for the presence of subunit mRNAs, which are not observed 
through in situ hybridization studies. 
It should also be noted that the RT -PCR described in Chapter 3 of this thesis was used as 
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a descriptive tool for detennining the type of GABAA receptor subunit transcripts at early 
and later stages of murine embryogenesis and was not used to quantitate the levels of the 
various transcripts present at each developmental stage. The importance of determining what 
GABAA receptor subunit transcripts are present during embryonic development is manifest 
in the important role GABAA receptors play in such processes as neurite extension and 
synaptogenesis during neonatal development (Hansen et at., 1987; Meier et at., 1987; Wolff 
et al., 1987) and in the observation that administration of benzodiazepines during pregnancy 
causes biochemical and behavioral manifestations in the progeny that can persist into 
adulthood (Simmons et at., 1984a,b; Kellogg, 1988). Ma et al., 1993 used a hybrid 
approach that involved RT-PCR and in situ hybridization analysis to identify all GABAA 
receptor subunit mRNAs 0.6 which was not detectable by either method and 8, which was 
weakly detected only by RT-PCR. Two anatomically distinctive sets of subunit mRNAs 
were found by in situ hybridisation within the ventricular zone and mantle zone of the E 19 
day rat. The mRNA expressions declined during postnatal development, by region-selective 
depletion, with 0.4, 0.5, ~ 1. ~2 and "(3 subunit mRNAs becoming barely detectable (Ma et 
al., 1993). 
7.3.2 Postnatal Expression of GABAA receptor subunit mRNAs in murine 
eNS during postnatal development 
7.3.2.1 GABAA ion channel receptor pharmacology 
Comparative levels of GABAA receptor subunit mRNAs were described in Chapter 4 of 
this thesis, where in situ hybridization was used to detennine the distribution of the 
transcripts in the postnatal and adult murine CNS. RT-PCR demonstrates the presence, in 
the PO eNS, of all GABAA receptor subunit mRNAs studied and this is in agreement with 
the in situ hybridization studies described in Chapter 4. The significance of which GABAA 
receptor subunit transcripts are the predominant isoforms during various stages of postnatal 
development is evident in the changes in GABAA receptor pharmacology during 
development. As has been observed in ligand binding studies, benzodiazepine, BZ type II 
receptors, are the predominant form of GABAA receptor subtype found at birth and in the 
early stages of postnatal development. When a subunit variants are transiently co-expressed 
with ~NJP and y2 GABAA receptor subunits in HEK-293 cells, the BZ type II subtype of 
GABAA receptor is observed. BZ I and BZ II receptors distribute unevenly over the rat 
brain. BZ I receptors predominate in the cerebellum. but are rare in the hippocampus (Faull 
and Villiger. 1988, Faull, Villiger and Holford, 1987, Olsen, McCabe and Wamsley 1990). 
In contrast, BZ II receptors are strongly expressed in the hippocampus and nearly absent 
from the cerebellum. Both receptor subtypes are equally expressd in the cortical layers 
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(Faull and Villiger, 1988; Faull, Villiger and Holford 1987; Olsen, McCabe and Wamsley 
1990). BZ type II receptors are also enriched in the striatum and spinal cord (Lo, Strittmatter 
and Snyder, 1983; Olsen and Tobin, 1990, Sieghart et ai., 1985). aR~2y2 receptors have 
similiarly low affinities for CL 218,872 and 2-oxoquazepam as a2~xy2 and aP~xy2 
receptors. However, the binding properties for imidazopyridines like zolpidem and alpidem 
. differ from conventional GABAAIBZ II receptors (Pritchett and Seeburg, 1990), and hence 
sensitivity to these imidazopyridines constitutes a unique subtype of the BZ II receptors. 
Recombinant receptors expressing aS~2y2 in HEK293 cells bind with high affinity 
muscimol and the imidazo-l,4-benzodiazepin, Ro-15-4513. Other benzodiazepines and ~­
carbolines are either not recognized by this receptor or at an affinity two to three orders of 
magnitude lower than that of aI, a2, a.3 or as- containing receptors. 
To add further complexity, Nusser et aI., (1996) have recently demonstrated that some 
subunits of the GABAA receptor expressed in the hippocampus are selectively localized at 
subsets of GABAergic synapses. The a 1 subunit has been found in most GABergic 
synapses on all postsynaptic domains of pyramidal cells. In contrast, the a2 subunit was 
located only in the subset of synapses on the somata and dendrites, but in most synapses on 
axon initial segments innervated by axo-axonic cells. 
7.3.3 Differences in the expression of GABAA receptor subunit mRNAs 
between rat and mouse at PO. 
One striking difference between a GABAA receptor subunit mRNA expression at PO in 
the rat and mouse CNS, is the detection, in the mouse of the a6 subunit transcript in the 
external granule cell layer of the cerebellum. Another example of differences between rat and 
mouse expression of GABAA receptor subunit mRNAs during postnatal development is 
found in the hippocampus, where the "(1 subunit transcript is abundantly expressed in both 
pyramidal cells and dentate granule cells in the PO rat brain, but is absent from all regions of 
the hippocampus in the PO mouse brain. The 12T subunit mRNA was expressed at high 
levels in the dentate granule cells of the PO mouse brain, but was only weakly present in the 
PO rat dentate granule cells. The 13 subunit mRNA was present in the PO mouse cerebellum, 
but was absent from the PO rat cerebellum. Changes in y2 subunit expression during 
development are believed to play a key role in the change from zinc sensitive embryonic 
GABAA receptor responses to zinc insensitive responses in the adult ( Smart et al., 1991; 
Xie and Smart, 1991). 
7.3.4 Differences in the expression of GABAA receptor subunit mRNAs 
between rat and mouse at P6 and P7. 
By postnatal days 6 and 7, the GABAA receptor a.l subunit transcript was abundantly 
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expressed in the murine CNS, while the same transcript was only weakly expressed in the 
P6 rat CNS. a2 transcript expression also differed between the two species. In the P6 rat 
CNS, a2 expression was abundant in the hippocampus, septum, cortex, and various 
thalamic nuclei. In contrast, in the murine P7 CNS, a2 mRNA expression was abundant in 
hippocampal pyramidal cells, but only moderately expressed in dentate gryus granule cells. 
In the P7 mouse, the a2 transcript was weakly expressed in the cortex and and several 
thalamic nuclei. In the P7 mouse CNS, the a6 transcript was also abundantly expressed 
throughout the internal and external granule cell layers, which is in contrast to expression of 
the a6 transcript in the P6 rat cerebellum, where the transcript is found in only the outer 
granule cell layer. 
One of the major differences between rat and mouse GABAA receptor ontogeny occurs 
around postnatal days 6 and 7. At this period in postnatal development, GABAA receptor ~ 
and 1 subunit mRNA expression occurs in the cerebellum, where there is an absence of ~ 1 , 
~PI 11, and y3 expression in the rat. There is also virtually no expression of the 0 subunit in 
the rat P6 CNS, whereas in the mouse CNS, the 0 subunit mRNA can be found in cerebellar 
granule cells, throughout all layers of the cortex and in some thalamic nuclei. 
7.3.5 Differences in the expression of GABAA receptor subunit mRNAs 
between rat and mouse at P12 and P14. 
By P12, the a2 transcript is found in both the rat and mouse cerebellar granule cells. 
While in contrast to the distribution of the a3 subunit in rat (Laurie et al., 1992), the a3 
transcript is absent from mouse CA3 pyramidal cells and dentate gyrus granule cells. By 
P12, the PI subunit is absent from the rat cerebellum, but is expressed at moderate levels in 
mouse P14 cerebellum. This discrepancy is also true for the ~P subunit mRNA, where the 
p3 is abundantly expressed in the mouse P14 cerebellum, but is absent or weakly expressed 
in the rat P12 cerebellum. The 0 subunit mRNA is present in the same distribution and at 
similar levels in the P12 rat and P14 mouse CNS. 
The differences that exist between the development of GABAA receptor subunit mRNAs 
in the rat and mouse central nervous systems will have significant influences on subunit 
combinations and hence GABAA receptor composition. Differences in channel gating and 
desensitization rates are likely to be more important physiologically and have been described 
for several combinations of subunits (Levitan et al., 1988a and b; Saxen and MacDonald 
1994). Recombinantly expressed GABAA receptors consisting of aI, a3 or a mixed ala3, 
coinjected with a ~ and 1 subunit, had up to a five fold range in GABA sensitivity, differing 
sensitivity to diazepam, and different kinetics (Verdoorn 1994). Different subunit 
combinations also have differential sensitivity to endogenous allosteric modulators such as 
zinc and the neurosteroids (Draguhn et aI., 1990; Puia et al., 1991; Smart et al., 1991), and 
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differential phosphorylation by protein kinases (Krishek et aI., 1994). 
7.4 Post-transcriptional Modifications 
The majority of voltage- and ligand-gated channel genes undergo alternative splicing of 
mRNA (a notable exception is the mammalian Shaker potassium channel gene ex subunit). 
Extensive splicing occurs in AMPAlkainate receptors, where AMPA receptors (Glu-R A-D) 
contain a functional module of 38 amino acids in one of two versions, flip or flop. (Sommer 
et aI., 1990b). AMP A1kainate receptor subunits can also have alternate C-terminal sequences 
(Kohler et ai., 1994). The physiological effects of the flip versus flop versions have been 
extensively characterized with in vitro translation systems and also in recordings from 
mammalian brain slices. The overall level of flip versus flop is very similar, but considerable 
regional variations are observed, for instance, CA3 pyramidal cells exhibit exclusive flip 
expression while dentate granule cells have more flop than flip (Sommer et al., 1990b). 
Flip/flop versions are also expressed differentially during development, the flip form being 
expressed at a relatively constant level, and the flop variant increasing during development 
(Monyer, Seeburg and Wisden. 1991). The pharmacological properties of these receptors is 
very similar. except for sensitivity to cyclothiazide, a drug that reduces desensitization 
(Partin. Patneau and Mayer. 1994). The flip form of the receptor yields larger maximal 
responses to glutamate than flop homomultimers, and subunit mixtures exhibit intermediate 
values (Sommer et ai., 1990b). These differences are attributable to differences in rates of 
desensitization, GluR-C and GluR-D receptors showing faster desensitization in the flop 
form then in the flip form (Mossbacher et ai .• 1994; Partin, Patneau and Mayer, 1994). 
Since flop containing receptors can desensitize with a time constant in the region of 1 
millisecond, it has been proposed that such rapid desensitization might shape the decay time 
course of excitatory synaptic interactions (see review by Trussell. Raman and Zhang 1994). 
Measurements of the time course of synaptic currents at different synapses, and using single 
cell PCR analysis. supports the hypothesis that the decay of synaptic currents does depend 
on subunit combination, splice variants and RNA editing (Geiger et ai., 1995). Another 
splice form identified for the AMPA receptor is a C-terminal variant of GluR-D which is 
shorter than the originally described receptor (Gallo et al., 1992). Recently a similar 
phenomenon was described for GluR-B (Kohler, Kornau and Seeburg 1994). The 
functional consequences of these variants is unclear at present. 
A rather novel type of rnRNA processing has been described for the AMPNKA receptor 
family, in which specific nucleotide bases are subject to modification by RNA editing (see 
Seeburg 1996 for review). Single amino acid substitutions can dramatically alter the kinetic 
and calcium permeability of the receptor (see below). AMPAlkainate and serotonin receptors 
are the only eNS proteins that have been shown to undergo RNA editing so far although it 
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has been suggested that sodium channels may undergo a similar process (Simpson and 
Emerson 1996). 
7.4.1 Alternative splice variants of GABAA receptor subunit gene transcripts 
Alternative splice variants appear to be less extensive for GABA receptors, but have been 
observed for mammalian 12, p3 and a6, and in the chick P2 and P4 (Stephenson 1995). 
An exception to this rule is the invertebrate Rdl GABA receptor which shows extensive 
alternative splicing (ffrench-Constant and Rocheleau, 1993). This is rather reminiscent of 
the situation for the potassium channel gene Shaker which is encoded by numerous distinct 
genes in the mammal, but does not give rise to splice variants, and the Drosphila Shaker 
which is a single gene that undergoes multiple splicing events to generate channel diversity 
(Pongs 1994). 
Alternative splicing for p3 occurs at the N-terminal end where there is an alternate exon 
I, called exon la. (Kirkness and Fraser, 1993). The transcripts are of equal length, and 
while they do show different spatial and developmental patterns of expression, a functional 
difference has not yet been observed between these receptors. Among a6 subunit gene 
transcripts, a short form of the mRNA is found which lacked nuc1eotides 226-255 (Korpi et 
al., 1994). Interestingly this 10 amino acid deletion results in a non functional receptor, 
thought to result from the inability of the subunit to assemble. Alternate splicing of the "(2 
and chick P2 and P4 subunits affect a putative intracellular loop between domains ITI and N 
(Bateson et al., 1991; Harvey et al., 1994; Kofuji et al., 1991; Whiting et al., 1990). No 
functional consequences have been reported for the P4 subunit, but 12 and P2 subunits 
contain consensus phosphorylation sites within this domain (Harvey, Chinchetru and 
Darlison, 1994; Kofuji et al., 1991; Whiting, McKernan and Iversen 1990). 
The results presented in Chapter 5 of this thesis, describe the temporal regulation of the 
y2 splice variants in the murine CNS. The y2S splice variant is the only "(2 transcript 
expressed during murine embryonic development. The y2S splice variant is expressed as 
early as Ell in the neocortex, cerebellum primordium and spinal cord of the developing 
CNS. At postnatal day I, the "(2S transcript remains the only "(2 mRNA expressed in the 
cerebral cortex, septum and hippocampus. Expression of the y2L transcript was detected 
only in the day 1 globus pallidus, yet by day 7, the y2L transcript was detected in many other 
regions of the murine CNS including the inferior and superior colliculi, cerebral cortical 
layers 1 through 6, basal nuclei, septum, hippocampal CAl-3 pyramidal cells. In the adult 
murine CNS, the y2L mRNA is the predominant transcript, throughout the murine CNS, 
although co-localization of the two alternatively-spliced y2 transcripts does occur, in several 
regions including the hippocampus, thalamus, colliculi, and cerebral cortex. 
The ontogeny of y2 splice variant expression reported in Chapter 5 of this thesis furthers 
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a study of "{2L and "(2S GABAA receptor subunit mRNA expression in the rat brain reported 
by Gutierrez et at., 1996. In the Gutierrez et ai., (1996) study, in situ hybridization, dot blot 
analysis and quantitative immunocytochemistry were used to study the expression of "{2S 
and "{2L in two month old and 30 month old Sprague-Dawley and Fischer 344 rats. Using 
splice variant specific-"{2 antibodies, they demonstrated a small but significant increase in 
anti-"{2L immunoreactivity in cerebral cortical layers ill-V and in the subiculum, as well as an 
accompanying age-related decrease in "{2S protein expression in these regions. In contrast to 
the changes seen in "{2L protein abundance, there was no increase in "{2L mRNA expression. 
The probe used in the in situ hybridization studies (Gutierrez et ai., 1996) was not splice-
variant specific and therefore only detects changes in overall y2 gene expression. Dot blot 
analysis, however indicated that there were significant decreases in y2S mRNA expression, 
therefore suggesting an increase in "{2L mRNA abundance. Reconstitution of GABAAR in 
heterologous systems has shown that "{2S and "{2L subunits can associate with both a and ~ 
subunits to produce GABAA receptors with high affinity for benzodiazepines in which 
GAB A-induced opening of the CI- channel is potentiated by benzodiazepines (Angelotti et 
al., 1993; Hadingham et al., 1992; Horne, et al., 1992; Moss et al., 1991). Age-related 
changes in GABAA receptor CI- channel properties as well as allosteric interactions among 
subunits have been described (Concas et ai., 1988; Erdo and Wolff, 1989; Mhatre et al., 
1991) and may in part be accounted for changes in GABAA receptor subunit composition 
during aging. 
The role of phosphorylation in the ethanol sensitivity of GABA receptor subunits is an 
interesting, though co.ntroversial story. Ethanol sensitivity maybe related to GABAA 
receptor subunit composition and this hypothesis has been tested in oocytes expressing: 1) 
total RNA from long-sleep (LS) and short-sleep (SS) mice, which differ in the response of 
GABA receptors to ethanol, as well as in the sensitivity of the GABA receptor to 
benzodiazepines (Wafford et al., 1990); and 2) cRNAs encoding mouse 0.1, ~f and "{2L 
subunits (Wafford et ai., 1991). Ethanol sensitivity further depended on the PKC consensus 
site within the splice insert suggesting that phosphorylation was necessary for the effects of 
ethanol (Wafford and Whiting, 1992). Other groups, however, have suggested that the "{2L 
subunit is not necessarY (Kurata et ai., 1993; Sigel, Baur and Malherbe, 1993) for ethanol 
stimulation. In fact, Sigel, Baur and Maherbe, (1993) failed to repeat the results of Wafford 
et ai., (1991) using Xenopus oocytes to measure the ability of ethanol to stimulate, directly 
or indirectly, the response of GABAA 0.1 ~ 1"{2 L receptors to GABA application. Recently. 
Zhai et aI., (1998) demonstrated that there was no affect of ethanol on GABA-evoked 
currents in dissected rat dorsal root ganglion neurons and further demonstrated through RT-
PCR analysis that these neurons contain mRNAs for the "{2L and other GABAA receptor 
subunits. Mutagenesis studies with chimeras of the rho and glycine 0.1 subunit identified 
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two amino acids in transmembranes 2 and 3 that were sufficient for the enhancement of the 
GAB A-activated current via ethanol and volitle anaesthetics (Mihic et aI., 1997). 
The issue of the involvement of the "{2 GABAA subunit and phosphorylation in ethanol 
sensitivity remains to be resolved, but interestingly a recent study of a PKC 'Y null mutant 
mouse has suggested that PKC 'Y is required for the action of ethanol in cerebral cortex and 
cerebellum, at least for some measures of GABA function (Harris et al., 1995). 
7.S Post-translational processes 
As outlined above, it is during the post-translational period that a great number of diverse 
processes occur that can affect channel function. The channel must be assembled from the 
correct constituents to form an appropriate complex, the channel must be transported to an 
appropriate subcellular compartment, the channel must be inserted into the plasma 
membrane, and appropriate glycosylation events must occur. While these events are critical, 
very little is known concerning how these processes occur, how they are controlled and 
whether they can be modulated. Once channel assembly has occurred, however, a form of 
modulation, phosphorylation, can occur and has been extensively studied (Raymond, 
Blackstone and Huganir 1993; Swope et al., 1992). 
Ligand-gated ion channel superfamily members and members of the glutamate receptor 
family have canonical phosphorylation sites. For instance, all GABAA receptor ~ subunits 
have a consensus site for PKA phosphorylation, corresponding to serine 409 in ~ 1 (Swope 
et al., 1992;Ymer et al., 1989), and this residue can be phosphorylated by PKA or PKC 
(Moss, Doherty and Huganir,1992). The GABAA receptor y2 subunit, as discussed above, 
has two serine phosphorylation sites, one of which is missing in the y2S splice variant 
(Moss, Doherty and Huganir, 1992; Whiting, McKernan and Iversen, 1991). These sites 
are found on the intracellular loop between M3 and M4. Phosphorylation sites for tyrosine 
kinases and CaMK IT have also been identified (Pritchett et ai., 1989; McDonald and Moss, 
1994). There are also potential sites for PKC phosphorylation on a4, a6, 5, pI and p 2 
(Macdonald 1995). The action of PKA activation, in cells transiently expressing GABAA 
receptors, was to decrease the sensitivity to GABA (Moss et al., 1992), an effect similar to 
that seen in vivo for cultured mouse spinal neurons (Porter et al., 1990). Phosphorylation 
by PKC of a 1 ~ 1 or a 1 ~ 1"{2 receptor combinations expressed in oocytes or HEK293 cells 
also led to a decrease in GABA response, although these effects were dependent on the level 
of endogenous kinase activity (Krishek et al., 1994). The effects could be abolished by 
mutagenesis of the serine sites 409 E~NFD 327("{2) and 343(y2). The most potent site for 
phosphorylation was contained in the 8 amino acid segment unique to y2L. Similar effects 
were seen in acutely dissociated hippocampal neurons on application of phorbol esters 
(Stelzer, 1992). In contrast to these studies, recombinant al~ly2 receptors transiently 
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expressed in L929 cells are potentiated by activation of PKA or PKC (Angelotti, Uhler and 
Macdonald, 1993; Lin et al.. 1994). The effect of phosphorylation on GABA receptor 
function is therefore quite dependent on the expression system employed, and suggests that 
kinases can achieve bidirectional modulation of GABAA receptors. Recently Moss et al., 
(1995) have shown that a tyrosine kinase (vSRC) can enhance GABA whole-cell currents in 
HEK293 cells. Tyrosine residues in both ~ and y2L were phosphorylated, but the y2L 
subunit was critical for the enhancement of GABA currents. Similar effects were seen in 
cultured ganglionic neurons, and the tyrosine kinase inhibitor, genistein, reduced native 
GABA currents. These data suggest that constitutive phosphorylation of GABAA receptors 
is physiologically important, at least in some cell types. In Chapter 5, in situ hybridisation 
results indicate that during later stages of postnatal development and in the adult murine 
CNS, the y2L alternative-splice variant of the y2 GABAA receptor subunit mRNA is the 
predominant splice variant and therefore suggests that in a cell type specific manner GABAA 
responses are subject to modulation by phosphorylation through PKA or tyrosine kinase 
pathways. 
The effects of phosphorylation on ligand-gated ion channel receptor responses have also 
been reported for other members of the ligand-gated ion channel superfamily. For example, 
the nAChR has phosphorylation sites for protein kinase A (PKA), protein kinase C (PKC), 
and tyrosine kinases. Phosphorylation can accelerate the rate of receptor desensitization 
(Steinbach and Zempel, 1987), although this effect may not be universal (Cachelin and 
Colquhoun 1989). Phosphorylation may also playa part in receptor clustering at synaptic 
sites (Swope et ai., 1992). Phosphorylation of the glutamate receptors is quite widespread 
and has been proposed to play an important function as a possible mediator of synaptic 
plasticty (Roche, Tingley and Huganir, 1994). Phosphorylation of NMDA receptors via 
tyrosine kinases increases channel activity while phosphatase mediated dephosphorylation 
reduces activity (Lieberman and Mody, 1994; Wang et ai., 1994; Wang and Salter, 1994). 
PKC activity can also potentiate NMDA responses, but in this case by reducing Mg++ block 
(Chen and Huang 1992). Interestingly some of the consensus phosphorylation sites lie 
within regions that are alternatively spliced (Tingley et al., 1993). AMPA receptors are 
potentiated by PKA (Greengard et al., 1991), and synaptic transmission can be potentiated 
by activators of PKA (Chavez-Noriega and Stevens, 1994). PKC and Ca++/calmodulin-
dependent protein kinase IT (CaMK IT) have also been shown to phosphorylate AMPA 
receptors, leading to enhanced activity (Tan, Wenthold and Soderling, 1994). Hence 
phosphorylation can play key roles in desensitization, distribution and function. 
7.6 Molecular basis of subunit diversity 
Members of the ligand-gated ion channel superfamily are thought to be derived from a 
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common ancestral protein (Hille 1992) which may have arisen around 2,500 million years 
ago (Ortells and Lunt, 1995). The idea of common ancestry has given rise to the expectation 
that structure-function concepts might be generally applied to all members of the 
superfamily, and possibly to the closely related glutamate receptor family. Two key areas 
have been the focus of extensive study and they include: 1) what amino acid sequences and 
structures determine the properties of the ion channel pore and; 2) which amino acid residues 
are involved in forming the ligand binding site. The initial predicted secondary structure of 
the GABAA receptor is presented in Chapter 1, Figure 1.3. 
7.6.1 Ion selectivity in the ligand-gated ion channel superfamily 
The substituted-cysteine accessibility method (SCAM) has been used to probe the 
structure of ion channel pores. Individual residues are mutated to cysteine and a sulphydryl 
specific reagent is used to label the cysteine. If the residue is located within the ion channel 
pore then addition of the sulphydryl agent will alter agonist induced responses. Using this 
method Akabas et ai., (1994) have extensively investigated the M2 region of the nAChR a 
subunit. Examining residues 241-262 they found that GIU241, Thr244, Leu245, Ser248, 
Leu250, Leu251, Ser252, Va1255, Leu258 and GIU262 were all exposed in the channel lumen. 
These data are compatible with the M2 segment forming a helix (Numa, 1989), but with 
three amino acids in an extended conformation. These data are consistent with an a helical 
structure for M2, that has been proposed from diffraction X-ray crystalography for the 
acetylcholine receptor (Unwin, 1995). A similar though much less extensive analysis has 
been attempted with the GABAA receptor (Xu and Akabas, 1993). Residues 268-271 were· 
mutated to cysteine and labelled with a charged sulphydryl reagent. Although these data are 
limited they are consistent with an a helical structure and inconsistent with a ~ sheet 
conformation. Using sulphydryl reagents of varying sizes these authors have also suggested 
that the GABA channel is narrower than the nAChR channel (Xu and Akabas, 1993; Akabas 
et ai., 1992). 
The results reported in Chapter 6 of this thesis suggest that the conserved proline in Ml 
of GABAA receptor subunits can play a pivotal role in channel gating. Mutation of the 
al243pro-ala residue in Ml of the GABAA receptor al subunit and co-expression with wild-
type ~N and y2L subunits in transiently transfected HE293 cells resulted in a K<i for Ro15-
1788 binding that was not statistically different from receptors containing wild-type ~ 1, y2L 
subunits only. Western blot analysis of a 1 243pro-ala, ~NI y2L HEK membrane preparations 
demonstrated that the mutated al protein was absent from these preparations and suggests 
that the al subunit in a GABAA receptor complex is essential for efficient membrane 
integration. Mutation of the conserved Ml proline in the ~N subunit resulted in a K<i for 
Ro 15-1788 binding similar to that for a wild-type ai, ~ 1, y2L subunit combination. but the 
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K<t for muscimol binding of receptors containing the mutated ~ 1243pro-a1a subunit was 
significantly different from the K<t for wild-type GABAA receptor muscimol binding. The 
Bmax for muscimol receptor binding did not differ between the mutant ~N24PproJaNa and wild-
type receptor combinations indicating a true change in agonist affinity for the mutant receptor 
complex. Single channel recordings of GABAA aN~NE24PproJalaFy2i receptors acutely 
expressed in L929 fibroblasts demonstrated increases; 1) in channel conductance, 2) in the 
mean burst duration, and 3) in the number of openings per burst compared with the wildtype 
receptor combination (Greenfield et al., unpublished results). Acutely transfected L929 cells 
expressing the al ~N24PproJalay2i subtype demonstrated selectively reduced sensitivity to 
barbiturates, suggesting a role for the ~ subunit in barbiturate-induced enhancement of 
GABAA receptor currents. Whole cell patch recordings from HEK293 cells expressing the 
aI, ~ 1243pro-ala and y2L subunits demonstrated that currents elicited by application of 100 
J.1.M GABA were blocked by 100 J.1.M bicuculline and potentiated by 50 J.1.M diazepam 
(Zaman, 1993) and the ECso for GABA was statistically greater than wild-type (Zamin, 
1993), an observation which is in agreement with the binding results reported in Chapter 6 
of this thesis. 
In contrast to the possibility that there are shared or overlapping sites of action for GABA 
and barbiturates, Amin and Weiss (1993) created several mutations which provide evidence 
suggesting separate sites of binding for GABA and its modulators. For example two regions 
between the cysteine loop and the Ml transmembrane domain of the ~2 subunit, threonine 
(T160, T202) and tyrosine (Y157, Y205) residues, through site-directed mutagenesis have 
been identified as critical sites for the activation of currents by GABA but not by . 
pentobarbital. Mutation of either tyrosine led to a 50-fold decrease in GABA binding, while 
mutating either threonine decreased binding by 20 fold. Similar mutations in a or y were 
ineffectual. Since there was no effect on the maximal GABA activated current the authors 
concluded that gating efficiency was not impaired, and this was further supported by the 
observation that barbiturates could activate the mutant channel as effectively as wild type. 
These findings imply that the pentobarbital site is physically distinct from the GABA binding 
site. Our results demonstrate that mutation of ~N24PproJala affects the GABA binding site, as 
well as receptor assembly when the identical mutation is in the a1 subunit. The mutation in 
the ~ 1 subunit does not affect the ability of the receptor complex to integrate into the plasma 
membrane, as there was no change in the Bmax between mutant and wild-type aI, ~ I, y2L 
GABAA receptors. The effect of the proline mutation in the ~ subunit on both agonist and 
barbiturate binding suggests that the proline residue provides a pivotal point in the receptor 
complex which facilitates an allosteric interaction and the subsequent reorientation of the pore 
region into an open state. 
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7.6.2 Molecular determinants of the ligand binding site 
As illustrated above, analysis of GABA receptor ligand binding domains is rather more 
complex because of the diverse nature of interactions that have been characterized for these 
receptors. In addition to the expected agonist and antagonist binding domains one must also 
take into account the benzodiazepine site, barbiturate site and the steroid site. Initial studies 
used photoaffinity labeling and suggested that muscimol labeled the ~JsubunitI while 
flunitrazepam binding was localized to the a-subunit (Casalotti, Stephenson and Barnard, 
1986). A number of questions have been raised, however, concerning the validity of these 
findings, based mainly on difficulties in resolving individual components of the GABA 
receptor on the basis of molecular weight. Heterologous expression studies indicate that co-
expression of a and ~ subunits forms functional channels, but modulation by 
benzodiazepines is not seen unless 'Y is also present (Pritchett, Luddens and Seeburg, 1990; 
Knoflach et al., 1991). These data suggest that the a subunit alone does not confer 
benzodiazepine responsiveness. Sigel et al., (1992) have shown that residue Phe64 in the 
al subunit strongly affects both agonist and antagonist binding. This is interesting because 
this residue is located considerably closer to the N-terminus than those previously suggested 
to be involved in ligand interaction for nAChR or glycine receptors. A homologous mutation 
in the ~ subunit had a similar but smaller effect on GABA binding (30 fold versus 200 fold), 
while the effect in the 'Y subunit was small (6 fold change). This site can also be 
photoaffinity labeled by [3H]muscimol (Smith and Olsen, 1994). In contrast to these data, 
however, Amin and Weiss (1993) suggest that the ~ subunit is key to agonist binding, thus 
supporting previous photoaffinity labeling studies. 
The benzodiazepine binding site is quite complex in that not only does it show a normal 
spectrum of agonist, partial agonist and antagonist binding, it also is a site for inverse 
agonists i.e ligands that decrease the effectiveness of GABA (Macdonald and Olsen, 1994; 
Schofield et al., 1987). Early evidence from photoaffinity labelling indicated that the a 
subunit was the site of [3H]-flunitrazepam binding (Casalotti, Stephenson and Barnard 1986; 
Sieghart and Karobath, 1980), but the observation that a~ subunits expressed in oocytes 
showed benzodiazepine insensitive GABA responses led to a reevaluation of these data. Use 
of subunit specific antibodies, however, has confirmed these earlier observations, with 
mapping experiments indicating a region between residues 59-148 in the a subunit 
(Stephenson and Duggan,1989; Stephenson, Duggan and Pollard, 1990). Furthermore the 
benzodiazepine pharmacology of heterologously expressed a~"E2 subunit combinations 
depends on which of the a subunits is present (Benke et ai., 1991 b; Pritchett et ai., 1990). 
One of these a subunits a6 only binds benzodiazepine antagonists and inverse agonists 
(Luddens et at., 1990). Exploiting this interesting property the structural determinants of 
benzodiazepine binding were probed (Wieland, Luddens and Seeburg, 1992). It was found 
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that His 101 was a critical detenninant of binding. Replacing His with Arg (the equivalent a6 
residue) abolished diazepam binding. The effect was not dependent on pH indicating that 
charge properties were less important than steric factors. This mutation also determines 
whether GABA activated ion currents are potentiated by diazepam (Kleingoor et al., 1993). 
The reverse mutation in a6 ArglOO to His generated benzodiazepine sensitive receptors. 
Similar effects were seen with the antagonist flumazenil and with the type I specific ligand 
CL 218872. Zolpidem, which binds to a 1 with high affinity, a2 and a3 with intermediate 
affinity, and a4, as, and a6 with negligible affinity, did not bind to the mutant ai, but also 
did not bind to a6 with the His residue substitution. This indicates that other residues are 
important for zolpidem binding. In support of a role for other residues Pritchett and Seeburg 
(1991) found that mutating Glu-225 to GlY225 in a3 significantly increased the affinity for 
CL 218872. Mutation in the y2 subunit (Thq42 to Ser) can also affect benzodiazepine 
interactions, but in this case the effect appears to be to alter the efficiency of coupling binding 
to allosteric modulation (Mihic et ai., 1994). This mutation did not affect barbiturate or 
steroid modulation of GABA action. 
In Chapter 6 of this thesis we found that mutation of the conserved aspartic acid residue 
in the cysteine loop of a 1 and ~ 1 subunits to asparagine could have an effect on 
benzodiazepine binding and the ability of the receptor complex to integrate into the plasma 
membrane. In the experiment including a mutant a 1 O-N and wt~ 1 and wty2L subunits, 
neither Ro 15-1788 or muscimol binding was detected. Western blot analysis of membrane 
preparations used in the receptor binding analysis, demonstrated that immunoreactive 
products were present for both the a 1 and ~ 1 subunits, and mRNA analysis confirmed the 
presence of all three subunit (a 1, ~ 1, and y2L) mRNAs in the transiently transfected cells. 
The presence of GABAA receptor protein in the membrane preparations, but a lack of Ro 15-
1788 and muscimol binding suggests that this site in the cysteine loop can playa role in both 
agonist and antagonist binding. 
Conservation of the negative charge at the aspartic acid site in the cysteine loop of the ~ 1 
subunit (149D-E) resulted in receptors that were identical to the wild-type receptors in Ro15-
1788 binding affinity suggesting that charge rather then steric hindrance plays a key role in 
detennining the affinity of benzodiazepines at that site. In further comparison of wild-type 
and mutant receptors containing the ~ 1 D-E subunit, there was a signifcant decrease in the 
Bmax, and lack of muscimol binding for the mutant receptor membrane preparations. As 
discussed earlier, a decrease in the Bmax suggests that the assembly or efficient trafficking of 
the GABAA receptor complex was impaired. An increase in affinity for Ro 15-1788 in the 
mutant receptor containing the ~ 1 O-N subunit further suggests that the aspartic acid site in the 
cysteine loop plays a role in antagonist binding. 
In comparison to our results, Amin et al., (1994) also found that mutation of al and y2 
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GABAA receptor subunits to glutamic acid (conservative change) at the aspartic acid position 
in the cysteine loop resulted in either no impairment of GAB A-mediated activation or a slight 
decrease in the ECsQ, when al. ~2 and 12 subunit cRNAs were co-expressed in Xenopus 
oocytes. Similar to our results with the ~faJk mutation. Amin et ai., (1994) found that 
substitution of the aspartic acid position in the cysteine loop with asparagine in the ~2 
subunit resulted in no GAB A-activated currents. In Xenopus oocyte experiments, 
substitution of aspartic acid for glutamic acid (conservation of charge) in the ~2 subunit 
resulted in GAB A-activated currents, where there was no effect on the ECsQ, a dramatic 
decrease in the amplitude of the current and a decrease in the Hill coefficient. suggesting a 
decrease in the cooperativity of channel activation (Amin et ai .• 1994). Mutations involving 
changes to amino acids at positions 5 (leucine) and position 9 (proline) in the cysteine loop 
of the ~2 GABAA receptor subunit, when co-expressed in Xenopus oocytes with wild-type 
aI, 12 subunits generally resulted in only a slight impairment in activation of the GABA 
channel, suggesting that this impairment may occur indirectly through structural alterations 
of the protein (Amin et at., 1994). Our studies further the concept that multiple residues in 
both a and ~ subunits play key roles in determining the benzodiazepine binding site of 
GABAA receptors. 
In this thesis we have described the ontogeny of GABAA receptor subunits in the 
embryonic and postnatal murine CNS using RT-PCR and in situ hybridization analysis and 
compared these results with those reported for rat GABAA receptor subunit ontogeny. To 
further our understanding of the role conserved amino acids play in the binding sites for 
agonists and antagonists of GABAA receptors we employed site-directed mutagens is 
coupled with heterologous expression of mutant and wild-type subunits in HEK293 cells to 
determine binding affinities as well as GABAA receptor subunit mRNA and protein 
expression. 
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